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I. PROXY STATEMENT, LETTER TO SHAREHOLDERS 
 
 
June 14, 2017  
MERGER PROPOSAL—YOUR VOTE IS VERY IMPORTANT  
Dear Reynolds American Inc. Shareholders:  
British American Tobacco p.l.c., referred to as BAT, and Reynolds American Inc., referred 
to as RAI, have entered into an Agreement and Plan of Merger, dated as of January 16, 2017, as 
it and the plan of merger contained therein were amended as of June 8, 2017, and as it and the 
plan of merger contained therein may be further amended from time to time, referred to as the 
merger agreement, under which an indirect, wholly owned subsidiary of BAT will be merged 
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with and into RAI, and RAI will continue as the surviving corporation in the merger and an 
indirect, wholly owned subsidiary of BAT, referred to as the merger. If the merger is completed, 
RAI shareholders (other than BAT and its subsidiaries and excluded holders, as defined in the 
accompanying proxy statement/prospectus) will receive, in exchange for each share of RAI 
common stock owned immediately prior to the merger, (1) a number of BAT American 
Depositary Shares, referred to as BAT ADSs, representing 0.5260 of a BAT ordinary share plus 
(2) $29.44 in cash, without interest, collectively referred to as the merger consideration. Based 
on the number of shares of RAI common stock and BAT ordinary shares (excluding treasury 
shares) outstanding as of June 12, 2017, and the total number of shares of RAI common stock 
issuable under outstanding RAI equity awards that are expected to be settled for BAT ADSs in 
connection with the merger, it is expected that, immediately after completion of the merger, 
former RAI shareholders (other than BAT and its subsidiaries) will own approximately 19% of 
BAT’s share capital. The currently outstanding BAT ADSs have unlisted trading privileges on 
the New York Stock Exchange MKT, referred to as the NYSE MKT, where they trade under the 
trading symbol “BTI” (but, at or prior to the completion of the merger, all BAT ADSs will be 
listed on the New York Stock Exchange, referred to as the NYSE, for trading under the symbol 
“BTI”), and the shares of RAI common stock are currently listed on the NYSE, under the trading 
symbol “RAI.”  
RAI will hold a special meeting of its shareholders to vote on certain matters in connection 
with the merger. Attendance at the special meeting will be limited as more fully described in the 
accompanying proxy statement/prospectus. Admittance tickets will be required for the special 
meeting.  
RAI shareholders are cordially invited to attend the special meeting of RAI shareholders. The 
special meeting will be held at 9:00 a.m. (Eastern Time), on July 19, 2017, in the Reynolds 
American Plaza Building Auditorium at RAI’s corporate offices, 401 North Main Street, 
Winston-Salem, North Carolina 27101. At the special meeting, RAI shareholders will be asked 
to vote on the approval of the merger agreement, including the plan of merger contained therein. 
In addition, RAI shareholders will be asked to vote on the approval of, on a non-binding, 
advisory basis, the compensation payments that will or may be paid by RAI or BAT to RAI’s 
named executive officers and that are based on or otherwise relate to the merger and the 
agreements and understandings pursuant to which such compensation may be paid or become 
payable, referred to as the transaction-related named executive officer compensation, and to vote 
on the approval of the adjournment of the special meeting, if necessary or appropriate, to solicit 
additional proxies if there are not sufficient votes to approve the merger agreement.  
The exchange of the merger consideration for RAI common stock in the merger generally 
will be a taxable transaction to U.S. holders (as defined in “Special Factors Relating to RAI 
Proposal I: Approval of the Merger Agreement—Material U.S. Federal Income Tax 
Consequences”) for U.S. federal income tax purposes and may also be taxable under state, local 
and non-U.S. income and other tax laws. We encourage RAI shareholders to carefully review the 
information under “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Material U.S. Federal Income Tax Consequences” beginning on page 137 of the 
accompanying proxy statement/prospectus for a description of material U.S. federal income tax 
consequences of the merger.  
BAT currently holds approximately 42% of RAI’s outstanding common stock through its 
wholly owned subsidiaries, Brown & Williamson Holdings, Inc., a Delaware corporation and 
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indirect, wholly owned subsidiary of BAT, referred to as B&W, and Louisville Securities 
Limited, a private limited company incorporated under the laws of England and Wales and an 
indirect, wholly owned subsidiary of BAT, referred to as Louisville. As described in “Special 
Factors Relating to RAI Proposal I: Approval of the Merger Agreement—Position of BAT and 
Merger Sub as to the Fairness of the Merger” BAT does not believe it controls RAI for purposes 
of North Carolina corporate law.  
We cannot complete the merger without the approval of the merger agreement by RAI 
shareholders, including approval by holders of a majority of the outstanding shares of RAI 
common stock entitled to vote and present (in person or by proxy) and voting at the special 
meeting that are not owned by BAT or its subsidiaries or RAI’s subsidiaries. The Series B 
preferred stock of RAI, all of which is owned by a wholly owned subsidiary of RAI, is not 
entitled to vote. It is important that your shares of RAI common stock be represented and 
voted regardless of the size of your holdings. Whether or not you plan to attend the special 
meeting, we urge you to submit a proxy to have your shares of RAI common stock voted in 
advance of the special meeting by using one of the methods described in the accompanying 
proxy statement/prospectus.  
RAI, BAT and B&W are parties to a governance agreement pursuant to which entry into the 
transactions contemplated by the merger agreement, including the merger, requires the approval 
of a majority of the independent directors of RAI other than directors designated for nomination 
by B&W. In furtherance of this requirement, on October 28, 2016, the RAI board of directors 
appointed a transaction committee, consisting of all of the independent directors of RAI at that 
time other than directors designated for nomination by B&W, referred to as the Transaction 
Committee, to review and evaluate the merger and RAI’s other available strategic alternatives. 
Following extensive arm’s-length negotiations with BAT, the Transaction Committee 
unanimously approved, adopted and authorized the merger agreement and determined that the 
merger is fair to and in the best interests of RAI and its shareholders (other than BAT and its 
affiliates) and recommended that the RAI board of directors approve, adopt and authorize the 
merger agreement, including the merger and the other transactions contemplated thereby.  
The RAI board of directors recommends that RAI shareholders vote “FOR” the 
approval of the merger agreement, “FOR” the approval, on a non-binding, advisory basis, 
of the transaction-related named executive officer compensation and “FOR” the 
adjournment of the special meeting, if necessary or appropriate, to solicit additional 
proxies if there are not sufficient votes to approve the merger agreement.  
The accompanying proxy statement/prospectus provides important information regarding the 
special meeting and a detailed description of the merger agreement, the merger and the matters to 
be presented at the special meeting. We urge you to read the accompanying proxy 
statement/prospectus, including all documents incorporated by reference into the 
accompanying proxy statement/prospectus, and its annexes carefully and in their entirety. 
Please pay particular attention to “Risk Factors” beginning on page 154 of the 
accompanying proxy statement/prospectus.  
We hope to see you at the special meeting and look forward to the successful completion of 








    
  Susan M. Cameron     
  Chairman of the Board     
  Reynolds American Inc.   
 
  
II. PROXY DISCUSSION OF BASIC INFORMATION ON THE TRANSACTION, 
INCLUDING A SUMMARY  
 
A. ABOUT THIS PROXY STATEMENT/PROSPECTUS (YOU MAY WANT 
TO REFER TO THIS SECTION WHEN READING THE SUMMARY UNDER 
1.2.B, BELOW)  
This proxy statement/prospectus, which forms part of the registration statement on Form F-
4 filed by BAT with the U.S. Securities and Exchange Commission, constitutes a prospectus of 
BAT under Section 5 of the Securities Act of 1933, as amended, with respect to the BAT 
ordinary shares (which will be represented by BAT ADSs) to be issued to RAI shareholders as 
the stock portion of the merger consideration. This proxy statement/prospectus also constitutes a 
proxy statement for RAI under Section 14(a) of the Securities Exchange Act of 1934, as 
amended. In addition, it constitutes a notice of meeting with respect to the special meeting of 
RAI shareholders.  
You should rely only on the information contained in or incorporated by reference into this 
proxy statement/prospectus. No one has been authorized to provide you with information that is 
different from that contained in, or incorporated by reference into, this proxy 
statement/prospectus. This proxy statement/prospectus is dated June 14, 2017. You should not 
assume that the information contained in this proxy statement/prospectus is accurate as of any 
date other than that date. You should not assume that the information incorporated by reference 
into this proxy statement/prospectus is accurate as of any date other than the date of such 
information. The mailing of this proxy statement/prospectus to RAI shareholders shall not create 
any implication to the contrary.  
This proxy statement/prospectus shall not constitute an offer to sell, or the solicitation 
of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or 
from any person to whom it is unlawful to make any such offer or solicitation. Information 
contained in this proxy statement/prospectus regarding BAT has been provided by BAT 
and information contained in this proxy statement/prospectus regarding RAI has been 
provided by RAI.  
This proxy statement/prospectus is not a prospectus published in accordance with the 
Prospectus Rules made under Part VI of the United Kingdom Financial Services and 
Markets Act 2000 (as set out in the Financial Conduct Authority Handbook), referred to as 
the UK Prospectus Rules. BAT intends to publish a prospectus as required by the UK 
Prospectus Rules, in connection with its proposed issue of BAT ordinary shares, and 
application for admission to list such shares on the premium listing segment of the Official 
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List of the UKLA and to trading on the main market for listed securities of the LSE. A 
copy of such prospectus may be obtained at BAT’s website (www.bat.com) following 
approval by the UKLA. BAT also intends to mail to BAT shareholders a shareholder 
circular relating to the general meeting of BAT’s shareholders to be held for the purpose of 
obtaining the approval of holders of BAT ordinary shares of the merger agreement and the 
applicable transactions contemplated thereby, and authorization for directors of BAT to 
allot and issue the BAT ordinary shares underlying the BAT ADSs constituting the stock 
portion of the merger consideration. The web address of BAT has been included as an 
inactive textual reference only. The BAT prospectus, circular and website are not 
incorporated by reference into, and do not form a part of, this proxy statement/prospectus.  
Unless otherwise indicated or as the context otherwise requires, all references in this proxy 
statement/prospectus to:  
  
  
•   “acquisition facility” refer to the term loan facilities agreement, dated as of January 16, 
2017, among B.A.T. International Finance p.l.c. and B.A.T Capital Corporation, as 
original borrowers, BAT, as guarantor, HSBC Bank plc, as agent, HSBC Bank USA, 
National Association, as U.S. agent and the lenders and financial institutions party 
thereto, providing for unsecured and unsubordinated term loan facilities in an aggregate 
principal amount of up to $25.0 billion for the purpose of financing the merger, paying 
related taxes, fees, costs and expenses and refinancing an existing revolving credit 
facility of RAI;  
  
  •   “ADRs” refer to American depositary receipts that evidence ADSs;  
  
  •   “ADSs” refer to American depositary shares;  
  
  
•   “Amended and Restated Omnibus Plan” refer to the Reynolds American Inc. Amended 
and Restated 2009 Omnibus Incentive Compensation Plan;  
 
  
•   “B&W” refer to Brown & Williamson Holdings, Inc., f/k/a Brown & Williamson 




•   “B&W business combination” refer to the combination of the U.S. assets, liabilities and 
operations, other than certain specified assets and liabilities, of BAT’s wholly owned 
subsidiary, B&W, with RJR Tobacco Company in July 2004;  
  
  
•   “BAT” refer to British American Tobacco p.l.c., a public limited company incorporated 
under the laws of England and Wales;  
  
  
•   “BAT ADSs” refer to BAT’s American depositary shares, each of which represents one 





•   “BAT ADS ratio change” refer to the change from each BAT ADS representing two 
BAT ordinary shares to each BAT ADS representing one BAT ordinary share as of 
February 14, 2017;  
  
  •   “BAT board of directors” refer to the board of directors of BAT;  
  
  
•   “BAT circular” refer to the shareholder circular relating to the general meeting of BAT’s 
shareholders to be held for the purpose of obtaining the approval of holders of BAT 
ordinary shares of the merger agreement and the applicable transactions contemplated 
thereby, and authorization for directors of BAT to allot and issue the BAT ordinary 
shares underlying the BAT ADSs constituting the stock portion of the merger 
consideration, in each case on a poll by the holders of not less than a majority of BAT 
ordinary shares, present in person or by proxy who are entitled to vote at such BAT 
general meeting;  
  
  •   “BATGET” refer to the BAT Group Employee Trust;  
  
  •   “BAT Group” refer collectively to BAT and its subsidiaries;  
  
  
•   “BAT Group management board” refer to the members of the management board of the 
BAT Group as described in “Business of BAT—Directors and Management Board—BAT 
Group Management Board” beginning on page 276 of this proxy statement/prospectus;  
  
  
•   “BAT ordinary shares” refer to ordinary shares, nominal value 25 pence per share, of 
BAT;  
  
  •   “BAT parties” refer to BAT, Louisville, B&W, BATUS and Merger Sub;  
  
  •   “BAT pension fund” refer to the British American Tobacco p.l.c. Pension Fund;  
  
  
•   “BAT prospectus” refer to the BAT prospectus relating to the admission of the BAT 
ordinary shares underlying the BAT ADSs constituting the stock portion of the merger 
consideration to the premium listing segment of the Official List of the UKLA and to 
trading on the main market for listed securities of the LSE;  
  
  
•   “BAT shareholder approval” refer to the approval of holders of BAT ordinary shares of 
the merger agreement and the applicable transactions contemplated thereby as a Class 1 
transaction and authorization for directors of BAT to allot and issue the BAT ordinary 
shares underlying the BAT ADSs constituting the stock portion of the merger 
consideration, in each case, on a poll by the holders of not less than a majority of BAT 
ordinary shares, present in person or by proxy who are entitled to vote at the BAT 
shareholders’ meeting;  
  





•   “cash-out RSU” refer to each RAI RSU and each RAI performance share, in each case, 




•   “cash in lieu of fractional BAT ADSs” refer to the cash payment that holders of RAI 
common stock are entitled to receive in lieu of fractional BAT ADSs. Under the terms of 
the merger agreement such cash payment equals the product obtained by multiplying 
(1) the amount of the net proceeds (less any commissions, transfer taxes and out-of-
pocket costs and expenses of the exchange agent) from the sale on the NYSE of the 
excess of (a) the aggregate number of BAT ADSs (rounded up to the nearest whole 
number) to be issued as the stock portion of the merger consideration over (b) the 
aggregate whole number of BAT ADSs to be distributed to holders of shares of RAI 
common stock by (2) a fraction, the  
 
  
numerator of which is the amount of the fractional BAT ADSs to which such holder of 
shares of RAI common stock is entitled (after taking into account all shares of RAI 
common stock exchanged by such holder) and the denominator of which is the aggregate 
amount of fractional BAT ADSs to which all applicable holders of RAI common stock 
are entitled;  
  
  •   “Centerview” refer to Centerview Partners UK LLP;  
  
  
•   “Class 1 transaction” refer to a transaction for a listed company, the size of which results 
in a 25% threshold being reached under any one of the class tests set out in the UK 
Listing Rules;  
  
  •   “Code” refer to the U.S. Internal Revenue Code of 1986, as amended;  
  
  •   “combined company” refer to the BAT Group after the completion of the merger;  
  
  •   “completion date” refer to the completion date of the merger;  
  
  
•   “continuing employee” refer to employees of the RAI Group that remain as employees of 




•   “DCP” refer to the Deferred Compensation Plan for Directors of Reynolds American 
Inc.;  
  





•   “deposit agreement” refer to the Amended and Restated Deposit Agreement, dated as of 
December 1, 2008, and amended as of February 14, 2017, and as further amended from 
time to time, among BAT, Citibank, N.A., as depositary bank, and all holders and 
beneficial owners from time to time of BAT ADSs issued thereunder;  
  
  •   “Deutsche Bank” refer to Deutsche Bank AG, London Branch;  
  
  
•   “Divestiture” refer to the acquisition by a wholly owned subsidiary, n/k/a ITG Brands, 
LLC, of Imperial Brands, PLC, f/k/a Imperial Tobacco Group, PLC, on June 12, 2015, of 
certain assets (1) owned by certain RAI subsidiaries or affiliates relating to the cigarette 
brands WINSTON, KOOL and SALEM, and (2) owned by certain Lorillard subsidiaries 
or affiliates relating to the cigarette brand MAVERICK and the “e-vapor” brand BLU 
(including SKYCIG), as well as Lorillard’s owned and leased real property, and certain 
transferred employees, together with associated liabilities;  
  
  •   “DOJ” refer to the U.S. Department of Justice;  
  
  




•   “EIAP” refer to the Equity Incentive Award Plan for Directors of Reynolds American 
Inc.;  
  
  •   “ESP” refer to the Reynolds American Inc. Executive Severance Plan;  
  
  •   “EURIBOR” refer to Euro Interbank Offered Rate;  
  
  •   “EV” refer to enterprise value;  
  
  •   “Exchange Act” refer to the U.S. Securities Exchange Act of 1934, as amended;  
  
  •   “exchange agent” refer to Citibank, N.A., as exchange agent for the merger;  
  
  
•   “excluded holders” refer to holders of shares of RAI common stock who have not voted, 
or caused or permitted to be voted, any shares of RAI common stock in favor of the 
approval of the merger agreement at the special meeting and who have properly asserted 
(and not lost or effectively withdrawn) their rights of appraisal in accordance with Article 
13 of NCBCA (however, in the case of the RAI Savings Plan and the Puerto Rico SIP, 
the trustee of the RAI Savings Plan and the custodian of the Puerto Rico SIP shall be 
treated as excluded holders with respect to shares of RAI common stock as to which such 
trustee or custodian has exercised appraisal rights even though such trustee or custodian 
may have voted other shares in the applicable plan in favor of approval of the merger 
agreement);  
  




  •   “FDA” refer to the U.S. Food and Drug Administration;  
 
  •   “FII GLO” refer to Franked Investment Income Group Litigation Order;  
  
  
•   “foreign private issuer” refer to a foreign company that qualifies as a “foreign private 
issuer” as defined in Rule 3b-4(c) of the Exchange Act and Rule 405 of the Securities 
Act—a company ceases to be a “foreign private issuer” at such time as more than 50% of 
its outstanding voting securities are directly or indirectly held of record by U.S. residents 
and any of the following circumstances applies: (1) the majority of its executive officers 
or directors are U.S. citizens or residents, (2) more than 50% of its assets are located in 
the United States or (3) its business is administered principally in the United States;  
  
  •   “FSMA” refer to the UK Financial Services Market Act 2000;  
  
  •   “FTC” refer to the U.S. Federal Trade Commission;  
  
  •   “FTSE” refer to Financial Times Stock Exchange;  
  
  
•   “global drive brands” refer to DUNHILL, KENT, LUCKY STRIKE, PALL MALL and 
ROTHMANS, collectively;  
  
  
•   “governance agreement” refer to the governance agreement, dated as of July 30, 2004, as 
amended, among RAI, BAT and B&W;  
  
  •   “Goldman Sachs” refer to Goldman Sachs & Co. LLC, f/k/a Goldman, Sachs & Co.;  
  
  












•   “IFRS” refer to International Financial Reporting Standards as issued by the International 
Accounting Standards Board;  
  
  
•   “IFRS (EU)” refer to International Financial Reporting Standards as adopted by the 
European Union;  
  
  •   “J.P. Morgan” refer to J.P. Morgan Securities LLC;  
  





•   “Key Markets” refer to Americas, Western Europe, Eastern Europe, Middle East, Asia 
and Asia-Pacific;  
  
  •   “key strategic brands” refer to STATE EXPRESS 555 and SHUANG XI;  
  
  •   “Lazard” refer to Lazard Frères & Co. LLC;  
  
  •   “LIBOR” refer to London Interbank Offered Rate;  
  
  
•   “Lorillard” refer to Lorillard, LLC, a Delaware limited liability company and a wholly 
owned subsidiary of RAI, f/k/a Lorillard, Inc., a Delaware corporation;  
  
  
•   “Lorillard merger” refer to the acquisition by RAI of Lorillard on June 12, 2015, in a 
cash and stock transaction;  
  
  
•   “Louisville” refer to Louisville Securities Limited, a private limited company 
incorporated under the laws of England and Wales and an indirect, wholly owned 
subsidiary of BAT;  
  
  •   “LSE” refer to London Stock Exchange plc;  
  
  




•   “menthol regulatory action” refer to any law, judgment or action enacted, promulgated, 
proposed or threatened by the FDA or any other governmental entity that could have the 
effect of banning or materially restricting the use of menthol in any product sold or 
distributed by RAI or BAT or any of their respective subsidiaries;  
 
  
•   “merger” refer to the merger of Merger Sub with and into RAI; as a result of the merger, 
the separate corporate existence of Merger Sub will cease, and RAI will continue as the 
surviving corporation in the merger and an indirect, wholly owned subsidiary of BAT. 
Upon the completion of the merger, all of the title to all real estate and other property 
owned by each of RAI and Merger Sub will vest in RAI as the surviving corporation, and 




•   “merger agreement” refer to the Agreement and Plan of Merger, dated as of January 16, 
2017, as it and the plan of merger contained therein were amended as of June 8, 2017, 
and as it and the plan of merger contained therein may be further amended from time to 
time, among BAT, BATUS, RAI and Merger Sub, a copy of which is attached as Annex 





•   “merger consideration” refer to the consideration, per share of RAI common stock, to be 
received in the merger by RAI shareholders (other than the BAT Group and excluded 
holders), consisting of:  
  
  
•   a number of BAT ADSs representing 0.5260 of a BAT ordinary share (the “stock 
portion of the merger consideration”), plus  
  
  •   $29.44 in cash, without interest (the “cash portion of the merger consideration”);  
  
  
•   “Merger Sub” refer to Flight Acquisition Corporation, a North Carolina corporation and 
an indirect, wholly owned subsidiary of BAT;  
  
  
•   “MSA” refer to the Master Settlement Agreement, dated as of November 23, 1998, 
among 46 U.S. states, the District of Columbia and five U.S. territories listed on the 
signature pages thereto, Philip Morris Incorporated, RJR Tobacco Company, B&W, 
Lorillard Tobacco Company, LLC, f/k/a Lorillard Tobacco Company, and various 
subsequent participating manufacturers listed on the National Association of Attorneys 
General’s list of “Participating Manufacturers,” as amended, supplemented or replaced;  
  
  •   “NCBCA” refer to the North Carolina Business Corporation Act;  
  
  
•   “next generation products” refer, in relation to BAT’s view of such products, to any 
tobacco or nicotine product developed to offer adult tobacco consumers potentially less 
risky alternatives to smoking conventional cigarettes and include (1) vapor products 
(such as e-cigarettes), which are battery powered electronic devices which heat a solution 
to create a vapor which can be inhaled, and (2) tobacco heating products, which are 
battery powered electronic devices that operate with specifically designed consumables 
containing tobacco, to deliver a real tobacco taste and aroma, and, in relation to RAI’s 
view of such products, to the above-mentioned products as well as (a) any device that 
employs a chemical reaction or combustible, carbonaceous fuel source for heat 
generation to produce an aerosol from a physically separate source and (b) products that 
contain nicotine for therapeutic purposes (such as products characterized as gums, 
lozenges and inhalers that are intended to be nicotine replacement therapy, referred to as 
NRT, products, and products characterized as devices that are intended to be used for 
NRT purposes);  
  
  •   “NYSE” refer to the New York Stock Exchange;  
  
  •   “NYSE MKT” refer to the NYSE MKT;  
  
  
•   “Other Directors” refer to the independent directors, as defined in the governance 
agreement, of RAI (other than any independent directors designated for nomination by 
B&W), and references to Other Directors comprising the Transaction Committee refer to 
such independent directors of RAI as of October 28, 2016 and cease to include Thomas 
C. Wajnert following his retirement from the RAI board of directors effective as of the 




  •   “PCAOB” refer to the U.S. Public Company Accounting Oversight Board;  
  
  •   “plan of merger” refer to the plan of merger contained in the merger agreement;  
  
  
•   “Puerto Rico SIP” refer to the Puerto Rico Savings & Investment Plan sponsored by 
RAI;  
  
  •   “RAI” refer to Reynolds American Inc., a North Carolina corporation;  
 
  
•   “RAI-Lorillard merger agreement” refer to the Agreement and Plan of Merger, dated as 
of July 15, 2014, among Lorillard, RAI and Lantern Acquisition Co., a Delaware 
corporation and wholly owned subsidiary of RAI;  
  
  
•   “RAI articles of incorporation” refer to the Restated Articles of Incorporation of RAI, 
effective as of May 5, 2016;  
  
  •   “RAI board of directors” refer to the board of directors of RAI;  
  
  
•   “RAI bylaws” refer to the Amended and Restated Bylaws of Reynolds American Inc., 
dated December 1, 2016;  
  
  
•   “RAI change in control” refer to a “change in control” or “change of control” (or other 
similar phrase) within the meaning of the RAI severance and equity incentive 
arrangements;  
  
  •   “RAI common stock” refer to RAI common stock, par value $0.0001 per share;  
  
  
•   “RAI DSU” refer to each RAI deferred stock unit that is payable in shares of RAI 
common stock or the value of which is determined with reference to the value of shares 
of RAI common stock;  
  
  
•   “RAI governance committee” refer to the RAI board of directors’ Corporate Governance 
and Nominating Committee;  
  
  •   “RAI Group” refer collectively to RAI and its subsidiaries;  
  
  •   “RAI’s financial advisors” refer to J.P. Morgan and Lazard;  
  
  
•   “RAI performance share” refer to any RAI performance share award subject to 
performance-based vesting, payable in shares of RAI common stock;  
  





•   “RAI retention RSU” refer to three RAI RSU grants that were made prior to the date of 
the merger agreement that will be assumed, and will not vest and settle upon the 
completion of the merger;  
  
  
•   “RAI RSU” refer to any RAI restricted stock unit award subject solely to time-based 
vesting and not performance-based vesting (other than performance-based vesting only 
for purposes of Section 162(m) of the Code), payable in shares of RAI common stock;  
  
  •   “RAI Savings Plan” refer to the RAI 401k Savings Plan;  
  
  
•   “RAI shareholder approvals” refer to (1) the approval of the merger agreement by the 
affirmative vote of the holders of a majority of the outstanding shares of RAI capital 








•   “Remuneration Policy” refer to the forward-looking remuneration policy for BAT 
directors and former directors, as approved at the 2016 annual general meeting of BAT;  
  
  
•   “RJR Tobacco Company” refer to R. J. Reynolds Tobacco Company, a North Carolina 
corporation and an indirect, wholly owned subsidiary of RAI;  
  
  
•   “rollover RSU” refer to each RAI RSU or RAI performance share that, in either case, is 
not a cash-out RSU;  
  
  
•   “RSU exchange ratio” refer to the sum of (1) 0.5260 plus (2) the quotient of (a) $29.44 
over (b) the closing price of one BAT ADS on the last trading date preceding the 
completion date as reported on the NYSE MKT;  
  
  •   “SEC” refer to the U.S. Securities and Exchange Commission;  
  
  •   “Securities Act” refer to the U.S. Securities Act of 1933, as amended;  
  
  •   “SFNTC” refer to Santa Fe Natural Tobacco Company, Inc.;   
  
•   “share issuance” refer to the issuance of BAT ordinary shares represented by BAT ADSs 
to holders of RAI common stock (other than the BAT Group or excluded holders) as the 
stock portion of the merger consideration;  
  
  
•   “share repurchase agreement” refer to the Share Repurchase Agreement, dated as of 
July 25, 2016, as it may be amended from time to time, among B&W, Louisville and 
RAI;  
  




  •   “SIP” refer to the British American Tobacco p.l.c. Employee Share Ownership Plan;  
  
  
•   “special meeting” refer to the special meeting that RAI will hold for its shareholders to 
vote on certain matters in connection with the merger, and is the meeting to which this 
proxy statement/prospectus relates;  
  
  
•   “State Settlement Agreements” refer to the MSA, together with settlement agreements 
with the states of Mississippi, Florida, Texas and Minnesota;  
  
  
•   “tobacco litigation” refer to United States v. Philip Morris, et al., No. 99-02496 
(D.D.C.), and any other actions or judgments regarding any health or other impacts or 
alleged health or other impacts, including impacts cognizable under the Racketeer 
Influenced and Corrupt Organizations Act, from the development, manufacture, 
distribution, sale, advertising, marketing and/or use of any tobacco product (including 
products that are derived from tobacco, such as products containing tobacco-derived 
nicotine), including for the avoidance of doubt any and all actions or judgments 
regarding the presence of or exposure to smoke from any tobacco product;  
  
  
•   “Transaction Committee” refer to the special committee formed by the RAI board of 
directors, initially formed to review and evaluate BAT’s initial October 20, 2016 
proposal, the merger and RAI’s other available strategic alternatives consisting of all of 
the Other Directors as of October 28, 2016, but which ceased to include Thomas C. 
Wajnert following his retirement from the RAI board of directors effective as of the close 
of business on December 31, 2016;  
  
  
•   “transaction-related named executive officer compensation” refer to the compensation 
payments that will or may be paid by RAI or BAT to RAI’s named executive officers 
and that are based on or otherwise relate to the merger and the agreements and 
understandings pursuant to which such compensation may be paid or become payable;  
  
  •   “Transaction Committee’s financial advisor” refer to Goldman Sachs;  
  
  •   “Treasury” refer to the U.S. Department of the Treasury;  
  
  •   “UBS” refer to UBS Limited;  
  
  
•   “UKLA” refer to the FCA acting in its capacity as the competent authority for the 
purposes of Part VI of FSMA;  
  
  
•   “unaffiliated shareholder approval” refer to the approval of the merger agreement by the 
affirmative vote of the holders of a majority of the shares of RAI common stock that are 
entitled to vote as of the RAI record date and present (in person or by proxy) and voting 






•   “Unaffiliated Shareholders” refer to the holders of RAI capital stock other than the BAT 




•   “UK Regulations” refer to the Large and Medium-size Companies and Group (Accounts 
and Reports) (Amendment) Regulations 2013;  
  
  •   “U.S. GAAP” refer to U.S. Generally Accepted Accounting Principles; and  
  
  •   “UURBS” refer to the unfunded approved retirement benefit scheme sponsored by BAT.  
All brands, unless otherwise noted, referred to herein are trademarks owned or licensed by the 
BAT Group or the RAI Group, as applicable.  
When used in describing aspects of the BAT Group’s business, reference to volume is an 
unaudited operating measure and is calculated as the total global cigarette volume of the BAT 
Group’s brands sold by its subsidiaries.  
References to the price of the BAT ADSs prior to February 14, 2017 are adjusted to give effect 
to the BAT ADS ratio change unless otherwise indicated.  
References to “ton” refer to metric tonnes.  
Presentation of Financial Information  
This proxy statement/prospectus contains or is accompanied by:  
  
  
•   the unaudited consolidated financial statements of BAT for the year ended December 31, 
2014, prepared on the basis of IFRS;  
  
  
•   the audited consolidated financial statements of BAT as of December 31, 2016 and 2015 
and for each of the years in the two-year period ended December 31, 2016, prepared on 
the basis of IFRS (together with the unaudited consolidated financial statements of BAT 
for the year ended December 31, 2014, referred to in this proxy statement/prospectus as 
the BAT Group’s consolidated financial statements);  
  
  
•   the unaudited condensed consolidated financial statements of RAI as of March 31, 2017, 
and for the three months ended March 31, 2017 and 2016, prepared on the basis of U.S. 
GAAP (referred to in this proxy statement/prospectus as the RAI Group’s unaudited 
condensed consolidated financial statements); and  
  
  
•   the audited consolidated financial statements of RAI as of December 31, 2016 and 2015 
and for each of the years in the three-year period ended December 31, 2016, prepared on 
the basis of U.S. GAAP (referred to in this proxy statement/prospectus as the RAI 
Group’s consolidated financial statements).  
Unless indicated otherwise, financial data presented in this proxy statement/prospectus has 
been taken from the BAT Group’s consolidated financial statements, the RAI Group’s 
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consolidated financial statements and the RAI Group’s unaudited condensed consolidated 
financial statements included in and attached to, respectively, this proxy statement/prospectus.  
BAT’s financial statements for 2014, which were prepared in accordance with IFRS (EU), 
are included on BAT’s website and can be found at http://www.bat.com/bat2014financials. 
These financial statements start on page 121 and the audit report can be found on page 120. 
These financial statements, which were prepared in accordance with IFRS (EU), are the same as 
those that would be prepared using IFRS (IASB). They were audited by PricewaterhouseCoopers 
LLP, referred to as PwC, in accordance with International Standards on Auditing (UK and 
Ireland). PwC issued its report on those statements on February 25, 2015. At the time its report 
was issued, PwC was independent under the Financial Reporting Council’s Ethical Standards 
and the International Ethics Standards Board for Accountants’ Code of Ethics. PwC is no longer 
independent under such standards. Accordingly, PwC could neither issue nor consent to the 
issuance of an audit report on the financial statements of BAT for 2014. These financial 
statements and the audit report thereon, included on BAT’s website, are not incorporated by 
reference into this proxy statement/prospectus and should not be considered to be part of this 
proxy statement/prospectus.  
This proxy statement/prospectus also contains the unaudited pro forma condensed 
combined financial information of BAT as of and for the year ended December 31, 2016 after 
giving effect to the merger, referred to in this proxy statement/prospectus as Pro Forma Financial 
Information. See “BAT Unaudited Pro Forma Condensed Combined Financial Information” 
beginning on page 351 of this proxy statement/prospectus.  
 
The financial information set forth in this proxy statement/prospectus has been rounded for 
ease of presentation. Accordingly, in certain cases, the sum of the numbers in a column in a table 
may not conform to the total figure given for that column.  
For additional information on the presentation of financial information in this proxy 
statement/prospectus, see the BAT Group’s consolidated financial statements beginning on page 
FIN-1 of this proxy statement/prospectus and the RAI Group’s consolidated financial statements 
and the RAI Group’s unaudited condensed consolidated financial statements, attached as Annex 
G and Annex H to this proxy statement/prospectus, respectively.  
Exchange Rates  
BAT publishes its consolidated financial statements in pounds sterling, while RAI publishes 
its consolidated financial statements in U.S. dollars. In this proxy statement/prospectus, 
references to “$,” “U.S. dollars” or “USD” are to the lawful currency of the United States of 
America, references to “£,” “pounds sterling,” “pence” or “GBP” are to the lawful currency of 
the United Kingdom, references to “Cdn$” and “Canadian dollars” are to the lawful currency of 
Canada, references to “€” or “euro” are to the single currency adopted by participating member 
states of the European Union, referred to as the EU, relating to Economic and Monetary Union, 
references to “Swiss franc” and “CHF” are to the lawful currency of Switzerland, references to 
“R$” and “Brazilian real” are to the lawful currency of Brazil, references to “South African 
rand” are to the lawful currency of South Africa and references to “Korean Won” are to the 
lawful currency of South Korea.  
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References to the “Sterling-Dollar exchange rate” refer to the pound sterling—U.S. dollar 
exchange rate as quoted by the Bloomberg Composite Rate on such date at the time of LSE 
market close, except (1) in relation to October 20, 2016 where it refers to the pound sterling—
U.S. dollar exchange rate as quoted by the Bloomberg Composite Rate on such date at 9:00 p.m. 
UK time and (2) where another time is specified, in which case it refers to the pound sterling—
U.S. dollar exchange rate as quoted by the Bloomberg Composite Rate on such date at such 
specified time.  
The following table sets forth the high and low noon buying rates of each month of the last 
six months, as certified for customs purposes by the Federal Reserve Bank of New York, for the 
pound sterling expressed in U.S. dollars per pound sterling.  
  
Period    High     Low   
December 2016      1.2708      1.2222  
January 2017      1.2620      1.2118  
February 2017      1.2643      1.2427  
March 2017      1.2583      1.2152  
April 2017      1.2938      1.2398  
May 2017      1.3018      1.2795  
The following table sets forth for each year the average of the noon buying rates on the last 
business day of each month of that year, as certified for customs purposes by the Federal Reserve 
Bank of New York, for the pound sterling expressed in U.S. dollars per pound sterling for each 
of the five most recent fiscal years.  
  
Period    Average  
Year ended December 31, 2012      1.5924  
Year ended December 31, 2013      1.5668  
Year ended December 31, 2014      1.6461  
Year ended December 31, 2015      1.5250  
Year ended December 31, 2016      1.3444  
On June 9, 2017, the latest practicable date prior to this filing, the noon buying rate was 
£1.00 = $1.2737.  
 
The rates presented above may differ from the actual rates used in preparation of financial 
information appearing in this proxy statement/prospectus. The presentation of such rates is not 
meant to suggest that the U.S. dollar amounts actually represent the pound sterling amounts or 
that such amounts could have been converted to U.S. dollars at any particular rate.  
Industry Data  
References to market share are the BAT Group’s estimates based on the latest available data 
from a number of internal and external sources.  
U.S. industry shipment volume and retail market share data that appear in this proxy 
statement/prospectus have been obtained from Management Science Associates, Inc., referred to 
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as MSAi. This information is included in this proxy statement/prospectus because it is used 
primarily as an indicator of the relative performance of industry participants, brands and market 
trends. All U.S. market share results that appear, except as noted otherwise, in this document are 
based on U.S. cigarette (or smokeless tobacco products, as applicable) shipments to retail outlets, 
referred to as STR data, based on information submitted by wholesale locations and processed 
and managed by MSAi. However, you should not rely on the STR data reported by MSAi as 
being a precise measurement of actual market share as the shipments to retail outlets do not 
reflect actual consumer sales and do not track all volume and trade channels. Accordingly, the 
STR data of the U.S. tobacco industry as reported by MSAi may overstate or understate actual 
market share. Moreover, you should be aware that in a product market experiencing overall 
declining consumption, a particular product can experience increasing market share relative to 





This summary highlights selected information from this proxy statement/prospectus. It may 
not contain all of the information that is important to you. You are urged to read this entire 
proxy statement/prospectus and the other documents referred to or incorporated by reference 
into this proxy statement/prospectus in order to fully understand the merger and the merger 
agreement. See “Where You Can Find More Information” beginning on page 445 of this proxy 
statement/prospectus. Each item in this summary refers to the beginning page of this proxy 
statement/prospectus on which that subject is discussed in more detail.  
The Companies (See page 198)  
British American Tobacco p.l.c.  
BAT is the parent holding company of the BAT Group, a global tobacco and next 
generation products group with brands sold in over 200 markets. According to the BAT Group’s 
internal estimates, the BAT Group is a market leader in more than 55 countries by volume, 
producing the cigarette chosen by one in eight of the world’s one billion smokers. The BAT 
Group, excluding the BAT Group’s associated undertakings, is organized into four regions: Asia-
Pacific, Americas, Western Europe and Eastern Europe, Middle East and Africa, referred to as 
EEMEA.  
The BAT Group manufactures and sells traditional tobacco products, which are composed 
of cigarettes, fine cut (roll-your-own and make-your-own tobacco), Swedish-style snus and 
cigars, alongside next generation products, including vapor products and tobacco heating 
products. The BAT Group’s five global drive brands are DUNHILL, KENT, LUCKY STRIKE, 
PALL MALL and ROTHMANS. The BAT Group’s cigarette portfolio also includes other 
international and local brands, such as VOGUE, VICEROY, KOOL, PETER STUYVESANT, 
CRAVEN A, BENSON & HEDGES, JOHN PLAYER GOLD LEAF, STATE EXPRESS 555 
and SHUANG XI.  
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BAT has had a significant global presence in the tobacco industry for over 100 years. The 
British-American Tobacco Company Ltd., referred to as BAT Ltd., was incorporated in 1902, 
when the Imperial Tobacco Company and the American Tobacco Company agreed to form a 
joint venture company. BAT Ltd. inherited companies and quickly expanded into major markets, 
including India and Ceylon, Egypt, Malaya, Northern Europe and East Africa. In 1927, BAT Ltd. 
expanded into the U.S. market through its acquisition of B&W. During the 1960s, 1970s and 
1980s, the BAT Group diversified its business under the umbrella of B.A.T Industries p.l.c., with 
acquisitions in the paper, cosmetics, retail and financial services industries, among others. 
Various business reorganizations followed as the business was eventually refocused on the BAT 
Group’s core cigarette, cigars and tobacco products businesses with British American Tobacco 
p.l.c. becoming a separately listed entity on the LSE in 1998.  
In July 2004, the U.S. assets, liabilities and operations, other than certain specified assets 
and liabilities, of BAT’s wholly owned subsidiary, B&W, were combined with RJR Tobacco 
Company. RAI was previously formed as a new holding company for these combined 
businesses. In connection with the B&W business combination, B&W acquired beneficial 
ownership of approximately 42% of RAI’s outstanding common stock. In June 2015, in 
connection with the Lorillard merger, the BAT Group invested $4.7 billion to maintain its 
approximate 42% equity position in RAI following the Lorillard merger.  
BAT’s ordinary shares are listed on the LSE under the trading symbol “BATS” and are 
classified as a premium listing. BAT ordinary shares also have a secondary listing on the JSE 
under the abbreviated name “BATS” and the trading symbol “BTI.”  
BAT ordinary shares trade in the form of BAT ADSs in the United States. The currently 
outstanding BAT ADSs have unlisted trading privileges on the NYSE MKT where they trade 
under the trading symbol “BTI.” None of BAT’s securities are currently listed on any U.S. 
securities exchange or registered pursuant to the securities laws of the United States.  
BAT’s principal executive offices are located at Globe House, 4 Temple Place, London 
WC2R 2PG, United Kingdom, and its telephone number is +44 (0) 207 845 1000. BAT’s 
website address is www.bat.com. The web address of BAT has been included as an inactive 
textual reference only. BAT’s website and the information contained therein or connected thereto 
are not intended to be incorporated into this proxy statement/prospectus.  
Flight Acquisition Corporation  
Flight Acquisition Corporation, referred to as Merger Sub, is a North Carolina corporation 
and an indirect, wholly owned subsidiary of BAT. Merger Sub was incorporated on January 12, 
2017, solely for the purpose of effecting the merger. It has not carried on any activities to date, 
except for activities incidental to its formation and activities undertaken in connection with the 
transactions contemplated by the merger agreement. Merger Sub’s principal executive offices are 
located at Wells Fargo Capitol Center, Suite 2300, 150 Fayetteville Street, Raleigh, North 
Carolina 27601, and its telephone number is (919) 821-6731.  
Reynolds American Inc.  
RAI, the parent company of the RAI Group, is a holding company whose wholly owned 
operating subsidiaries include the second largest tobacco company in the United States, RJR 
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Tobacco Company; SFNTC, the manufacturer and marketer of the NATURAL AMERICAN 
SPIRIT brand of cigarettes and other tobacco products in the United States; the second largest 
smokeless tobacco products manufacturer in the United States, American Snuff Company, LLC; 
R. J. Reynolds Vapor Company, referred to as RJR Vapor, a marketer of digital vapor cigarettes 
in the United States; Niconovum USA, Inc. and Niconovum AB, marketers of nicotine 
replacement therapy products in the United States and Sweden, respectively; and until their sale 
on January 13, 2016, SFR Tobacco International GmbH, referred to as SFRTI, and various 
foreign subsidiaries affiliated with SFRTI, distributors and marketers of the NATURAL 
AMERICAN SPIRIT brand of cigarettes and other tobacco products outside the United States.  
RAI’s reportable operating segments include the RJR Tobacco segment, the Santa Fe 
segment and the American Snuff segment:  
  
  
•   The RJR Tobacco segment consists of the primary operations of RJR Tobacco Company 
and includes three of the top four best-selling cigarettes in the United States: 
NEWPORT, CAMEL and PALL MALL. These brands, and RJR Tobacco’s other 
brands, including DORAL, MISTY and CAPRI, are manufactured in a variety of styles 
and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco 
offers a smokeless tobacco product, CAMEL Snus. RJR Tobacco manages contract 
manufacturing of cigarettes and tobacco products through arrangements with BAT 
affiliates, and manages the export of tobacco products to U.S. territories, U.S. duty-free 
shops and U.S. overseas military bases. In the United States, RJR Tobacco also manages 
the premium cigarette brands DUNHILL, which RJR Tobacco Company licenses from 
the BAT Group, and STATE EXPRESS 555, which RJR Tobacco Company licenses 
from CTBAT International Co. Ltd., referred to as CTBAT, a joint venture between the 
BAT Group and China National Tobacco Corporation, referred to as CNTC.  
  
  
•   The Santa Fe segment consists of the primary operations of SFNTC and includes the 
manufacturing and marketing of premium cigarettes and other tobacco products under 
the NATURAL AMERICAN SPIRIT brand in the United States.  
  
  
•   The American Snuff segment consists of the primary operations of American Snuff 
Company, LLC. American Snuff is the second largest smokeless tobacco products 
manufacturer in the United States,  
 
  
and offers adult tobacco consumers a range of differentiated smokeless tobacco products, 
primarily moist snuff. The moist snuff category is divided into premium, price-value and 
popular-price brands. American Snuff’s primary brands include its largest selling moist 
snuff brands, GRIZZLY, in the price-value category, and KODIAK, in the premium 
category.  
Included in All Other, among other RAI subsidiaries, are RJR Vapor, Niconovum USA, 
Inc., Niconovum AB, and until their sale on January 13, 2016, SFRTI and various foreign 
subsidiaries affiliated with SFRTI.  
RAI was incorporated in the State of North Carolina on January 2, 2004, and its common 
stock is listed on the NYSE under the trading symbol “RAI.” RAI’s headquarters are located at 
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401 North Main Street, Winston-Salem, North Carolina 27101, and its telephone number is 
(336) 741-2000. RAI’s website address is www.reynoldsamerican.com. The web address of RAI 
has been included as an inactive textual reference only. RAI’s website and the information 
contained therein or connected thereto are not intended to be incorporated into this proxy 
statement/prospectus.  
Special Meeting (See page 200)  
General  
The special meeting will be held at 9:00 a.m. (Eastern Time), on July 19, 2017, in the 
Reynolds American Plaza Building Auditorium at RAI’s corporate offices, 401 North Main 
Street, Winston-Salem, North Carolina 27101. At the special meeting, RAI shareholders will be 
asked to vote on the approval of the merger agreement. In addition, RAI shareholders will be 
asked to vote on the approval of, on a non-binding, advisory basis, the transaction-related named 
executive officer compensation and to vote on the approval of the adjournment of the special 
meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes 
to approve the merger agreement.  
The approval of the merger agreement by RAI shareholders, including the unaffiliated 
shareholder approval, is a condition to the obligations of BAT and RAI to complete the merger. 
The approval, on a non-binding, advisory basis, of the transaction-related named executive 
officer compensation is not a condition to the obligations of BAT or RAI to complete the merger. 
The approval of the adjournment of the special meeting, if necessary or appropriate, to solicit 
additional proxies if there are not sufficient votes to approve the merger agreement also is not a 
condition to the obligations of BAT or RAI to complete the merger.  
Record Date  
The RAI board of directors has fixed the close of business on June 12, 2017, as the RAI 
record date, for determination of the RAI shareholders entitled to vote at the special meeting and 
any adjournment or postponement thereof. Only RAI record holders on the RAI record date are 
entitled to receive notice of, and to vote at, the special meeting or any adjournment or 
postponement thereof.  
As of the RAI record date, there were 1,426,422,676 shares of RAI common stock 
outstanding and entitled to vote at the special meeting, held by approximately 11,529 record 
holders. As of the RAI record date, there were 1,000,000 shares of Series B preferred stock of 
RAI, all of which is owned by a wholly owned subsidiary of RAI and are not entitled to vote. Of 
the 1,426,422,676 shares of RAI common stock outstanding and entitled to vote at the special 
meeting, 825,054,505 shares are not owned, directly or indirectly, by the BAT Group or any of 
RAI’s subsidiaries. Pursuant to the terms of the merger agreement, BAT has agreed to cause all 
shares of RAI common stock held by the BAT Group to be voted in favor of approval of the 
merger agreement and the other proposals to be considered at the special meeting. However, 
while the shares of RAI common stock held by the BAT Group will be included for purposes of 
determining whether, as required by law, a majority of the outstanding shares of RAI capital 
stock have approved the merger agreement, completion of the merger also requires receipt of the 
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unaffiliated shareholder approval. Each outstanding share of RAI common stock is entitled to 





A quorum of shareholders is necessary to hold a valid meeting. The record holders, present 
in person or by proxy at the special meeting, of a majority of the shares of RAI common stock 
entitled to vote constitute a quorum. Abstentions and broker non-votes will be counted in 
determining the existence of a quorum.  
Required Vote  
  
Item        Vote Necessary* 
RAI Proposal I 
   
Approval of the Merger Agreement 
   
Approval requires the affirmative vote, 
in person or by proxy, of holders of a 
majority of the outstanding shares of 
RAI capital stock entitled to vote as of 
the RAI record date. The Series B 
preferred stock of RAI, all of which is 
owned by a wholly owned subsidiary 
of RAI, is not entitled to vote. 
  
Approval also requires obtaining the 
unaffiliated shareholder approval, 
which requires the affirmative vote of 
a majority of the outstanding shares of 
RAI common stock that are entitled to 
vote as of the RAI record date and 
present (in person or by proxy) and 
voting at the special meeting that are 
not owned by the BAT Group or any 
of RAI’s subsidiaries. 
   
RAI Proposal II 
   
Non-Binding, Advisory Vote on 
Transaction-Related Named Executive 
Officer Compensation 
   
Approval requires the affirmative vote 
of holders of a majority of the shares 
of RAI common stock that are entitled 
to vote as of the RAI record date and 
present (in person or by proxy) and 
voting at the special meeting. 
   
RAI Proposal III 
   
Adjournment of Special Meeting 
   
Approval requires the affirmative vote 
of holders of a majority of the shares 
of RAI common stock that are entitled 
to vote as of the RAI record date and 
present (in person or by proxy) and 




* Under the rules of the NYSE, if you hold your shares of RAI common stock in street name, 
your nominee or intermediary may not vote your shares without instructions from you. Without 
your voting instructions, a broker non-vote will occur on RAI Proposal I, RAI Proposal II and 
RAI Proposal III. Abstentions from voting and broker non-votes will have the same effect as a 
vote “AGAINST” approval of the merger agreement by holders of a majority of the 
outstanding shares of RAI capital stock entitled to vote as of the RAI record date; however, 
abstentions from voting and broker non-votes will have no effect on determining whether the 
unaffiliated shareholder approval is obtained. Abstentions and broker non-votes will have no 
effect on RAI Proposal II or RAI Proposal III.  
Share Ownership of and Voting by RAI Directors and Executive Officers  
At the RAI record date, RAI’s directors and executive officers and their affiliates 
beneficially owned and had the right to vote 1,648,567 shares of RAI common stock at the 
special meeting, which represents less than 1.00% of the shares of RAI common stock entitled to 
vote at the special meeting.  
  
RAI’s directors and executive officers intend to vote their shares “FOR” the approval of the 
merger agreement, “FOR” the approval, on a non-binding, advisory basis, of the transaction-
related named executive officer compensation and “FOR” the approval of the adjournment of 
the special meeting, if necessary or appropriate, to solicit additional proxies if there are not 
sufficient votes to approve the merger agreement.  
The Merger and the Merger Agreement (See page 207)  
The merger agreement provides that, on the terms and subject to the conditions in the 
merger agreement, and in accordance with the NCBCA, upon the completion of the merger, 
Merger Sub will merge with and into RAI. As a result of the merger, the separate corporate 
existence of Merger Sub will cease, and RAI will continue as the surviving corporation in the 
merger and an indirect, wholly owned subsidiary of BAT. The merger will not be completed 
without the approval of the merger agreement by RAI shareholders, including the unaffiliated 
shareholder approval.  
A copy of the merger agreement is attached as Annex A to this proxy statement/prospectus. 
You are urged to read the merger agreement in its entirety because it is the legal document 
that governs the merger. See “Special Factors Relating to RAI Proposal I: Approval of the 
Merger Agreement” and “The Merger Agreement” beginning on pages 41 and 207, respectively, 
of this proxy statement/prospectus.  
Assuming the satisfaction (or, to the extent legally permissible, waiver) of the conditions to 
BAT’s and RAI’s obligations to complete the merger, BAT and RAI expect the merger to be 
completed on or about July 25, 2017. However, the merger is subject to various conditions, and it 
is possible that factors outside the control of BAT and RAI could result in the merger being 
completed at a later time, or not at all. An end date of December 31, 2017, after which the parties 
may terminate the merger agreement, has been set for the completion of the merger, subject to an 
extension of five business days if, on December 31, 2017, BAT has not completed all or any 
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portion of the financing it needs to fund the merger and the transactions contemplated by the 
merger agreement. Financing, however, is not a condition to the completion of the merger.  
What RAI Shareholders Will Receive in the Merger (See page 208)  
If the merger is completed, each share of RAI common stock (other than shares of RAI 
common stock owned by the BAT Group or excluded holders) automatically will be converted 
into the right to receive the merger consideration, consisting of (1) a number of BAT ADSs 
representing 0.5260 of a BAT ordinary share plus (2) $29.44 in cash, without interest. No 
fractional BAT ADSs will be issued in the merger, and RAI shareholders will receive cash in 
lieu of fractional BAT ADSs.  
Based on the closing price of a BAT ordinary share of £47.63 and the Sterling-Dollar 
exchange rate of 1.2056, in each case, on January 16, 2017, the last trading day of the BAT 
ordinary shares before the public announcement of the merger agreement, the merger 
consideration represented approximately $59.64 in value per share of RAI common stock. Based 
on the closing price of a BAT ordinary share of £54.62 and the Sterling-Dollar exchange rate of 
1.2662, in each case, on June 12, 2017, the most recent practicable trading day prior to the date 
of this proxy statement/prospectus, the merger consideration represented approximately $65.82 
in value for each share of RAI common stock. Because the merger agreement provides for a 
fixed number of BAT ADSs and BAT ordinary shares underlying those BAT ADSs to be 
issued as part of the consideration payable in exchange for each share of RAI common 
stock, the value of the merger consideration that RAI shareholders will receive will depend 
on the market price of BAT ordinary shares underlying such BAT ADSs and the Sterling-
Dollar exchange rate at the time the merger is completed. As a result, the value of the 
merger consideration that RAI shareholders will receive upon the completion of the merger 
could be greater than, less than or the same as the value of the merger consideration on the 




BAT’s Purposes and Reasons for the Merger (See page 54)  
For the factors considered by the BAT board of directors in approving the merger 
agreement, see “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—BAT’s Purposes and Reasons for the Merger” beginning on page 54 of this proxy 
statement/prospectus.  
RAI’s Purposes and Reasons for the Merger; Recommendation of the Transaction 
Committee; Recommendation of the RAI Board of Directors (See page 62)  
The Transaction Committee, after extensive negotiations with BAT, unanimously 
(1) determined that entering into the merger agreement and completing the merger and the other 
transactions contemplated by the merger agreement are fair to and in the best interests of RAI 
and its shareholders (other than BAT and its affiliates), (2) approved, adopted and authorized the 
merger agreement, including the merger and the other transactions contemplated thereby, 
(3) recommended to the RAI board of directors that the RAI board of directors approve, adopt 
and authorize the merger agreement, including the merger and the other transactions 
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contemplated thereby, (4) recommended that RAI shareholders approve the merger agreement 
and (5) declared the merger agreement and the merger advisable.  
The RAI board of directors (other than Mr. Abelman and Mr. Oberlander, who recused 
themselves from all discussion and consideration of the merger), having received the unanimous 
approval and recommendation of the Transaction Committee, (1) adopted the merger agreement, 
including the merger and the other transactions contemplated thereby, (2) determined that the 
terms of the merger and the other transactions contemplated by the merger agreement are fair to 
and in the best interests of RAI and its shareholders (other than BAT and its affiliates), 
(3) recommended that RAI shareholders approve the merger agreement and (4) declared that the 
merger agreement and the merger are advisable.  
The RAI board of directors recommends that RAI shareholders vote “FOR” the approval of 
the merger agreement. For the factors considered by the RAI board of directors in reaching this 
decision, see “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
RAI’s Purposes and Reasons for the Merger; Recommendation of the Transaction Committee; 
Recommendation of the RAI Board of Directors” beginning on page 62 of this proxy 
statement/prospectus.  
In addition, the RAI board of directors recommends that RAI shareholders vote “FOR” the 
approval, on a non-binding, advisory basis, of the transaction-related named executive officer 
compensation and “FOR” the approval of the adjournment of the special meeting, if necessary or 
appropriate, to solicit additional proxies if there are not sufficient votes to approve the merger 
agreement. See “RAI Proposal II: Non-Binding, Advisory Vote on Transaction-Related Named 
Executive Officer Compensation” and “RAI Proposal III: Adjournment of Special Meeting” 
beginning on pages 349 and 350, respectively, of this proxy statement/prospectus for a more 
detailed discussion of the recommendation.  
Opinion of the Transaction Committee’s Financial Advisor (See page 70)  
The Transaction Committee retained Goldman Sachs as its financial advisor in connection 
with the merger. In connection with this engagement, the Transaction Committee requested that 
Goldman Sachs deliver the opinion described below.  
Opinion of Goldman Sachs  
On January 16, 2017, Goldman Sachs rendered its oral opinion, which was subsequently 
confirmed in writing, to the RAI board of directors and the Transaction Committee that, as of 
January 16, 2017, and based upon and subject to the factors and assumptions set forth therein, 
the consideration, consisting of (1) a number of  
  
BAT ADSs (each BAT ADS representing, as of the date of the opinion, two BAT ordinary 
shares and currently representing one BAT ordinary share) equal to 0.5260 divided by the ADS 
Ratio (as defined in the merger agreement), plus (2) $29.44 in cash, to be paid to the holders of 
shares of RAI common stock (other than the BAT Group) pursuant to the merger agreement was 
fair from a financial point of view to such holders, the amounts in (1) and (2) collectively 
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referred to as the merger consideration throughout this section and in other instances where the 
opinion of Goldman Sachs is referenced.  
The full text of the written opinion of Goldman Sachs, dated January 16, 2017, which 
sets forth the assumptions made, procedures followed, matters considered and limitations 
on the review undertaken in connection with the opinion, is attached as Annex B to this 
proxy statement/prospectus. The summary of the Goldman Sachs opinion provided in this 
proxy statement/prospectus is qualified in its entirety by reference to the full text of 
Goldman Sachs’ written opinion. Goldman Sachs’ advisory services were provided for the 
information and assistance of the Transaction Committee and Goldman Sachs’ opinion was 
provided for the information and assistance of the RAI board of directors and the 
Transaction Committee, in each case in connection with their consideration of the merger. 
The Goldman Sachs opinion is not a recommendation as to how any holder of shares of 
RAI common stock should vote with respect to the merger or any other matter.  
The full text of Goldman Sachs’ written opinion, dated January 16, 2017, should be 
read carefully and in its entirety for a description of the assumptions made, procedures 
followed, matters considered and qualifications and limitations on the opinion and the 
review undertaken by Goldman Sachs in connection with rendering its opinion.  
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval 
of the Merger Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion 
of Goldman Sachs” beginning on page 70 of this proxy statement/prospectus, which is qualified 
in its entirety by reference to the full text of Goldman Sachs’ written opinion.  
Opinions of RAI’s Financial Advisors (See page 80)  
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in 
connection with the merger. In connection with this engagement, the RAI board of directors 
requested that RAI’s financial advisors deliver the opinions described below.  
Opinion of J.P. Morgan  
On January 16, 2017, at the meeting of the RAI board of directors at which the merger 
agreement was approved, J.P. Morgan rendered to the RAI board of directors an oral opinion, 
subsequently confirmed by delivery to the RAI board of directors of a written opinion, dated 
January 16, 2017, to the effect that, as of such date and based upon and subject to the factors, 
procedures, qualifications, assumptions and any limitations set forth in its written opinion, the 
consideration per share of RAI common stock, consisting of (1) a number of BAT ADSs 
representing 0.5260 of a BAT ordinary share as of the effective time of the proposed merger plus 
(2) $29.44 in cash, taken together, to be paid to the holders of RAI common stock (other than the 
BAT Group) in the proposed merger was fair, from a financial point of view, to such holders (the 
consideration described in (1) and (2) is being collectively referred to as the merger 
consideration throughout this section).  
The full text of J.P. Morgan’s written opinion, dated January 16, 2017, is attached as Annex 
C to this proxy statement/prospectus and is incorporated herein by reference. The full text of the 
opinion contains a discussion of, among other things, the assumptions made, procedures 
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followed, matters considered and qualifications and any limitations on the opinion and the 
review undertaken by J.P. Morgan in connection with rendering its  
opinion. The summary of the opinion of J.P. Morgan set forth in this proxy 
statement/prospectus is qualified in its entirety by reference to the full text of such opinion. 
RAI shareholders are urged to read J.P. Morgan’s opinion attached as Annex C and the 
summary beginning on page 81 of this proxy statement/prospectus carefully and in their 
entirety. J.P. Morgan’s opinion was addressed to the RAI board of directors (in its capacity as 
such) in connection with and for the purposes of its evaluation of the merger, was directed only 
to the fairness, from a financial point of view, of the merger consideration to be paid to the 
holders of RAI common stock (other than the BAT Group) in the merger and did not address any 
other aspect of the merger. J.P. Morgan was not authorized to and did not solicit any expressions 
of interest from any other parties with respect to the sale of all or any part of RAI or any other 
alternative transaction. J.P. Morgan expressed no opinion as to the fairness of any consideration 
to be paid in connection with the merger to the holders of any other class of securities, creditors 
or other constituencies of RAI or as to the underlying decision by RAI to engage in the merger. 
The issuance of J.P. Morgan’s opinion was approved by a fairness committee of J.P. Morgan. 
The opinion does not constitute a recommendation to any shareholder of RAI as to how such 
shareholder should vote with respect to the merger or any other matter. The full text of J.P. 
Morgan’s written opinion, dated January 16, 2017, should be read carefully and in its 
entirety for a description of the assumptions made, procedures followed, matters 
considered and qualifications and any limitations on the opinion and the review 
undertaken by J.P. Morgan in connection with rendering its opinion.  
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval 
of the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of J.P. Morgan” 
beginning on page 81 of this proxy statement/prospectus, which is qualified in its entirety by 
reference to the full text of J.P. Morgan’s written opinion.  
Opinion of Lazard  
On January 16, 2017, at a meeting of the RAI board of directors held to evaluate the 
merger, Lazard rendered to the RAI board of directors an oral opinion, which was confirmed by 
delivery of a written opinion dated January 16, 2017, to the effect that, as of that date and based 
upon and subject to the matters described in its opinion, the merger consideration per share of 
RAI common stock, consisting of (1) a number of BAT ADSs representing 0.5260 of a BAT 
ordinary share plus (2) $29.44 in cash to be paid to holders of shares of RAI common stock, 
other than the BAT Group and holders of shares of RAI common stock who have not voted, or 
caused or permitted to be voted, any shares of RAI common stock in favor of the adoption of the 
plan of merger, as defined in the merger agreement, at the special meeting and who have 
properly asserted (and not lost or effectively withdrawn) their rights of appraisal in accordance 
with Article 13 of the NCBCA, was fair, from a financial point of view, to such holders.  
The full text of Lazard’s written opinion, dated January 16, 2017, to the RAI board of 
directors which sets forth, among other things, the procedures followed, assumptions made, 
matters considered and limitations on the scope of review undertaken, is attached to this proxy 
statement/prospectus as Annex D and is incorporated into this proxy statement/prospectus by 
reference. The summary of Lazard’s opinion set forth in this proxy statement/prospectus is 
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qualified in its entirety by reference to the full text of Lazard’s written opinion attached as Annex 
D. You are encouraged to read Lazard’s opinion and this section carefully and in their entirety. 
Lazard’s opinion was for the benefit of the RAI board of directors (in its capacity as such) 
and Lazard’s opinion was rendered to the RAI board of directors in connection with its 
evaluation of the merger. Lazard’s opinion was not intended to and does not constitute a 
recommendation to any RAI shareholder as to how such shareholder should vote or act 
with respect to the merger or any matter relating thereto.  
The full text of Lazard’s written opinion, dated January 16, 2017, should be read 
carefully and in its entirety for a description of the procedures followed, assumptions 
made, matters considered and limitations on the scope of the review undertaken by Lazard 
in connection with its opinion.  
  
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval 
of the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of Lazard” 
beginning on page 96 of this proxy statement/prospectus, which is qualified in its entirety by 
reference to the full text of Lazard’s written opinion.  
Financing of the Merger (See page 113)  
BAT currently intends to finance the cash portion of the merger consideration, which is 
estimated to be $24.4 billion, and related fees and expenses with drawings under the acquisition 
facility.  
On January 16, 2017, B.A.T. International Finance p.l.c. and B.A.T Capital Corporation, 
each a wholly owned subsidiary of BAT, as original borrowers, and BAT, as guarantor, entered 
into an acquisition facility with HSBC Bank plc, as agent, HSBC Bank USA, National 
Association, as U.S. agent, and the financial institutions party thereto, as mandated lead 
arrangers and banks. Under the acquisition facility, the lenders are providing unsecured and 
unsubordinated term loan facilities in an aggregate principal amount of up to $25.0 billion, 
available for the purpose of financing the merger, paying related taxes, fees, costs and expenses 
and refinancing an existing revolving credit facility of RAI.  
The acquisition facility consists of four credit facilities: (1) a $15.0 billion bridge facility 
which, subject to two six-month extension options exercisable at BAT’s option, matures on the 
date falling 12 months after the earlier of (a) the date that the merger is completed and (b) the 
business day falling six months after January 16, 2017 (the earlier of (a) and (b) being referred to 
as the start date), (2) a $5.0 billion bridge facility which, subject to two six-month extension 
options exercisable at BAT’s option, matures on the date falling 24 months after the start date, 
(3) a $2.5 billion term loan which matures on the date falling 36 months after the start date and 
(4) a $2.5 billion term loan which matures on the date falling 60 months after January 16, 2017. 
It is currently expected that the funded acquisition facility will be refinanced by bond issuances 
in due course. As an alternative to drawing on the acquisition facility, BAT may issue new bonds 
to finance a portion of the cash portion of the merger consideration. BAT has not entered into 
any definitive documentation with respect to any such bond issuances. There can be no assurance 
that any replacement, supplemental or refinance financing will be available at all or on 
acceptable terms.  
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See “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Financing of the Merger” beginning on page 113 of this proxy statement/prospectus.  
Interests of Certain RAI Directors and Executive Officers (See page 115)  
When considering the recommendation of the RAI board of directors that RAI shareholders 
approve the merger agreement, you should be aware that certain RAI directors and executive 
officers have interests in the merger that are different from, or in addition to, those of RAI 
shareholders generally. These interests may present such directors and executive officers with 
actual or potential conflicts of interest. The RAI board of directors and the Transaction 
Committee were aware of these interests during their deliberations on the merits of the merger 
and in deciding to recommend that RAI shareholders vote to approve the merger agreement at 
the special meeting.  
These interests include:  
  
  
•   Treatment of Equity Awards for RAI Executive Officers. RAI’s executive officers have 
been granted RAI RSUs and RAI performance shares. Under the terms of the merger 
agreement, upon the completion of the merger, (1) each outstanding cash-out RSU will 
be canceled and converted into the right of the holder to receive the merger consideration 
for each share of RAI common stock subject to such cash-out RSU, subject to applicable 
proration, plus any accrued dividend equivalents earned in respect of such cash-out RSU, 
in each case, less any required withholding taxes; and (2) each outstanding rollover RSU 
will continue to be subject to substantially the same terms and conditions as were 
applicable immediately prior to the completion of the merger and will be converted into a  
  
 
restricted stock unit of BAT with respect to a target number of BAT ADSs (rounded 
down to the nearest whole BAT ADS and with any fractional BAT ADSs settled in cash) 
equal to the product of (a) the target number of shares of RAI common stock subject to 
the rollover RSU immediately prior to the completion of the merger and (b) the RSU 






•   Treatment of Equity Awards for RAI Directors. Certain RAI directors hold RAI DSUs. 
Under the terms of the merger agreement, upon the completion of the merger, (1) each 
outstanding RAI DSU attributable to the DCP will be converted into a number of 
deferred stock units tracking the value of BAT ADSs, determined by multiplying such 
RAI DSU by the RSU exchange ratio, and the resulting deferred stock units will be 
payable in accordance with the terms of the DCP and applicable existing deferral 
elections, (2) each outstanding RAI DSU attributable to an initial stock award, a pro rata 
annual stock award or an annual stock award under the EIAP will be converted into the 
right of the holder to receive, as soon as practicable upon the completion of the merger, 
either (a) cash equal in value to the merger consideration, (b) BAT ADSs, with the 
number of BAT ADSs received based on the RSU exchange ratio, or (c) the merger 
consideration, in all cases pursuant to each director’s election, less any applicable 
withholding taxes, and (3) each outstanding RAI DSUs attributable to a quarterly equity 
award under the EIAP will be converted into the right of the holder to receive cash equal 
in value to the merger consideration, payable as soon as practicable upon the completion 
of the merger, less any applicable withholding taxes.  
  
  
•   Treatment of Bonuses under Annual Incentive Award Program. RAI’s executive officers 
are eligible to receive bonuses under the annual incentive award program. Under the 
terms of the merger agreement, the 2017 annual bonuses will be calculated and paid in 
the ordinary course of business consistent with past practice. In the event the completion 
of the merger occurs prior to December 31, 2017, BAT and RAI will work together in 
good faith to specify the process for determining the achievement of performance goals 
with respect to the 2017 annual bonuses. Under the terms of the merger agreement, the 
2017 annual bonuses will not vest or pay out upon the completion of the merger; 
however, if an executive officer experiences an involuntary termination of employment 
in 2017 where such executive officer is eligible for and accepts severance benefits, the 
executive officer would be entitled to receive a pro-rated 2017 annual bonus payment 
based on actual performance, with such proration based on the number of months, 
rounded up to the nearest whole month, that have elapsed in fiscal year 2017 through the 




•   RAI Change in Control and Termination Benefits. RAI maintains two types of severance 
arrangements with its executive officers that provide severance benefits upon certain 
terminations of employment: (1) a standard form of severance agreement between certain 
executive officers and RAI, referred to as a severance agreement, and (2) the ESP. The 
severance agreements provide an executive officer party to such an agreement with 
severance and other benefits following any such executive officer’s termination of 
employment without cause or a termination of employment during the 24-month period 
following an RAI change in control for “change of control good reason,” estimated at a 
total of $34,141,559 for all executive officers who are party to a severance agreement as 
a group, assuming the completion of the merger occurred on June 6, 2017 (the latest 
practicable date, determined pursuant to Item 402(t) of Regulation S-K) and all such 
executive officers were terminated without cause on such date. The ESP provides a 
participating executive officer with severance and other benefits following such 
executive officer’s termination of employment without cause or with “change in control 
good reason” within the 24 months following an RAI change in control, or a termination 
without cause during the 12-month period prior to an RAI change in control, estimated at 
a total of $18,067,438 for all executive officers who are participants in the ESP as a 
group, assuming the completion of the merger occurred on June 6, 2017 and all such 
executive officers were terminated without cause on such date. The severance 
arrangements applicable to certain of RAI’s executive officers have been modified in 






•   Retention Agreements and Severance Modifications. RAI has entered into arrangements 
with certain of its executive officers, consisting of a retention agreement with each such 
executive officer and modifications to the RAI severance arrangement applicable to the 
executive officer described above. Pursuant to the retention agreement, each such 
executive officer will be entitled to receive payment of a cash retention award if he or she 
remains employed until either December 31, 2019 (with respect to Ms. Crew) or 
December 31, 2020 (with respect to Mr. Fragnito and all other executive officers who are 
party to a retention agreement). The total amount of retention awards that may become 
payable to RAI’s executive officers, assuming employment until the applicable retention 
date, is $4,950,000. In the event Ms. Crew’s, Mr. Fragnito’s or any other executive 
officer’s employment is terminated for any reason prior to December 31, 2019 or 
December 31, 2020, as applicable, the retention award for such executive officer will be 
forfeited. Pursuant to the modifications to the severance arrangement applicable to him 
or her, the severance payments and benefits available to each such executive officer 
under the severance agreement or the ESP, as applicable and calculated as if the 
executive officer had terminated employment on the date of the completion of the 
merger, will be provided to such executive officer upon any termination of employment 
other than for cause during the period beginning on the date of the completion of the 
merger and ending on December 31, 2020 (with respect to Ms. Crew) or December 31, 
2022 (with respect to Mr. Fragnito and all other executive officers subject to the 
modified version of the severance agreement or the ESP, as applicable). Any termination 
of employment other than for cause during the applicable period will also be considered a 
termination of employment entitling the executive officer to severance benefits for 
purposes of any annual bonus or equity arrangement of RAI, or any affiliate or successor 
to RAI, that provides for special benefits upon such a termination.  
  
  
•   Indemnification and Insurance. RAI’s directors and executive officers are entitled to 
continued indemnification and, for a period of six years following the completion of the 
merger, insurance coverage through a “tail” directors’ and officers’ liability insurance 
policy purchased by RAI or BAT.  
Assuming the completion of the merger occurred on June 6, 2017 and all of RAI’s 
executive officers experienced a vesting termination and a qualifying termination, or a modified 
severance termination, as applicable, (each as defined below in “Special Factors Relating to RAI 
Proposal I: Approval of the Merger Agreement—Interests of Certain RAI Directors and 
Executive Officers”) on such date, (1) RAI’s named executive officers would potentially be 
entitled to payments and other benefits with the following values: Susan M. Cameron - $0 (with 
respect to her service as a named executive officer of RAI); Debra A. Crew - $25,640,634; 
Andrew D. Gilchrist - $19,283,890; Martin L. Holton III - $10,417,090; Joseph P. Fragnito - 
$6,158,886; and Jeffery S. Gentry - $2,498,272; and (2) RAI’s other executive officers as a 
group would potentially be entitled to payments and other benefits with an aggregate value equal 
to $53,694,634. Assuming the completion of the merger occurred on June 6, 2017 and a 
complete payment under the DCP occurred at such time, RAI’s non-employee directors would be 
entitled to payment of the following amounts with respect to RAI DSUs: Jerome B. Abelman - 
$0; John A. Boehner - $853,478; Susan M. Cameron - $297,469 (with respect to her service on 
the RAI board of directors in 2013 and 2014 prior to her re-reappointment as President and Chief 
Executive Officer of RAI); Martin D. Feinstein - $9,025,127; Luc Jobin - $1,352,017; Murray S. 
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Kessler - $89,867; Holly Keller Koeppel - $8,176,385; Robert Lerwill - $0; Jean-Marc Lévy - 
$22,930; Nana Mensah - $3,490,767; Lionel L. Nowell, III - $11,230,609; Ricardo Oberlander - 
$0; Ronald S. Rolfe - $689,349; Thomas C. Wajnert - $0; and John J. Zillmer - $1,615,969.  
These interests may cause the directors and executive officers of RAI to view the proposals 
relating to the merger differently and more favorably than RAI shareholders generally may view 
them. For more information on the interests of RAI’s directors and executive officers in the 
merger, including the individual components of and the assumptions underlying such payments 
and benefits, see “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Interests of Certain RAI Directors and Executive Officers” beginning on page 115 
of this proxy statement/prospectus.  
  
 
Board of Directors of BAT Following the Merger (See page 135)  
Pursuant to the merger agreement, BAT will take all actions necessary to cause three 
directors serving on the RAI board of directors (other than directors designated for nomination 
by B&W) immediately prior to completion of the merger to be appointed as members of the 
BAT board of directors upon completion of the merger. Such directors will be selected by BAT 
prior to the completion of the merger after consultation with the Transaction Committee. See 
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—Board of 
Directors of BAT Following the Merger” on page 135 of this proxy statement/prospectus.  
Regulatory Approvals for the Merger (See page 136)  
Completion of the merger is conditioned upon the expiration or termination of the waiting 
period relating to the merger under the HSR Act and the earlier of the expiration of the waiting 
period required by the Japanese merger control regulations and the receipt of clearance from the 
Japan Fair Trade Commission.  
Pursuant to the requirements of the HSR Act, BAT and RAI filed Notification and Report 
Forms with respect to the merger with the FTC and DOJ on February 6, 2017 and requested early 
termination of the HSR Act waiting period. The applicable HSR Act waiting period for the 
merger expired on March 8, 2017.  
On March 23, 2017, BAT and RAI filed notifications for the merger with the Japan Fair 
Trade Commission. Approval from the Japan Fair Trade Commission was received on April 4, 
2017. As a result of the foregoing, the conditions related to antitrust approvals required as part of 
the closing conditions to the merger have now been satisfied.  
There can be no assurances as to the absence of any litigation challenging regulatory 
approvals received.  
See “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Regulatory Approvals for the Merger” beginning on page 136 of this proxy 
statement/prospectus.  
Material U.S. Federal Income Tax Consequences (See page 137)  
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The receipt of BAT ADSs and cash in exchange for RAI common stock in the merger 
generally will be a taxable transaction to U.S. holders (as defined in “Special Factors Relating to 
RAI Proposal I: Approval of the Merger Agreement—Material U.S. Federal Income Tax 
Consequences”) for U.S. federal income tax purposes. A U.S. holder of RAI common stock that 
receives BAT ADSs and cash in the merger generally will recognize capital gain or loss equal to 
the difference, if any, between (1) the sum of the fair market value of BAT ADSs and cash, 
including any cash in lieu of fractional BAT ADSs, received in the merger, and (2) such holder’s 
adjusted tax basis in such holder’s RAI common stock exchanged therefor. The determination of 
the actual tax consequences of the merger to a holder of RAI common stock will depend on the 
holder’s specific situation. Holders of RAI common stock should consult their own tax advisors 
as to the tax consequences of the merger in their particular circumstances, including the 
applicability and effect of the alternative minimum tax and any state, local, foreign or other tax 
laws and of changes in those laws. See “Special Factors Relating to RAI Proposal I: Approval of 
the Merger Agreement—Material U.S. Federal Income Tax Consequences” beginning on page 
137 of this proxy statement/prospectus.  
Material UK Tax Consequences (See page 142)  
The receipt of BAT ADSs and cash in exchange for RAI common stock in the merger 
generally will be a taxable transaction for UK tax purposes. A UK holder of RAI common stock 
who receives BAT ADSs and cash in the merger generally will recognize a capital gain or loss 
equal to the difference, if any, between (1) the sum of the fair market value of BAT ADSs and 
cash, including any cash in lieu of fractional BAT ADSs, received in the  
merger, and (2) such holder’s base cost for UK tax purposes in such holder’s RAI common stock 
exchanged thereunder. The determination of the actual tax consequences of the merger for a UK 
holder of RAI common stock will depend on the holder’s specific situation. Holders of RAI 
common stock should consult their own tax advisors as to the tax consequences of the merger in 
their particular circumstances, including the applicability and effect of any UK and foreign tax 
laws and of changes in those laws. See “Special Factors Relating to RAI Proposal I: Approval of 
the Merger Agreement—Material UK Tax Consequences” beginning on page 142 of this proxy 
statement/prospectus.  
Accounting Treatment (See page 145)  
The merger will be accounted for as a business combination using the acquisition method of 
accounting in accordance with IFRS under IFRS 3, Business Combinations, which requires that 
one of the two companies in the merger be designated as the acquirer for accounting purposes 
based on the evidence available. BAT will be treated as the accounting acquirer, and 
accordingly, will record assets acquired, including identifiable intangible assets, and liabilities 
assumed from RAI at their respective fair values at the date of completion of the merger. Any 
excess of the purchase price over the net fair value of such assets and liabilities will be recorded 
as goodwill. See “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Accounting Treatment” beginning on page 145 of this proxy statement/prospectus.  
Treatment of RAI Equity Awards (See page 146)  
Cash-Out RSUs  
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Upon the completion of the merger, each outstanding cash-out RSU will be canceled and 
converted into the right to receive (1) the merger consideration for each share of RAI common 
stock subject to such cash-out RSU, subject to applicable proration, and (2) cash for any accrued 
dividend equivalent right in respect of such cash-out RSU, in each case, less any required 
withholding taxes. If a cash-out RSU is also an RAI performance share, the number of shares of 
RAI common stock deemed subject to such cash-out RSU will be determined by the RAI board 
of directors (or a committee of the RAI board of directors) prior to the completion of the merger 
in accordance with the applicable award agreement and after reasonable consultation with BAT.  
RAI DSUs  
Upon the completion of the merger, each outstanding RAI DSU attributable to the DCP will 
be converted into a number of deferred stock units tracking the value of BAT ADSs, determined 
by multiplying such RAI DSU by the RSU exchange ratio, and the resulting deferred stock units 
will be payable in accordance with the terms of the DCP and applicable existing deferral 
elections. Upon the completion of the merger, each outstanding RAI DSU attributable to an 
initial stock award, a pro rata annual stock award or an annual stock award under the EIAP will 
be converted into the right of the holder to receive, as soon as practicable upon the completion of 
the merger, either (1) cash equal in value to the merger consideration, (2) BAT ADSs, with the 
number of BAT ADSs received based on the RSU exchange ratio, or (3) the merger 
consideration, in all cases pursuant to each director’s election, less any applicable withholding 
taxes. Upon the completion of the merger, each outstanding RAI DSU attributable to a quarterly 
equity award under the EIAP will be converted into the right of the holder to receive cash equal 
in value to the merger consideration, payable as soon as practicable upon the completion of the 
merger, less any applicable withholding taxes.  
Rollover RSUs  
Upon the completion of the merger, each outstanding rollover RSU will be converted into a 
restricted stock unit of BAT with respect to a target number of BAT ADSs (rounded down to the 
nearest whole BAT ADS and with any fractional BAT ADSs settled in cash) equal to the product 
of (1) the target number of shares of RAI  
  
common stock subject to the rollover RSU immediately prior to the completion of the merger 
and (2) the RSU exchange ratio, subject to adjustment as provided in the merger agreement to 
prevent dilution (each referred to as an adjusted RSU). Each adjusted RSU will be subject to 
substantially the same terms and conditions applicable to the related rollover RSU immediately 
prior to the completion of the merger, except that the form of payment upon vesting and 
settlement will be in BAT ADSs. If the rollover RSU was subject to performance-based vesting 
prior to the completion of the merger, then the adjusted RSU will continue to provide for 
performance-based vesting following the completion of the merger based on performance 
metrics agreed upon by BAT and RAI.  
Listing of BAT Ordinary Shares, Listing of BAT ADSs and Delisting and Deregistration of 
RAI Common Stock (See page 148)  
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Under the terms of the merger agreement, BAT is required to use its reasonable best efforts 
to cause (1) the BAT ordinary shares underlying the BAT ADSs constituting the stock portion of 
the merger consideration to be approved for admission to the premium listing segment of the 
Official List of the UKLA and to trading on the main market for listed securities of the LSE, 
subject only to the issue of such BAT ordinary shares upon completion of the merger, and (2) the 
BAT ADSs to be issued as the stock portion of the merger consideration to be approved for 
listing on the NYSE, subject to official notice of issuance, each prior to the completion of the 
merger. It is a condition to both parties’ obligations to complete the merger that such approvals 
are obtained. Accordingly, application will be made to have the BAT ordinary shares underlying 
the BAT ADSs constituting the stock portion of the merger consideration approved for listing by 
the UKLA and to trading on the main market for listed securities on the LSE and for the BAT 
ADSs to be issued as the stock portion of the merger consideration approved for listing on the 
NYSE. Application will also be made to have BAT ordinary shares underlying the BAT ADSs 
constituting the stock portion of the merger consideration to be listed on the JSE.  
As a result of the registration of BAT’s ordinary shares with the SEC pursuant to the 
registration statement of which this proxy statement/prospectus forms a part, BAT will become 
subject to the periodic reporting requirements under the Exchange Act and BAT’s ADR 
program, including the existing BAT ADSs issued as part of that program, will be automatically 
converted to a Level 3 ADR program upon completion of the merger with no action required by 
the holders of existing BAT ADSs. Following the completion of the merger, existing BAT ADSs 
will be fungible with the BAT ADSs to be issued as the stock portion of the merger 
consideration.  
If the merger is completed, there will no longer be any publicly held shares of RAI common 
stock. Accordingly, RAI common stock will be delisted from the NYSE and will be deregistered 
under the Exchange Act as soon as practicable following the completion of the merger, and RAI 
will no longer be required to file periodic reports with the SEC in respect of RAI common stock.  
Periodic Reporting under United States Securities Laws  
Under the Exchange Act, for so long as BAT continues to qualify as a foreign private 
issuer, BAT will be required to publicly file with the SEC an annual report on Form 20-F within 
four months of the end of the financial year covered by the report. As a foreign private issuer, 
BAT will also be required to publicly furnish to the SEC current reports on Form 6-K promptly 
after the occurrence of specified significant events, including material information that it makes 
or is required to make public pursuant to English law, files or is required to file with any stock 
exchange on which BAT ordinary shares trade and which was made public by that exchange, or 
is otherwise distributed or required to be distributed to shareholders of BAT. As a foreign private 
issuer listed on the NYSE, BAT will also be required to submit semi-annual financial statements 
on Form 6-K to the SEC within six months of the end of the relevant second quarter.  
If BAT no longer qualified as a foreign private issuer, BAT would be required to publicly 
file with the SEC an annual report on Form 10-K within 90, 75 or 60 days of the end of the 




with the time period determined based on BAT’s aggregate worldwide market value, the period 
of time for which it has been subject to SEC reporting requirements and certain other factors. In 
addition, BAT would be required to publicly file with the SEC quarterly reports on Form 10-Q 
within 45 or 40 days (depending on the same factors) of the end of the applicable financial 
quarter. BAT would also be required to publicly file with the SEC current reports on Form 8-K 
typically within four business days after the occurrence of specified significant events, and under 
Regulation FD, BAT would be required to simultaneously or promptly make public disclosure of 
any material nonpublic information shared with securities market professionals or shareholders 
of BAT who are reasonably likely to trade on the basis of the information. Further, BAT would 
be subject to certain disclosure and procedural requirements applicable to proxy solicitations 
under Section 14 of the Exchange Act, and members of the BAT board of directors, the BAT 
Group management board and principal shareholders of BAT would be subject to the disclosure 
and other requirements of Section 16 of the Exchange Act in respect of their ownership of, and 
transactions in, BAT securities.  
NYSE Rules  
For so long as the BAT ADSs will be listed on the NYSE, BAT will be required to meet 
certain requirements relating to ongoing communication and disclosure to holders of BAT ADSs, 
including a requirement to make any annual report filed with the SEC simultaneously available 
on or through BAT’s website and to comply with the timely alert policy of the NYSE with 
respect to earnings and dividend announcements, combination transactions, tender offers, stock 
splits, major management changes and any substantive items of an unusual or non-recurrent 
nature. Subject to certain exceptions, the rules of the NYSE permit a foreign private issuer to 
follow its home country practice in lieu of the corporate governance requirements of the NYSE, 
including, for example, certain board, committee and director independence requirements. 
Foreign private issuers are, however, required to comply with the audit committee independence 
requirements imposed by Section 10A-3 of the Exchange Act. BAT will be required to disclose 
any significant ways in which its corporate governance practices differ from those followed by 
U.S. domestic companies under NYSE listing standards in its annual report on Form 20-F filed 
with the SEC or on its website.  
Merger Fees and Expenses (See page 153)  
Generally, all fees and expenses incurred in connection with the merger and the other 
transactions contemplated by the merger agreement will be paid by the party incurring such fees 
and expenses, whether or not the merger is completed. See “Special Factors Relating to RAI 
Proposal I: Approval of the Merger Agreement—Merger Fees and Expenses” beginning on page 
153 of this proxy statement/prospectus. In certain circumstances, BAT or RAI may be required 
to pay a termination fee to the other party.  
Certain Effects of the Merger (See page 150)  
If the conditions to the completion of the merger are either satisfied or, to the extent legally 
permissible, waived, Merger Sub will be merged with and into RAI. As a result of the merger, 
the separate corporate existence of Merger Sub will cease, and RAI will continue as the 
surviving corporation in the merger and an indirect, wholly owned subsidiary of BAT. Upon the 
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completion of the merger, each share of RAI common stock (other than shares of RAI common 
stock owned by the BAT Group or excluded holders) will be automatically converted into the 
right to receive the merger consideration, consisting of (1) a number of BAT ADSs representing 
0.5260 of a BAT ordinary share plus (2) $29.44 in cash, without interest. No fractional BAT 
ADSs will be issued in the merger, and RAI shareholders will receive cash in lieu of fractional 
BAT ADSs. Following completion of the merger, RAI common stock will no longer be publicly 
traded, and shareholders will cease to have any ownership interest in RAI.  
  
No Solicitation of Takeover or Alternative Proposals (See page 216)  
RAI has agreed, except as otherwise provided in the merger agreement, not to, and not to 
authorize or permit any of its subsidiaries or any of its or their respective officers, directors, 
employees or representatives to, directly or indirectly:  
  
  
•   solicit, initiate, knowingly encourage, induce or facilitate, or furnish or disclose non-
public information in furtherance of, any “company takeover proposal,” as defined under 
“The Merger Agreement—No Solicitation of Takeover or Alternative Proposals” 
beginning on page 216 of this proxy statement/prospectus, or any inquiry or proposal that 
would reasonably be expected to result in or lead to a company takeover proposal;  
  
  
•   enter into any agreement with respect to any company takeover proposal (except certain 
confidentiality agreements in accordance with the merger agreement); or  
  
  
•   enter into, participate in or continue any discussions or negotiations with any person 
(other than its representatives) regarding, or furnish or disclose to any person any non-
public information with respect to, or otherwise cooperate in any way with any person 
(whether or not a person making a company takeover proposal) with respect to, any 
company takeover proposal or any inquiry or proposal that would reasonably be expected 
to result in or lead to a company takeover proposal.  
Additionally, RAI has agreed to (1) immediately cease and cause to be terminated all 
discussions or negotiations with any person conducted prior to the date of the merger agreement 
with respect to a company takeover proposal or any inquiry or proposal that would reasonably be 
expected to result in or lead to a company takeover proposal, (2) promptly request each person, if 
any, that has executed a confidentiality agreement in the last 12 months in respect of a company 
takeover proposal to return or destroy all information RAI or its subsidiaries or representatives 
have furnished to such person or its representatives and (3) reasonably promptly terminate all 
physical and electronic data room access previously granted to any such person or its 
representatives.  
Notwithstanding these restrictions, the merger agreement provides that at any time prior to 
obtaining the RAI shareholder approvals, RAI and its representatives may, in response to a 
written company takeover proposal that the RAI board of directors or the Transaction Committee 
determines in good faith (after consultation with its outside legal counsel and financial advisor) 
is bona fide and constitutes, or is reasonably expected to result in or lead to, a “superior 
proposal,” as defined under “The Merger Agreement—No Solicitation of Takeover or Alternative 
Proposals” beginning on page 216 of this proxy statement/prospectus, and which was 
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unsolicited, was made after the date of the merger agreement and did not otherwise result from a 
breach of the non-solicitation obligations described above, subject to compliance with the 




•   furnish information to the person making such company takeover proposal and its 
representatives (provided that all such information has been or is provided to BAT prior 
to or substantially concurrent with the time it is provided to such person) pursuant to a 
confidentiality agreement that meets certain requirements set forth in the merger 
agreement; and  
  
  
•   participate in discussions regarding the terms of such company takeover proposal and the 
negotiation of such terms with, and only with, the person or group of persons making 
such company takeover proposal and its representatives,  
in each case, if and so long as the RAI board of directors or the Transaction Committee, as 
applicable, determines in good faith after consultation with its outside legal counsel that 
providing such information or engaging in such negotiations or discussions is reasonably likely 
to be required for the directors to comply with their fiduciary duties under applicable law.  
 
The merger agreement also requires RAI to (1) promptly, and in any event within 24 hours, 
advise BAT in writing of any company takeover proposal or any request for non-public 
information or inquiry that would reasonably be expected to result in, lead to or that 
contemplates a company takeover proposal, the identity of the person making such company 
takeover proposal, request or inquiry and the material terms of such company takeover proposal, 
request or inquiry, (2) keep BAT informed in all material respects on a reasonably current basis 
of the status, including any change to the material terms of such company takeover proposal, and 
(3) provide BAT copies of any draft definitive agreements or term sheets sent or provided to or 
by RAI from or to any third party in connection with a company takeover proposal as soon as 
practicable after receipt or delivery of the same.  
BAT has agreed, except as otherwise provided in the merger agreement, not to, and not to 
authorize or permit any of its subsidiaries or any of its or their respective officers, directors, 
employees or representatives to, directly or indirectly:  
  
  
•   solicit, initiate, knowingly encourage, induce or facilitate, or furnish or disclose non-
public information in furtherance of, an “alternative proposal,” as defined under “The 
Merger Agreement—No Solicitation of Takeover or Alternative Proposals” beginning on 
page 216 of this proxy statement/prospectus, or any inquiry or proposal that would 
reasonably be expected to result in or lead to an alternative proposal;  
  
  
•   enter into any agreement with respect to any alternative proposal (except certain 





•   enter into, participate in or continue any discussions or negotiations with any person 
(other than its representatives) regarding, or furnish or disclose to any person any non-
public information with respect to, or otherwise cooperate in any way with any person 
(whether or not a person making an alternative proposal) with respect to, any alternative 
proposal or any inquiry or proposal that would reasonably be expected to result in or lead 
to an alternative proposal.  
Additionally, BAT has agreed to (1) immediately cease and cause to be terminated all 
discussions or negotiations with any person conducted prior to the date of the merger agreement 
with respect to an alternative proposal or any inquiry or proposal that would reasonably be 
expected to result in or lead to an alternative proposal, (2) promptly request each person, if any, 
that has executed a confidentiality agreement in the last 12 months in respect of an alternative 
proposal to return or destroy all information BAT or its subsidiaries or representatives have 
furnished to such person or its representatives and (3) reasonably promptly terminate all physical 
and electronic data room access previously granted to any such person or its representatives.  
Notwithstanding these restrictions, the merger agreement provides that at any time prior to 
obtaining the BAT shareholder approval, BAT and its representatives may, in response to a 
written alternative proposal that the BAT board of directors determines in good faith (after 
consultation with its outside legal counsel and financial advisor) is bona fide and constitutes, or 
is reasonably expected to result in or lead to, a “superior alternative proposal,” as defined under 
“The Merger Agreement—No Solicitation of Takeover or Alternative Proposals” beginning on 
page 216 of this proxy statement/prospectus, and which was unsolicited, was made after the date 
of the merger agreement and did not otherwise result from a breach of the non-solicitation 
obligations described above, subject to compliance with the provisions of the merger agreement 
described in the following paragraph, take the following actions:  
  
  
•   furnish information to the person making such alternative proposal and its representatives 
(provided that all such information has been or is provided to RAI prior to or 
substantially concurrent with the time it is provided to such person) pursuant to a 
confidentiality agreement that meets certain requirements set forth in the merger 
agreement; and  
  
  
•   participate in discussions regarding the terms of such alternative proposal and the 
negotiation of such terms with, and only with, the person or group of persons making 







in each case, if and so long as the BAT board of directors determines in good faith after 
consultation with its outside legal counsel that providing such information or engaging in such 
negotiations or discussions is reasonably likely to be required for the directors to comply with 
their fiduciary duties under applicable law.  
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The merger agreement also requires BAT to (1) promptly, and in any event within 24 hours, 
advise RAI in writing of any alternative proposal or any request for non-public information or 
inquiry that would reasonably be expected to result in or lead to or that contemplates an 
alternative proposal, the identity of the person making such alternative proposal, request or 
inquiry and the material terms of such alternative proposal, request or inquiry, (2) keep RAI 
informed in all material respects on a reasonably current basis of the status, including any change 
to the material terms of such alternative proposal, and (3) provide RAI copies of any draft 
definitive agreements or term sheets sent or provided to or by such party from or to any third 
party in connection with an alternative proposal as soon as practicable after receipt or delivery of 
the same.  
Completion of the Merger is Subject to Certain Conditions (See page 227)  
The obligations of each of BAT and RAI to complete the merger are subject to the 
satisfaction or, to the extent legally permissible (and except with respect to the condition 
described in the second bullet below, which shall not be waivable) waiver on or prior to the 
completion date of the following conditions:  
  
  
•   the approval of the merger agreement by holders of a majority of the outstanding shares 
of capital stock of RAI entitled to vote as of the RAI record date (the Series B preferred 
stock of RAI, all of which is owned by a wholly owned subsidiary of RAI, is not entitled 
to vote);  
  
  •   receipt of the unaffiliated shareholder approval;  
  
  •   receipt of the BAT shareholder approval;  
  
  
•   the approval for listing of the BAT ADSs issuable as the stock portion of the merger 
consideration on the NYSE (subject to official notice of issuance);  
  
  
•   the approval for admission of the BAT ordinary shares underlying the BAT ADSs 
constituting the stock portion of the merger consideration on the premium listing 
segment of the Official List of the UKLA and to trading on the main market for listed 
securities of the LSE subject only to the issue of such BAT ordinary shares upon the 
completion of the merger;  
  
  
•   the expiration or termination of the applicable waiting period under the HSR Act and the 
earlier of the expiration of the waiting period required by the Japanese merger control 
regulations and the receipt of clearance from the Japan Fair Trade Commission;  
  
  
•   the absence of any legal restraints that prevent, make illegal or prohibit the completion of 
the merger or the issuance of the BAT ordinary shares underlying the BAT ADSs 





•   declaration by the SEC of the effectiveness of the registration statement filed on Form F-
4 of which this proxy statement/prospectus forms a part and of the registration statement 
on Form F-6 relating to the BAT ADSs to be issued as the stock portion of the merger 
consideration (and the absence of any stop order suspending the effectiveness of such 
registration statements or any proceedings seeking such a stop order);  
  
  
•   the filing of the BAT prospectus and BAT circular with the UKLA, the approval of such 
prospectus and circular by the UKLA and the mailing of the BAT circular and the 




•   the other party having performed in all material respects all obligations required to be 
performed by it under the merger agreement that are required to be performed on or prior 
to the completion date and each party having received a certificate signed by the chief 
executive officer, chief financial officer or the finance director of the other party, as 




•   the representations and warranties of the other party relating to organization, standing 
and power, capital structure, authority, execution and delivery, enforceability, and, in the 
case of RAI, the representations and warranties relating to brokers, schedules of fees and 
expenses and opinions of financial advisors being true and correct in all material respects 
as of the date of the merger agreement and as of the completion date (except to the extent 
expressly made as of an earlier date, in which case, as of such earlier date);  
  
  
•   the representation and warranty of the other party relating to the absence of a material 
adverse effect on the other party being true and correct in all respects as of the date of the 
merger agreement and as of the completion date;  
  
•   each other representation and warranty of the other party being true and correct (ignoring 
any “materiality” or “material adverse effect” qualifiers) as of the date of the merger 
agreement and as of the completion date (except to the extent expressly made as of an 
earlier date, in which case, as of such earlier date), except where the failure of such 
representations and warranties to be so true and correct, individually and in the 
aggregate, has not had and would not reasonably be expected to have a material adverse 
effect; and  
  
  
•   receipt of an officer’s certificate executed by the chief executive officer, chief financial 
officer or the finance director of the other party certifying that the three preceding 
conditions have been satisfied.  
In addition, the obligations of BAT and Merger Sub to complete the merger are conditioned 
on the absence of any antitrust restriction, as defined under “The Merger Agreement—Efforts to 
Complete the Merger” beginning on page 223 of this proxy statement/prospectus.  
Termination of the Merger Agreement (See page 229)  
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The merger agreement may be terminated at any time prior to the completion of the merger, 
whether before or after receipt of the RAI shareholder approvals or the BAT shareholder 
approval, under the following circumstances:  
  
  
•   by mutual written consent of BAT and RAI (in the case of RAI, acting through or on the 
recommendation of the Transaction Committee); or  
  
  
•   by either BAT or RAI (in the case of RAI, acting through or on the recommendation of 
the Transaction Committee) in the event that:  
  
  
•   the merger is not completed by the end date, except that no party may terminate the 
merger agreement if the merger is not completed by the end date if such party has 
breached a representation, warranty or covenant in the merger agreement and such 
breach has been a principal cause of or resulted in the failure of the transactions 
contemplated by the merger agreement to be completed on or before the end date 
(and, in the event all conditions to the completion of the merger have been satisfied 
but the end date, by its terms, would occur before the expiration of the five business 
days contemplated in the merger agreement (related to the completion of the 
financing of the merger), the end date will be extended by the number of days 
necessary to provide BAT with such five business day period);  
  
  
•   a legal restraint that prevents, makes illegal or prohibits the completion of the 
merger or the issuance of the BAT ordinary shares underlying the BAT ADSs 
constituting the stock portion of the merger consideration has become final and 
nonappealable, as long as the terminating party has complied in all material respects 
with its obligations to use its reasonable best efforts to complete the merger and the 
other transactions contemplated by the merger agreement as promptly as practicable 
(as described in “The Merger Agreement—Efforts to Complete the Merger” 
beginning on page 223 of this proxy statement/prospectus);  
  
•   the RAI shareholders vote on and fail to approve the merger agreement at the 
special meeting;  
  
  
•   BAT shareholders vote on and fail to approve the merger agreement or to authorize 
the BAT directors to allot and issue the BAT ordinary shares underlying the BAT 






•   the other party breaches or fails to perform any of its covenants or agreements in the 
merger agreement, or if the other party’s representations or warranties fail to be true 
and correct, in either case, such that the applicable conditions to the terminating 
party’s obligations to complete the merger would not then be satisfied and such 
breach is not capable of being cured by the end date or has not been cured within 30 
days after giving written notice to the other party of such breach, except that no 
party may terminate the merger agreement for this reason if such party is then in 
material breach of any covenant or agreement in the merger agreement or if such 
party’s representations or warranties are not true and correct such that the applicable 
conditions to the other party’s obligations to complete the merger would not then be 
satisfied; or  
  
  
•   prior to obtaining the approval of the other party’s shareholders required to 
complete the merger, the board of directors of the other party (or any committee 
thereof) (1) withholds, withdraws, modifies or qualifies (in a manner adverse to the 
terminating party) or proposes publicly to withhold, withdraw, modify or qualify (in 
a manner adverse to the terminating party), its recommendation to its shareholders 
to vote in favor of approving the merger agreement and in the case of BAT, the 
share issuance, or (2) approves, recommends or declares advisable or proposes 
publicly to approve, recommend or declare advisable an alternative proposal, as 
defined under “The Merger Agreement—No Solicitation of Takeover or Alternative 
Proposals” beginning on page 216 of this proxy statement/prospectus, in the case of 
BAT, or a company takeover proposal, as defined under “The Merger Agreement—
No Solicitation of Takeover or Alternative Proposals” beginning on page 216 of this 
proxy statement/prospectus, in the case of RAI.  
If the merger agreement is terminated, the merger agreement will become void and have no 
effect, without any liability or obligation on the part of any party, except in the case of a willful 
and material breach of the merger agreement and except that certain provisions of the merger 
agreement, including those relating to confidentiality, the indemnification obligations of BAT in 
connection with the financing, fees and expenses (including termination fees), effect of 
termination and certain other general provisions, will survive termination of the merger 
agreement. If either party receives any payments for damages from another party as a result of a 
breach of the merger agreement and also receives a termination fee, the amount of such 
payments for damages made by the applicable party as a result of any such breaches will be 
reduced by the amount of such termination fee.  
Expenses and Termination Fees Under the Merger Agreement (See page 230)  
Except as described below, each party will pay all fees and expenses incurred by it in 
connection with the merger agreement and the transactions contemplated by the merger 
agreement.  
If the merger agreement is terminated, BAT will be entitled to receive a termination fee of 





•   the RAI board of directors or any committee thereof changes its recommendation and 
either (1) the merger agreement is terminated because the RAI shareholder approvals are 
not obtained at the special meeting or no special meeting is held prior to the end date or 




•   (1) the merger agreement is terminated (or in certain circumstances could have been 
terminated) because the merger has not occurred by the end date (and at such time all 
antitrust approvals have been  
  
  
obtained and no legal restraint preventing the completion of the merger is in effect), the 
RAI shareholder approvals are not obtained at the special meeting or RAI breached its 
obligations under the merger agreement, (2) prior to such termination, shareholder vote 
or breach, as applicable, and after the date of the merger agreement, a company takeover 
proposal that contemplates acquiring a majority of the capital stock or assets of RAI was 
made or made known to RAI or its shareholders and (3) within 12 months after such 
termination, RAI or any of its subsidiaries enters into a definitive agreement with respect 
to, or completes, such company takeover proposal.  
If the merger agreement is terminated, RAI will be entitled to receive a termination fee of 
$1.0 billion from BAT in the event that:  
  
  
•   the BAT board of directors or any committee thereof changes its recommendation and 
either (1) the merger agreement is terminated because the BAT shareholder approval is 
not obtained at the general meeting or no general meeting is held prior to the end date or 




•   (1) the merger agreement is terminated (or in certain circumstances could have been 
terminated) because the merger has not occurred by the end date (and at such time all 
antitrust approvals have been obtained, no legal restraint preventing the completion of 
the merger is in effect and no antitrust restriction is in effect), the BAT shareholder 
approval is not obtained at the general meeting or BAT breached its obligations under the 
merger agreement, (2) prior to such termination, shareholder vote or breach, as 
applicable, and after the date of the merger agreement, an alternative proposal that 
contemplates acquiring a majority of the capital stock or assets of BAT is publicly 
proposed or announced and (3) within 12 months after such termination, BAT enters into 
a definitive agreement with respect to, or completes, such alternative proposal.  
In addition, the merger agreement provides that RAI will be entitled to receive a 
termination fee of $500.0 million from BAT in the event that the merger agreement is terminated 
because the merger has not occurred by the end date and at the time of termination (1) all 
antitrust approvals that are conditions to completion of the merger have not been obtained, a 
legal restraint attributable to an antitrust law is in effect that prevents the completion of the 
merger or an antitrust restriction is in effect and (2) all other conditions to completion of the 
merger have been satisfied (or, in the case of any condition that by its nature is to be satisfied at 
completion, would be satisfied if the completion were to occur on the date of such termination). 
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The conditions related to antitrust approvals required as part of the conditions to completion of 
the merger have been satisfied. RAI will also be entitled to receive a termination fee of $500.0 
million from BAT in the event that the merger agreement is terminated because a legal restraint 
attributable to an antitrust law that prevents the completion of the merger has become final and 
nonappealable. BAT will not be required to pay the termination fees described in this paragraph 
if RAI has not complied with its obligation to use reasonable best efforts to complete the merger 
as promptly as practicable. See “The Merger Agreement—Efforts to Complete the Merger” 
beginning on page 223 of this proxy statement/prospectus for details on the efforts RAI is 
required to use to complete the merger.  
Comparison of Shareholder Rights (See page 391)  
RAI shareholders will have different rights once they become BAT shareholders due to 
differences between the organizational documents of BAT and RAI and differences between 
North Carolina law, where RAI is incorporated, and the laws of England and Wales, where BAT 
is incorporated. See “Comparison of Shareholder Rights” beginning on page 391 of this proxy 
statement/prospectus.  
Appraisal Rights (See page 416 and Annex E)  
Under North Carolina law, holders of shares of RAI common stock on the RAI record date 
who (1) are entitled to vote on the proposal to approve the merger agreement, (2) do not vote in 
favor of the proposal to  
  
approve the merger agreement, (3) properly deliver notice of their intent to demand payment for 
their shares of RAI common stock and (4) who otherwise comply with the requirements of 
Article 13 of the NCBCA will be entitled to seek appraisal for, and obtain payment in cash for 
the “fair value” of, their shares of RAI common stock (plus interest) in lieu of receiving the 
merger consideration if the merger is completed. These rights are occasionally referred to as 
appraisal rights in this proxy statement/prospectus. In addition, a participant in the RAI Savings 
Plan or the Puerto Rico SIP, as applicable, who instructs the trustee of the RAI Savings Plan or 
the custodian of the Puerto Rico SIP, as applicable, to not vote the shares of RAI common stock 
that are considered allocated to such participant’s account in favor of the proposal to approve the 
merger agreement may further instruct the trustee of the RAI Savings Plan or the custodian of the 
Puerto Rico SIP, as applicable, to exercise appraisal rights in connection with the merger under 
Article 13 of the NCBCA. The relevant provisions of the NCBCA are attached as Annex E to this 
proxy statement/prospectus. You are encouraged to read these provisions carefully and in their 
entirety.  
A shareholder who properly asserts appraisal rights has no assurance that such holder will 
receive an amount more than the merger consideration and, in fact, may receive an amount the 
same as or even less than the merger consideration. This also applies to a participant in the RAI 
Savings Plan or the Puerto Rico SIP, as applicable, who instructs the trustee of the RAI Savings 
Plan or the custodian of the Puerto Rico SIP, as applicable, to exercise appraisal rights in 
connection with the merger under Article 13 of the NCBCA. A beneficial owner may assert 
appraisal rights only if such beneficial owner also submits to RAI the record holder’s written 
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consent to such assertion not later than the “Demand Deadline” and may assert appraisal rights 
only with respect to all shares of RAI common stock of which it is the beneficial owner.  
To assist you in your determination of whether to assert your appraisal rights, copies of the 
RAI Group’s consolidated financial statements (together with the report of RAI’s independent 
registered public accounting firm regarding such statements) contained in RAI’s Annual Report 
on Form 10-K for the year ended December 31, 2016, and the RAI Group’s unaudited condensed 
consolidated financial statements contained in RAI’s Quarterly Report on Form 10-Q for the 
quarter ended March 31, 2017, are attached as Annex G and Annex H, respectively, to this proxy 
statement/prospectus. See “Where You Can Find More Information” beginning on page 445 of 
this proxy statement/prospectus.  
Multiple steps must be taken to properly assert and perfect appraisal rights. Moreover, due 
to the complexity of the procedures for asserting the right to seek appraisal, shareholders who are 
considering asserting such rights are encouraged to seek the advice of legal counsel. Failure to 
comply strictly with these provisions may result in loss of the right of appraisal. Voting against 
or abstaining from voting on the proposal to approve the merger agreement is not enough to 
satisfy the requirements of the NCBCA. A shareholder must also comply with all of the 
conditions relating to the separate written notice of intent to assert appraisal rights with respect to 
the merger and the other requirements set forth in Article 13 of the NCBCA.  
  
III. GOLDMAN’S OPINION TO TRANSACTION COMMITTEE OF RAI BOARD 
A. PROXY DISCUSSION OF OPINION OF GOLDMAN  
 
Opinion of the Transaction Committee’s Financial Advisor  
The Transaction Committee retained Goldman Sachs as its financial advisor in connection 
with the merger. In connection with this engagement, the Transaction Committee requested that 
Goldman Sachs deliver the opinion described below.  
Opinion of Goldman Sachs  
On January 16, 2017, Goldman Sachs rendered its oral opinion, which was subsequently 
confirmed in writing, to the RAI board of directors and the Transaction Committee that, as of 
January 16, 2017, and based upon and subject to the factors and assumptions set forth therein, 
the consideration, consisting of (1) a number of BAT ADSs (each BAT ADS representing, as of 
the date of the opinion, two BAT ordinary shares and currently representing one BAT ordinary 
share) equal to 0.5260 divided by the ADS Ratio (as defined in the merger agreement), plus 
(2) $29.44 in cash, to be paid to the holders of shares of RAI common stock (other than the BAT 
Group) pursuant to the merger agreement was fair from a financial point of view to such holders, 
the amounts in (1) and (2) collectively referred to as the merger consideration throughout this 
section and in other instances where the opinion of Goldman Sachs is referenced.  
The full text of the written opinion of Goldman Sachs, dated January 16, 2017, which 
sets forth the assumptions made, procedures followed, matters considered and limitations 
on the review undertaken in connection with the opinion, is attached as Annex B to this 
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proxy statement/prospectus. The summary of the Goldman Sachs opinion provided in this 
proxy statement/prospectus is qualified in its entirety by reference to the full text of 
Goldman Sachs’ written opinion. Goldman Sachs’ advisory services were provided for the 
information and assistance of the Transaction Committee and Goldman Sachs’ opinion was 
provided for the information and assistance of the RAI board of directors and the 
Transaction Committee, in each case in connection with their consideration of the merger. 
The Goldman Sachs opinion is not a recommendation as to how any holder of shares of 
RAI common stock should vote with respect to the merger or any other matter.  
In connection with rendering the opinion described above and performing its related 
financial analyses, Goldman Sachs reviewed, among other things:  
  
  •   the merger agreement;  
  
  
•   the Amended and Restated Deposit Agreement, dated as of December 1, 2008, by and 
among BAT, the depositary and the holders and beneficial owners of the BAT ADSs 
issued thereunder;  
  
  
•   annual reports to RAI shareholders and Annual Reports on Form 10-K of RAI for the 
five fiscal years ended December 31, 2015, and annual reports to shareholders of BAT 
for the five fiscal years ended December 31, 2015;  
  
  
•   certain interim reports to RAI shareholders and Quarterly Reports on Form 10-Q of RAI, 
and certain interim reports to shareholders of BAT;  
  
  •   certain other communications from RAI and BAT to their respective shareholders;  
  
  •   certain publicly available research analyst reports for RAI and BAT;  
  
  •   certain financial information for BAT prepared by its management; and  
  
  
•   certain internal financial analyses and forecasts for RAI and BAT prepared by RAI 
management, in each case, as approved for Goldman Sachs’ use by RAI (which are 
referred to in this section of the proxy statement/prospectus as the Forecasts and, in the 
case of the RAI Forecasts, which are described below in the section entitled “—RAI 
Unaudited Prospective Financial Information” beginning on page 108 of this proxy 
statement/prospectus), including certain operating synergies projected by 
RAI management to result from the merger, as approved for Goldman Sachs’ use by RAI 
(referred to in this section of the proxy statement/prospectus as the Synergies).  
  
Goldman Sachs also held discussions with members of the senior managements of RAI and 
BAT regarding their assessment of the strategic rationale for, and the potential benefits of, the 
merger and the past and current business operations, financial condition and future prospects of 
RAI and BAT; reviewed the reported price and trading activity for the shares of RAI common 
stock, the BAT ordinary shares and the BAT ADSs; compared certain financial and stock market 
information for RAI and BAT with similar information for certain other companies the securities 
of which are publicly traded; reviewed the financial terms of certain recent business 
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combinations in the tobacco industry and in other industries; and performed such other studies 
and analyses, and considered such other factors, as Goldman Sachs deemed appropriate.  
For purposes of rendering its opinion described above, Goldman Sachs, with the consent of 
RAI, relied upon and assumed the accuracy and completeness of all of the financial, legal, 
regulatory, tax, accounting and other information provided to, discussed with or reviewed by 
Goldman Sachs, without assuming any responsibility for independent verification thereof. In that 
regard, Goldman Sachs assumed, with the consent of RAI, that the Forecasts, including the 
Synergies, were reasonably prepared on a basis reflecting the best available estimates and 
judgments of the management of RAI as of the date that Goldman Sachs rendered its opinion. 
Goldman Sachs did not make an independent evaluation or appraisal of the assets and liabilities 
(including any contingent, derivative or other off-balance-sheet assets and liabilities) of RAI or 
BAT or any of their respective subsidiaries, nor was any such evaluation or appraisal furnished 
to Goldman Sachs. Goldman Sachs assumed that all governmental, regulatory or other consents 
and approvals necessary for the consummation of the merger will be obtained without any 
adverse effect on RAI or BAT or on the expected benefits of the merger in any way meaningful 
to its analysis. Goldman Sachs has also assumed that the merger will be consummated on the 
terms set forth in the merger agreement, without the waiver or modification of any term or 
condition the effect of which would be in any way meaningful to its analysis.  
Goldman Sachs’ opinion does not address the underlying business decision of RAI to 
engage in the merger, or the relative merits of the merger as compared to any strategic 
alternatives that may be available to RAI; nor does it address any legal, regulatory, tax or 
accounting matters. Goldman Sachs was not requested to solicit, and did not solicit, interest from 
other parties with respect to an acquisition of, or other business combination with, RAI or any 
other alternative transaction. Goldman Sachs’ opinion addresses only the fairness from a 
financial point of view to the holders (other than the BAT Group) of shares of RAI common 
stock, as of the date of the opinion, of the consideration to be paid to such holders pursuant to the 
merger agreement. Goldman Sachs opinion does not express any view on, and does not address, 
any other term or aspect of the merger agreement or the merger or any term or aspect of any 
other agreement or instrument contemplated by the merger agreement or entered into or amended 
in connection with the merger, including the fairness of the merger to, or any consideration 
received in connection therewith by, the holders of any other class of securities, creditors, or 
other constituencies of RAI; nor as to the fairness of the amount or nature of any compensation 
to be paid or payable to any of the officers, directors or employees of RAI, or class of such 
persons, in connection with the merger, whether relative to the consideration to be paid to the 
holders (other than the BAT Group) of shares of RAI common stock pursuant to the merger 
agreement or otherwise. Goldman Sachs does not express any opinion as to the prices at which 
the BAT ADSs or the BAT ordinary shares will trade at any time or as to the impact of the 
merger on the solvency or viability of RAI or BAT or the ability of RAI or BAT to pay their 
respective obligations when they come due. Goldman Sachs’ opinion was necessarily based on 
economic, monetary, market and other conditions as in effect on, and the information made 
available to Goldman Sachs as of, the date of the opinion and Goldman Sachs assumed no 
responsibility for updating, revising or reaffirming its opinion based on circumstances, 
developments or events occurring after the date of its opinion. Goldman Sachs’ advisory services 
were provided for the information and assistance of the Transaction Committee and Goldman 
Sachs’ opinion was provided for the information and assistance of the RAI board of directors and 
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the Transaction Committee, in each case in connection with their consideration of the merger, 
and Goldman Sachs’ opinion does not constitute a recommendation as to how any holder of 
shares of RAI common stock should vote with respect to the merger or any other matter. 
Goldman Sachs’ opinion was approved by a fairness committee of Goldman Sachs.  
  
Summary of Financial Analyses  
The following is a summary of the material financial analyses delivered by Goldman Sachs 
to the RAI board of directors and the Transaction Committee in connection with rendering the 
opinion described above. The following summary, however, does not purport to be a complete 
description of the financial analyses performed by Goldman Sachs, nor does the order of 
analyses described represent relative importance or weight given to those analyses by Goldman 
Sachs. Some of the summaries of the financial analyses include information presented in tabular 
format. The tables must be read together with the full text of each summary and are alone not a 
complete description of Goldman Sachs’ financial analyses. Except as otherwise noted, the 
following quantitative information, to the extent that it is based on market data, is based on 
market data as it existed on or before January 16, 2017 and is not necessarily indicative of 
current market conditions.  
Summary of the Merger Consideration. To calculate the implied value of the BAT ADSs to 
be issued as part of the consideration to be paid to the holders (other than the BAT Group) of 
shares of RAI common stock pursuant to the merger agreement, Goldman Sachs used a BAT 
ADS to BAT ordinary share exchange ratio of 0.2630 (calculated by dividing the ordinary share 
exchange ratio of 0.5260 by 2.0 since each BAT ADS represented two BAT ordinary shares as of 
the date of the merger agreement, which was prior to the effective date of the BAT ADS ratio 
change) and the closing price per BAT ADS on January 13, 2017 of $115.21 (before giving 
effect to the BAT ADS ratio change). Goldman Sachs then calculated (1) the implied 
consideration; (2) the premium represented by such implied consideration as compared to the 
closing price per share of RAI common stock as of October 20, 2016, the last trading day prior to 
BAT’s announcement of a proposal to merge with RAI; and (3) the total illustrative equity value 
and EV implied by such implied consideration, calculated using the number of fully diluted 
outstanding shares of RAI common stock, as per the merger agreement, and the net debt of RAI 
as of December 31, 2016, as provided by RAI management. The following table presents a 
summary of these calculations:  
  
Cash Consideration    $ 29.44  
Ordinary Share Exchange Ratio      0.5260x  
ADS Exchange Ratio(1)      0.2630x  
Implied Stock Consideration as of 
January 13, 2017    $ 30.30  
Implied Merger Consideration as of 
January 13, 2017    $ 59.74  
Implied Premium to October 20, 2016      26.6 %  
Illustrative Implied Equity Value    $  85,608 million  




(1) Calculated by dividing the ordinary share exchange ratio of 0.5260 by 2.0 since each BAT 
ADS represented two BAT ordinary shares as of the date of the merger agreement, which 
was prior to the effective date of the BAT ADS ratio change.  
Illustrative Public Market Present Value of Future Share Price Analysis. Goldman Sachs 
performed an illustrative analysis of the implied present value of the potential future value per 
share of RAI common stock at the year-end of each of calendar years 2017 through 2020. 
Goldman Sachs multiplied the one-year forward estimated earnings per share estimates for 
calendar years 2018 through 2021, respectively, as set forth in the Forecasts, by forward price to 
earnings per share multiples ranging from 16.5x to 20.2x. The calculation was adjusted for the 
present value of shares of RAI common stock repurchased and estimated dividends per share of 
common stock paid, as per the RAI Forecasts. Goldman Sachs then discounted these values for 
calendar years 2017 through 2020 back to December 31, 2016 using a discount rate of 6.5%, 
reflecting an estimate of RAI’s cost of equity. The following table presents the results of 
Goldman Sachs’ analysis:  
  
     
Illustrative Present Value 
of Future Share Price 
Dec-2017    $45.03 – $54.69 
Dec-2018    $47.34 – $57.09 
Dec-2019    $51.20 – $61.38 
Dec-2020    $54.72 – $65.24 
  
Illustrative Discounted Cash Flow Analysis. Using the Forecasts, Goldman Sachs 
performed an illustrative discounted cash flow analysis on RAI. Utilizing illustrative discount 
rates ranging from 5.0% to 6.5%, reflecting estimates of RAI’s weighted average cost of capital, 
Goldman Sachs, using mid-year convention, discounted to present value as of December 31, 
2016 (1) estimates of the projected cash flows of RAI for the fiscal years ending December 31, 
2017 through December 31, 2021, as per the RAI Forecasts, and (2) a range of illustrative 
terminal values for RAI as of December 31, 2021, which were calculated by applying perpetuity 
growth rates ranging from (0.5)% to 0.5% to a terminal year estimate of the projected cash flows 
of RAI, as reflected in the Forecasts. Goldman Sachs then derived ranges of illustrative 
enterprise values for RAI by adding together the ranges of present values it derived above. 
Goldman Sachs then subtracted from such range of illustrative enterprise values the net debt of 
RAI as of December 31, 2016 of $10,899 million, as provided by RAI management, to derive a 
range of implied equity values for RAI. Goldman Sachs then divided the range of implied equity 
values it derived by the number of fully diluted outstanding shares of RAI common stock, as per 
the merger agreement, to derive a range of implied equity values per share of RAI common stock 
of $45.16 to $72.17.  
Selected Transactions Analysis. Goldman Sachs analyzed certain information relating to the 
following selected transactions in the tobacco industry from 2005 through 2015 that, in the 
experience and professional judgment of Goldman Sachs, involve companies that are engaged in 
businesses analogous to RAI’s and BAT’s businesses.  
  
Date of Announcement   Acquirer    Target    
EV (dollars 
in billions)    




June 2015    BAT    TDR d.o.o.    $0.6   12.5x 
March 2015    BAT    Souza Cruz S.A.    $14.2   16.0x 
July 2014    RAI    Lorillard, Inc.    $27.6   13.9x 
May 2012 
   
Japan 
Tobacco Inc.    
Gryson NV 
   
$0.6 
   
12.3x 
May 2011 
   
BAT 
   
Productora Tabacalera de 
Colombia, S.A.S. (Protabaco)   
$0.5 
   
11.3x 
June 2009 
   
BAT 
   
PT Bentoel Internasional 
Investama Tbk    
$0.7 
   
14.0x 
September 2008 
   
Altria Group, 
Inc.    
UST Inc. 
   
$11.7 
   
12.0x 
February 2008 
   
BAT 
   
Skandinavisk 
Tobakskompagni A/S    
$4.0 
   
11.2x 
February 2008    BAT    Tekel    $1.7   11.4x 
November 2007 
   
Altria Group, 
Inc.    
John Middleton, Inc. 
   
$2.9 
   
15.0x 
July 2007 
   
Imperial 
Brands PLC    
Altadis S.A. 
   
$22.4 
   
14.2x 
February 2007 
   
Imperial 
Brands PLC    
Commonwealth Brands, Inc. 
   
$1.9 
   
10.9x 
December 2006 
   
Japan 
Tobacco Inc.    
Gallaher Group PLC 
   
$18.5 
   
13.0x 
April 2006    RAI    Conwood Company, LP, 
Conwood Sales Co., LP, 
Rosswil LLC and Scott 
Tobacco LLC 
   $3.5   13.6x 
            
While none of the companies (other than RAI) that participated in the selected transactions 
is directly comparable to RAI, the companies that participated in the selected transactions are 
companies with operations that, for purposes of analysis, may be considered similar to certain 
aspects of the RAI Group’s results, market size and product profile.  
  
For each of the selected transactions, Goldman Sachs calculated and compared the EV of 
the target at the applicable offer price as a multiple of the target’s publicly disclosed last twelve 
months (referred to in this section as LTM) EBITDA at the time of announcement. The 
calculation of the median value excluded the multiple applicable to the acquisition of Lorillard, 
Inc. by RAI announced in July 2014, which represented an EV / LTM EBITDA multiple of 
13.9x, which was referenced for information purposes, but the multiple for this transaction was 
excluded from the calculation of the median, as such transaction involved significant geographic 
overlap and was not deemed to be comparable to the proposed transaction. The following table 
presents the results of this analysis:  
  
Selected Transactions    EV / LTM EBITDA 
High    16.0x 
Median    12.5x 
Low    10.9x 
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Goldman Sachs applied the range of EV / LTM EBITDA ratios of 10.9x to 16.0x in respect 
of the selected transactions to the estimated EBITDA of RAI for fiscal year 2016 as per the 
Forecasts. After dividing by the number of fully diluted shares of RAI common stock 
outstanding, as per the merger agreement, Goldman Sachs calculated a range of implied equity 
values per share of RAI common stock of $38.12 to $59.51.  
Selected Historical Premia Analysis. Goldman Sachs reviewed and analyzed the acquisition 
premia for the selected transactions in the tobacco industry described above. Although none of 
the companies (other than RAI) that participated in the selected transactions is directly 
comparable to RAI, the companies that participated in the selected transactions are companies 
with operations that, for purposes of analysis, may be considered similar to certain aspects of the 
RAI Group’s results, market size and product profile. The following table presents the results of 
this analysis:  
  
     Premium 
High(1)    29% 
Median(1)    22% 
Low    15% 
  
  (1) Does not include RAI’s acquisition of Lorillard, Inc.  
  
Goldman Sachs also reviewed and analyzed the acquisition premia for all announced 
transactions greater than $250 million from 2004 through 2016 and which involved the 
acquisition of a U.S.-based target, using information obtained from Thomson Reuters as of 
December 31, 2016. Announced premia were calculated relative to the target’s closing share 
price one day prior to announcement. The following table presents the results of this analysis:  
  










2004 (37 cash-stock; 122 total)   15.1%   19.6% 
2005 (47 cash-stock; 155 total)   16.9%   21.6% 
2006 (36 cash-stock; 211 total)   16.3%   20.6% 
2007 (47 cash-stock; 229 total)   22.2%   21.2% 
2008 (21 cash-stock; 88 total)   11.7%   28.6% 
2009 (18 cash-stock; 65 total)   32.5%   31.5% 
2010 (22 cash-stock; 129 total)   34.4%   33.4% 
2011 (27 cash-stock; 123 total)   31.1%   32.3% 
2012 (19 cash-stock; 101 total)   33.4%   31.1% 
2013 (23 cash-stock; 109 total)   17.9%   24.5% 
2014 (40 cash-stock; 129 total)   26.0%   26.3% 
2015 (53 cash-stock; 153 total)   27.3%   25.3% 
2016 (46 cash-stock; 168 total)   31.6%   28.1% 
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Precedent Transactions Median 
(for all years)   26.0%   26.3% 
Finally, Goldman Sachs reviewed and analyzed the acquisition premia for all announced 
transactions greater than $1.0 billion from 2005 through 2016 and which involved the acquisition 
of a U.S.-based target by an existing significant shareholder, using information obtained from 
Deal Point Data. The following table presents the results of this analysis:  
  
     Premium 
Median    29.4% 
Average    30.1% 
Using a range of premia on the selected precedent tobacco transactions described above of 
15% to 29%, the median premia on cash-stock transactions described above of 26.0%, and the 
average of premia on transactions involving significant shareholders described above of 30.1%, 
Goldman Sachs applied a range of 15% to 30% acquisition premia to the closing price per share 
of RAI common stock as of October 20, 2016, the last trading day prior to BAT’s announcement 
of a proposal to merge with RAI, to calculate a range of implied equity values per share of RAI 
common stock of $54.25 to $61.32.  
Implied Value of the Consideration Based on Present Value of Pro Forma Future Share 
Price. Goldman Sachs also performed an illustrative analysis of the implied present value of the 
consideration to be paid to the holders (other than the BAT Group) of shares of RAI common 
stock pursuant to the merger agreement based on the cash portion of the consideration and the 
present value of the potential future value of the BAT ADSs to be issued as part of the 
consideration at December 31, 2020. Goldman Sachs multiplied the one-year forward estimated 
earnings per share for the pro forma combined company for the calendar year 2021, as set forth 
in the Forecasts, including the Synergies, by forward price to earnings per share multiples 
ranging from 15.6x to 18.8x. The calculation was adjusted for the present value of estimated 
dividends per share paid during calendar years 2017 through 2020, as per the Forecasts. 
Goldman Sachs then discounted these values back to December 31, 2016 using discount rates 
ranging from 6.5% to 8.5%, reflecting an estimate of the pro forma combined company’s cost of 
equity. This analysis resulted in a range of implied present values of the consideration to be paid 
to the holders (other than the BAT Group) of shares of RAI common stock pursuant to the 




The preparation of a fairness opinion is a complex process and is not necessarily susceptible 
to partial analysis or summary description. Selecting portions of the analyses or of the summary 
set forth above, without considering the analyses as a whole, could create an incomplete view of 
the processes underlying Goldman Sachs’ opinion. In arriving at its fairness determination, 
Goldman Sachs considered the results of all of its analyses and did not attribute any particular 
weight to any factor or analysis considered by it. Rather, Goldman Sachs made its determination 
as to fairness on the basis of its experience and professional judgment after considering the 
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results of all of its analyses. No company (other than RAI) or transaction used in the above 
analyses as a comparison is directly comparable to RAI or BAT or the merger.  
Goldman Sachs prepared these analyses for purposes of Goldman Sachs providing its 
opinion to the RAI board of directors and the Transaction Committee as to the fairness from a 
financial point of view of the consideration to be paid to the holders (other than the BAT Group) 
of RAI common stock pursuant to the merger agreement. These analyses do not purport to be 
appraisals nor do they necessarily reflect the prices at which businesses or securities actually 
may be sold. Analyses based upon forecasts of future results are not necessarily indicative of 
actual future results, which may be significantly more or less favorable than suggested by these 
analyses. Because these analyses are inherently subject to uncertainty, being based upon 
numerous factors or events beyond the control of the parties or their respective advisors, none of 
RAI, BAT, Goldman Sachs or any other person assumes responsibility if future results are 
materially different from those forecast.  
The consideration to be paid to the holders (other than the BAT Group) of RAI common 
stock pursuant to the merger agreement was determined through arm’s-length negotiations 
between the Transaction Committee and BAT and was approved by the RAI board of directors, 
after recommendation and approval by the Transaction Committee. Goldman Sachs provided 
advice to the Transaction Committee during these negotiations. Goldman Sachs did not, 
however, recommend any specific consideration to RAI, the RAI board of directors or the 
Transaction Committee or that any specific consideration constituted the only appropriate 
consideration for the merger.  
As described above, Goldman Sachs’ opinion to the RAI board of directors and the 
Transaction Committee was one of many factors taken into consideration by the Transaction 
Committee in making its recommendation to the RAI board of directors to approve the merger 
agreement and by the RAI board of directors in making its determination to approve the merger 
agreement. The foregoing summary does not purport to be a complete description of the analyses 
performed by Goldman Sachs in connection with the fairness opinion and is qualified in its 
entirety by reference to the written opinion of Goldman Sachs attached as Annex B to this proxy 
statement/prospectus.  
Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, 
principal investing, sales and trading, research, investment management and other financial and 
non-financial activities and services for various persons and entities. Goldman Sachs and its 
affiliates and employees, and funds or other entities they manage or in which they invest or have 
other economic interests or with which they co-invest, may at any time purchase, sell, hold or 
vote long or short positions and investments in securities, derivatives, loans, commodities, 
currencies, credit default swaps and other financial instruments of RAI, BAT, any of their 
respective affiliates and third parties, or any currency or commodity that may be involved in the 
merger. Goldman Sachs acted as financial advisor to the Transaction Committee in connection 
with, and participated in certain of the negotiations leading to, the merger. Goldman Sachs has 
provided certain financial advisory and/or underwriting services to RAI and/or its affiliates from 
time to time for which the Investment Banking Division of Goldman Sachs has received, and 
may receive, compensation, including having acted as a joint book-running manager with respect 
to a public offering of RAI’s 2.300% Senior Notes due 2018 (aggregate principal amount 
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$1,250,000,000), 3.250% Senior Notes due 2020 (aggregate principal amount $1,250,000,000), 
4.000% Senior Notes due 2022 (aggregate principal amount $1,000,000,000), 4.450% Senior 
Notes due 2025 (aggregate principal amount $2,500,000,000), 5.700% Senior Notes due 2035 
(aggregate principal amount $750,000,000) and 5.850% Senior Notes due 2045  
  
 (aggregate principal amount $2,250,000,000) in June 2015; as a lead dealer manager in 
connection with a tender offer for RAI’s 4.750% Senior Notes due 2042, 3.250% Senior Notes 
due 2022, 3.750% Senior Notes due 2023, 3.250% Senior Notes due 2020, 4.000% Senior Notes 
due 2022, 4.450% Senior Notes due 2025 and 4.850% Senior Notes due 2023 (aggregate 
principal amount $7,873,689,000) in February 2016; and as a participant in RAI’s 364-day senior 
unsecured term loan bridge facility (aggregate principal amount $9,000,000,000) in September 
2014. During the two-year period ended January 16, 2017, Goldman Sachs has received 
compensation for financial advisory and/or underwriting services provided by its Investment 
Banking Division to RAI and/or its affiliates of approximately $11 million. During the two-year 
period ended January 16, 2017, Goldman Sachs has not been engaged by BAT to provide 
financial advisory and/or underwriting services for which it has received compensation. 
Goldman Sachs may also in the future provide financial advisory and/or underwriting services to 
RAI, BAT and their respective affiliates for which the Investment Banking Division of Goldman 
Sachs may receive compensation.  
The Transaction Committee selected Goldman Sachs as its financial advisor because 
Goldman Sachs is an internationally recognized investment banking firm that has substantial 
experience in transactions similar to the merger. Pursuant to a letter agreement dated 
November 21, 2016, the Transaction Committee engaged Goldman Sachs to act as its financial 
advisor in connection with the possible sale of all or a portion of the stock or assets of RAI. 
Pursuant to the terms of this engagement letter, RAI has agreed to pay Goldman Sachs a 
transaction fee of 0.085% of the merger consideration, that is estimated, based on the 
information available as of the date of announcement of the merger agreement, at approximately 
$42 million, approximately $4 million of which has been paid and the remainder of which is 
contingent upon consummation of the merger. In addition, RAI has agreed to reimburse 
Goldman Sachs for certain of its expenses, including attorneys’ fees and disbursements, and to 
indemnify Goldman Sachs and related persons various liabilities, including certain liabilities 
under the federal securities law.  
Other Presentations by Goldman Sachs  
In addition to the presentation made to the RAI board of directors and the Transaction 
Committee on January 16, 2017 described under “Special Factors Relating to RAI Proposal I: 
Approval of the Merger Agreement—Opinion of the Transaction Committee’s Financial 
Advisor—Opinion of Goldman Sachs,” Goldman Sachs also made written and oral preliminary 
presentations to the Transaction Committee, and, in some cases, the RAI board of directors, on 
October 28, 2016, November 4, 2016, November 8, 2016, November 23, 2016, December 7, 
2016, December 20, 2016, January 5, 2017, January 10, 2017 and January 14, 2017. Copies of 
these written materials have been attached as exhibits to the Schedules 13E-3 filed with the SEC 
in connection with the merger. These written presentations will be available to any interested 
shareholder of RAI (or any representative of a shareholder who has been so designated in 
writing) to inspect and copy at RAI’s principal executive offices during regular business hours.  
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None of these other written and oral preliminary presentations by Goldman Sachs, alone or 
together, constitute, or form the basis of, an opinion of Goldman Sachs with respect to the 
merger consideration. Information contained in these other written and oral preliminary 
presentations is substantially similar to the information provided in Goldman Sachs’ written 
presentation to the RAI board of directors and to the Transaction Committee on January 16, 
2017, as described under “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Opinion of the Transaction Committee’s Financial Advisor.” A summary of these 
other preliminary presentations is provided below. The following summary, however, does not 
purport to be a complete description of these preliminary presentations or of the preliminary 
financial analyses performed by Goldman Sachs.  
  
  
•   The October 28, 2016 materials presented to the Transaction Committee and the RAI 
board of directors contained, among other information, a review of BAT’s October 20 
Proposal and preliminary process considerations.  
 
  
•   The November 4, 2016 materials presented to the Transaction Committee included, 
among other information, an updated review of BAT’s October 20 Proposal, a summary 
of preliminary financial projections, including synergies, then provided by RAI 
management, a review of process considerations, and a preliminary financial analysis of 
the then implied proposed merger consideration as a multiple of (1) RAI’s LTM EV / 
EBITDA, using RAI EBITDA for the twelve-month period ended September 30, 2016, 
based on information provided by RAI management, (2) RAI’s next twelve months 
(referred to in this section as NTM) EV / EBITDA, using the preliminary financial 
projections provided by RAI management that had been approved for Goldman Sachs’ 
use by RAI management, (3) NTM price to earnings (referred to in this section as P / E), 
using the preliminary financial projections provided by RAI management that had been 
approved for Goldman Sachs’ use by RAI management, and (4) 2017 year-end P / E, 
using the preliminary financial projections provided by RAI management that had been 
approved for Goldman Sachs’ use by RAI management. Goldman Sachs then compared 
these preliminary calculated multiples to the corresponding multiples for BAT, certain 
selected transactions and/or certain selected companies in the tobacco industry. The 
following table presents a summary of these preliminary calculations:  
  
LTM EV / EBITDA     
      
RAI(1)   15.4x 
Selected Transactions(2)   12.0x – 15.1x 
  
NTM EV / EBITDA    
      
RAI(1)   14.7x 
BAT   11.6x 
Selected Companies(3)   12.3x 
  
NTM P / E    
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RAI(1)   22.7x 
BAT   16.6x 
Selected Companies(3)   18.7x 
  
2017E P / E    
      
RAI(1)   22.2x 
  
  (1) Implied by BAT’s October 20 Proposal.  
  
(2) Includes the following selected transactions in the tobacco industry: BAT’s 
acquisition of Souza Cruz S.A. (announced in March 2015), RAI’s acquisition of 
Lorillard (announced in July 2014), Altria Group, Inc.’s acquisition of UST Inc. 
(announced in September 2008), Imperial Brands PLC’s acquisition of Altadis S.A. 
(announced in July 2007) and Japan Tobacco Inc.’s acquisition of Gallaher Group 
PLC (announced in December 2006).  
  
(3) Includes the following publicly traded corporations in the tobacco industry: Altria 
Group, Inc., Imperial Brands PLC, ITC Limited, Japan Tobacco Inc. and Philip 
Morris International Inc.  
  
  
•   The November 8, 2016 materials presented to the Transaction Committee and the RAI 
board of directors included, among other information, an updated review of BAT’s 
October 20 Proposal, a summary of preliminary financial projections, including 




•   A preliminary illustrative public market present value of future share price analysis 
similar to that described above under “Special Factors Relating to RAI Proposal I: 
Approval of the Merger Agreement—Opinion of the Transaction Committee’s 
Financial Advisor—Opinion of Goldman Sachs—Summary of Financial Analyses—
Illustrative Public Market Present Value of Future Share Price Analysis,” using the 




that had been approved for Goldman Sachs’ use by RAI management, applying the 
same 16.5x to 20.2x forward price to earnings per share multiples and using a 
discount rate of 5.9% as an estimate of RAI’s cost of equity. On the basis of such 
preliminary analysis, Goldman Sachs calculated a preliminary illustrative range of 
the implied present value of the potential future value per share of RAI common 





•   A preliminary illustrative discounted cash flow analysis similar to that described 
above under “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion 
of Goldman Sachs—Summary of Financial Analyses—Illustrative Discounted Cash 
Flow Analysis,” using the preliminary financial projections provided by RAI 
management that had been approved for Goldman Sachs’ use by RAI management, 
applying the same perpetuity growth rates ranging from (0.5)% to 0.5% and 
utilizing illustrative discount rates ranging from 5.0% to 6.0%, reflecting estimates 
of RAI’s weighted average cost of capital. On the basis of such preliminary analysis, 
Goldman Sachs derived a preliminary illustrative range of implied equity values per 
share of RAI common stock of $48.86 to $71.67.  
  
  
•   A preliminary selected transactions analysis similar to that described above under 
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Opinion of the Transaction Committee’s Financial Advisor—Opinion of Goldman 
Sachs—Summary of Financial Analyses—Selected Transactions Analysis,” using 
RAI EBITDA for the twelve-month period ended September 30, 2016. On the basis 
of such preliminary analysis, Goldman Sachs calculated a preliminary illustrative 
range of implied equity values per share of RAI common stock of $37.82 to $59.18.  
  
  
•   A preliminary selected historical premia analysis similar to that described above 
under “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion 
of Goldman Sachs—Summary of Financial Analyses—Selected Historical Premia 
Analysis,” which indicated the same preliminary illustrative range of implied equity 
values per share of RAI common stock of $54.25 to $61.32.  
  
  
•   The November 23, 2016 materials presented to the Transaction Committee included, 
among other information, an updated review of BAT’s October 20 Proposal and a 
summary of selected news and commentary relating to the transaction.  
  
  
•   The December 7, 2016 materials presented to the Transaction Committee included, 
among other information, an updated review of BAT’s October 20 Proposal and 
December 5 Proposal, a summary of selected news and commentary relating to the 
Transaction, a summary of preliminary financial projections, including synergies, then 
provided by RAI management, a review of process considerations, and the following 





•   A preliminary illustrative public market present value of future share price analysis 
similar to that described above under “Special Factors Relating to RAI Proposal I: 
Approval of the Merger Agreement—Opinion of the Transaction Committee’s 
Financial Advisor—Opinion of Goldman Sachs—Summary of Financial Analyses—
Illustrative Public Market Present Value of Future Share Price Analysis,” using the 
preliminary financial projections provided by RAI management that had been 
approved for Goldman Sachs’ use by RAI management, applying the same 16.5x to 
20.2x forward price to earnings per share multiples and using a discount rate of 
6.5% as an estimate of RAI’s cost of equity. On the basis of such preliminary 
analysis, Goldman Sachs calculated a preliminary illustrative range of the implied 
present value of the potential future value per share of RAI common stock on 
December 31, 2020 of $54.82 to $65.16.  
  
  
•   A preliminary illustrative discounted cash flow analysis similar to that described 
above under “Special Factors Relating to RAI Proposal I: Approval of the Merger 




Transaction Committee’s Financial Advisor—Opinion of Goldman Sachs—
Summary of Financial Analyses—Illustrative Discounted Cash Flow Analysis,” 
using the preliminary financial projections provided by RAI management that had 
been approved for Goldman Sachs’ use by RAI management, applying the same 
perpetuity growth rates ranging from (0.5)% to 0.5% and utilizing illustrative 
discount rates ranging from 5.0% to 6.5%, reflecting estimates of RAI’s weighted 
average cost of capital. On the basis of such preliminary analysis, Goldman Sachs 
derived a preliminary illustrative range of implied equity values per share of RAI 
common stock of $44.76 to $71.67.  
  
  
•   A preliminary selected transactions analysis similar to that described above under 
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Opinion of the Transaction Committee’s Financial Advisor—Opinion of Goldman 
Sachs—Summary of Financial Analyses—Selected Transactions Analysis,” using 
RAI EBITDA for the twelve-month period ended September 30, 2016. On the basis 
of such analysis, Goldman Sachs calculated a preliminary illustrative range of 
implied equity values per share of RAI common stock of $37.82 to $59.18.  
  
  
•   A preliminary selected historical premia analysis similar to that described above 
under “Special Factors Relating to RAI Proposal I: Approval of the Merger 
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion 
of Goldman Sachs—Summary of Financial Analyses—Selected Historical Premia 
Analysis,” which indicated the same preliminary illustrative range of implied equity 





•   The December 20, 2016 materials presented to the Transaction Committee included, 
among other information, an updated review of BAT’s October 20 Proposal, December 5 
Proposal and December 20 Proposal.  
  
  
•   The January 5, 2017 materials presented to the Transaction Committee included, among 
other information, an updated review of BAT’s October 20 Proposal, December 5 
Proposal and December 20 Proposal and the Transaction Committee’s December 20 
Counterproposal, an overview of accretion and dilution modeling assumptions and a 




•   The January 10, 2017 materials presented to the Transaction Committee and the RAI 
board of directors included, among other information, an illustrative analysis of the effect 
of different exchange ratios based on the cash portion of the merger consideration.  
  
  
•   The January 14, 2017 materials presented to the Transaction Committee and the RAI 
board of directors included, among other information, an updated review of BAT’s 
October 20 Proposal and January 10 Proposal.  
The preliminary financial analyses in these other written and oral preliminary presentations 
were based on market, economic and other conditions as they existed as of the dates of the 
respective presentations as well as other information that was available at those times. 
Accordingly, the results of the financial analyses differed due to changes in those conditions. 
Among other things, the results of certain analyses changed as RAI’s financial results changed as 
well as projections made by management of RAI were revised or adjusted. Finally, Goldman 
Sachs continued to refine various aspects of its financial analyses with respect to RAI and BAT 
over time.  
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PERSONAL AND CONFIDENTIAL  
January 16, 2017  
Board of Directors  
Transaction Committee of the Board of Directors  
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Reynolds American Inc.  
401 North Main Street  
Winston Salem, NC 27101  
Ladies and Gentlemen:  
You have requested our opinion as to the fairness from a financial point of view to the holders 
(other than British American Tobacco p.l.c. (“BAT”) and its subsidiaries) of the outstanding 
shares of common stock, par value $0.0001 per share (the “Shares”), of Reynolds American Inc. 
(the “Company”) of the Consideration (as defined below) to be paid to such holders pursuant to 
the Agreement and Plan of Merger, dated as of January 16, 2017 (the “Agreement”), by and 
among BAT, BATUS Holdings, Inc., an indirect wholly owned subsidiary of BAT, Flight 
Acquisition Corporation, an indirect wholly owned subsidiary of BAT (“Acquisition Sub”), and 
the Company. The Agreement provides that Acquisition Sub will be merged with and into the 
Company (the “Merger”) and each outstanding Share (other than Dissenting Shares (as defined 
in the Agreement) and Shares held by BAT or its subsidiaries) will be converted into $29.44 in 
cash (the “Cash Consideration”), and that number of American depositary shares (“BAT ADS”) 
of BAT (each BAT ADS representing, as of the date of the Agreement, two ordinary shares, par 
value £0.25 per share (“BAT Ordinary Shares”) of BAT), equal to 0.5260 divided by the ADS 
Ratio (as defined in the Agreement) (the “Stock Consideration”; together with the Cash 
Consideration, the “Consideration”).  
Goldman, Sachs & Co. and its affiliates are engaged in advisory, underwriting and financing, 
principal investing, sales and trading, research, investment management and other financial and 
non-financial activities and services for various persons and entities. Goldman, Sachs & Co. and 
its affiliates and employees, and funds or other entities they manage or in which they invest or 
have other economic interests or with which they co-invest, may at any time purchase, sell, hold 
or vote long or short positions and investments in securities, derivatives, loans, commodities, 
currencies, credit default swaps and other financial instruments of the Company, BAT, any of 
their respective affiliates and third parties, or any currency or commodity that may be involved in 
the transaction contemplated by the Agreement (the “Transaction”). We have acted as financial 
advisor to the Transaction Committee of the Board of Directors of the Company (the 
“Transaction Committee”) in connection with, and have participated in certain of the 
negotiations leading to, the Transaction. We expect to receive fees for our services in connection 
with the Transaction, the principal portion of which is contingent upon consummation of the 
Transaction, and the Company has agreed to reimburse certain of our expenses arising, and 
indemnify us against certain liabilities that may arise, out of our engagement. We have provided 
certain financial advisory and/or underwriting services to the Company and/or its affiliates from 
time to time for which our Investment Banking Division has received, and may receive, 
compensation, including having acted as a joint book-running manager with respect to a public 
offering of the Company’s 2.300% Senior Notes due 2018 (aggregate principal amount 
$1,250,000,000), 3.250% Senior Notes due 2020 (aggregate principal amount $1,250,000,000), 
4.000% Senior Notes due 2022 (aggregate principal amount $1,000,000,000), 4.450% Senior 
Notes due 2025 (aggregate principal amount $2,500,000,000), 5.700% Senior Notes due 2035 
(aggregate principal amount $750,000,000) and 5.850% Senior Notes due 2045 (aggregate 
principal amount $2,250,000,000) in June 2015; as a lead dealer manager in connection with a 
tender offer for the Company’s 4.750% Senior Notes due 2042, 3.250% Senior Notes due 2022, 
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3.750% Senior Notes due 2023, 3.250% Senior Notes due 2020, 4.000% Senior Notes due 2022, 
4.450% Senior Notes due 2025 and 4.850% Senior Notes due 2023 (aggregate principal amount 
$7,873,689,000) in February 2016; and as a participant in the Company’s 364-day senior 
unsecured term loan bridge facility (aggregate principal amount $9,000,000,000) in September 
2014. We may also in the future provide financial advisory and/or underwriting services to the 
Company, BAT and their respective affiliates for which our Investment Banking Division may 
receive compensation.  
In connection with this opinion, we have reviewed, among other things, the Agreement; the 
Amended and Restated Deposit Agreement, dated as of December 1, 2008, by and among BAT, 
Citibank, N.A., as Depositary, and the holders and beneficial owners of the BAT ADSs issued 
thereunder; annual reports to stockholders and Annual Reports on Form 10-K of the Company 
for the five fiscal years ended December 31, 2015, and annual reports to shareholders of BAT for 
the five fiscal years ended December 31, 2015; certain interim reports to stockholders and 
Quarterly Reports on Form 10-Q of the Company, and certain interim reports to shareholders of 
BAT; certain other communications from the Company and BAT to their stockholders and 
shareholders, respectively; certain publicly available research analyst reports for the Company 
and BAT; certain financial information for BAT prepared by its management; and certain 
internal financial analyses and forecasts for the Company and BAT prepared by the Company’s 
management, in each case, as approved for our use by the Company (the “Forecasts”), including 
certain operating synergies projected by the management of the Company to result from the 
Transaction, as approved for our use by the Company (the “Synergies”). We have also held 
discussions with members of the senior managements of the Company and BAT regarding their 
assessment of the strategic rationale for, and the potential benefits of, the Transaction and the 
past and current business operations, financial condition and future prospects of the Company 
and BAT; reviewed the reported price and trading activity for the Shares, the BAT Ordinary 
Shares and the BAT ADSs; compared certain financial and stock market information for the 
Company and BAT with similar information for certain other companies the securities of which 
are publicly traded; reviewed the financial terms of certain recent business combinations in the 
tobacco industry and in other industries; and performed such other studies and analyses, and 
considered such other factors, as we deemed appropriate.  
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the 
accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other 
information provided to, discussed with or reviewed by, us, without assuming any responsibility 
for independent verification thereof. In that regard, we have assumed with your consent that the 
Forecasts, including the Synergies, have been reasonably prepared on a basis reflecting the best 
currently available estimates and judgments of the management of the Company. We have not 
made an independent evaluation or appraisal of the assets and liabilities (including any 
contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or BAT or 
any of their respective subsidiaries and we have not been furnished with any such evaluation or 
appraisal. We have assumed that all governmental, regulatory or other consents and approvals 
necessary for the consummation of the Transaction will be obtained without any adverse effect 
on the Company or BAT or on the expected benefits of the Transaction in any way meaningful to 
our analysis. We have assumed that the Transaction will be consummated on the terms set forth 
in the Agreement, without the waiver or modification of any term or condition the effect of 





Our opinion does not address the underlying business decision of the Company to engage in the 
Transaction, or the relative merits of the Transaction as compared to any strategic alternatives 
that may be available to the Company; nor does it address any legal, regulatory, tax or 
accounting matters. We were not requested to solicit, and did not solicit, interest from other 
parties with respect to an acquisition of, or other business combination with, the Company or any 
other alternative transaction. This opinion addresses only the fairness from a financial point of 
view to the holders (other than BAT and its subsidiaries) of Shares, as of the date hereof, of the 
Consideration to be paid to such holders pursuant to the Agreement. We do not express any view 
on, and our opinion does not address, any other term or aspect of the Agreement or Transaction 
or any term or aspect of any other agreement or instrument contemplated by the Agreement or 
entered into or amended in connection with the Transaction, including, the fairness of the 
Transaction to, or any consideration received in connection therewith by, the holders of any other 
class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the 
amount or nature of any compensation to be paid or payable to any of the officers, directors or 
employees of the Company, or class of such persons, in connection with the Transaction, 
whether relative to the Consideration to be paid to the holders (other than BAT and its 
subsidiaries) of Shares pursuant to the Agreement or otherwise. We are not expressing any 
opinion as to the prices at which the BAT ADSs or the BAT Ordinary Shares will trade at any 
time or as to the impact of the Transaction on the solvency or viability of the Company or BAT 
or the ability of the Company or BAT to pay their respective obligations when they come due. 
Our opinion is necessarily based on economic, monetary, market and other conditions as in effect 
on, and the information made available to us as of, the date hereof and we assume no 
responsibility for updating, revising or reaffirming this opinion based on circumstances, 
developments or events occurring after the date hereof. Our advisory services and the opinion 
expressed herein are provided for the information and assistance of the Transaction Committee 
and the Board of Directors of the Company in connection with its consideration of the 
Transaction and such opinion does not constitute a recommendation as to how any holder of 
Shares should vote with respect to the Transaction or any other matter. This opinion has been 
approved by a fairness committee of Goldman, Sachs & Co.  
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the 
Consideration to be paid to the holders (other than BAT and its subsidiaries) of Shares pursuant 
to the Agreement is fair from a financial point of view to such holders.  
Very truly yours,  
  
/s/ Goldman, Sachs & Co. 
  
(GOLDMAN, SACHS & CO.) 
  
 




A. PROXY DISCUSSION OF OPINION OF JP MORGAN 
 
Opinions of RAI’s Financial Advisors  
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in 
connection with the merger. In connection with this engagement, the RAI board of directors 
requested that RAI’s financial advisors deliver the opinions described below.  
  
Opinion of J.P. Morgan  
On January 16, 2017, at the meeting of the RAI board of directors at which the merger 
agreement was approved, J.P. Morgan rendered to the RAI board of directors an oral opinion, 
subsequently confirmed by delivery to the RAI board of directors of a written opinion, dated 
January 16, 2017, to the effect that, as of such date and based upon and subject to the factors, 
procedures, qualifications, assumptions and any limitations set forth in its written opinion, the 
consideration per share of RAI common stock, consisting of (1) a number of BAT ADSs 
representing 0.5260 of a BAT ordinary share as of the effective time of the proposed merger plus 
(2) $29.44 in cash, taken together, to be paid to the holders of RAI common stock (other than the 
BAT Group) in the proposed merger was fair, from a financial point of view, to such holders (the 
consideration described in (1) and (2) is being collectively referred to as the merger 
consideration throughout this section, “Special Factors Relating to RAI Proposal I: Approval of 
the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of J.P. Morgan”).  
The full text of J.P. Morgan’s written opinion, dated January 16, 2017, which sets forth, 
among other things, the assumptions made, procedures followed, matters considered and 
qualifications and any limitations on the opinion and the review undertaken by J.P. Morgan in 
connection with rendering its opinion, is attached as Annex C to this proxy statement/prospectus 
and is incorporated herein by reference. The summary of the opinion of J.P. Morgan set forth 
in this proxy statement/prospectus is qualified in its entirety by reference to the full text of 
such opinion, and RAI shareholders are urged to read J.P. Morgan’s opinion attached as 
Annex C carefully and in its entirety. J.P. Morgan’s opinion was addressed to the RAI board of 
directors (in its capacity as such) in connection with and for the purposes of its evaluation of the 
merger, was directed only to the fairness, from a financial point of view, of the merger 
consideration to be paid to the holders of RAI common stock (other than the BAT Group) in the 
merger and did not address any other aspect of the merger. J.P. Morgan was not authorized to 
and did not solicit any expressions of interest from any other parties with respect to the sale of all 
or any part of RAI or any other alternative transaction. J.P. Morgan expressed no opinion as to 
the fairness of any consideration to be paid in connection with the merger to the holders of any 
other class of securities, creditors or other constituencies of RAI or as to the underlying decision 
by RAI to engage in the merger. The issuance of J.P. Morgan’s opinion was approved by a 
fairness committee of J.P. Morgan. The opinion does not constitute a recommendation to any 
shareholder of RAI as to how such shareholder should vote with respect to the merger or any 
other matter.  




  •   reviewed a draft dated January 16, 2017 of the merger agreement;  
  
  
•   reviewed certain publicly available business and financial information concerning RAI 
and BAT and the industries in which they operate;  
  
  
•   compared the proposed financial terms of the merger with the publicly available financial 
terms of certain transactions involving companies J.P. Morgan deemed relevant and the 
consideration paid for such companies;  
  
  
•   compared the financial and operating performance of RAI and BAT with publicly 
available information concerning certain other companies J.P. Morgan deemed relevant 
and reviewed the current and historical market prices of RAI common stock, BAT 




•   reviewed certain internal financial analyses and forecasts prepared by the management of 
RAI relating to the businesses of each of RAI (referred to in this section of the proxy 
statement/prospectus as the RAI projections) and BAT (which, in the case of the 
forecasts for BAT, were based in part on certain financial information for BAT prepared 
by the management of BAT and provided to RAI, and which are referred to in this 
section of the proxy statement/prospectus as the RAI projections for BAT), as well as the 
estimated amount and timing of the cost savings and related expenses and synergies 
expected to result from the merger (referred to in this section of the proxy 




•   performed such other financial studies and analyses and considered such other 
information as J.P. Morgan deemed appropriate for the purposes of its opinion.  
In addition, J.P. Morgan held discussions with certain members of the management of RAI 
and BAT with respect to certain aspects of the merger, and the past and current business 
operations of RAI and BAT, the financial condition and future prospects and operations of RAI 
and BAT, the effects of the merger on the financial condition and future prospects of RAI and 
BAT, and certain other matters J.P. Morgan believed necessary or appropriate to its inquiry.  
In giving its opinion, J.P. Morgan relied upon and assumed the accuracy and completeness 
of all information that was publicly available or was furnished to or discussed with J.P. Morgan 
by RAI and BAT or otherwise reviewed by or for J.P. Morgan, and J.P. Morgan did not 
independently verify (and, pursuant to its engagement letter with RAI, did not assume any 
obligation to undertake any such independent verification) any such information or its accuracy 
or completeness. J.P. Morgan did not conduct and was not provided with any valuation or 
appraisal of any assets or liabilities, nor did J.P. Morgan evaluate the solvency, of RAI or BAT, 
BATUS or Merger Sub under any state or federal laws relating to bankruptcy, insolvency or 
similar matters. In relying on financial analyses and forecasts provided to J.P. Morgan or derived 
therefrom, including the synergies, J.P. Morgan assumed that they had been reasonably prepared 
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based on assumptions reflecting the best currently available estimates and judgments by 
management as to the expected future results of operations and financial condition of RAI and 
BAT to which such analyses or forecasts relate. J.P. Morgan expressed no view as to such 
analyses or forecasts (including the synergies) or the assumptions on which they were based. 
J.P. Morgan also assumed that the merger and the other transactions contemplated by the merger 
agreement would have the tax consequences described in discussions with, and materials 
furnished to J.P. Morgan by, representatives of RAI, and would be consummated as described in 
the draft merger agreement, and that the definitive merger agreement would not differ in any 
material respects from the draft thereof furnished to J.P. Morgan. J.P. Morgan also assumed that 
the representations and warranties made by RAI and BAT, BATUS and Merger Sub in the 
merger agreement and the related agreements were and would be true and correct in all respects 
material to J.P. Morgan’s analysis. J.P. Morgan is not a legal, regulatory or tax expert and relied 
on the assessments made by advisors to RAI with respect to such issues. J.P. Morgan further 
assumed that all material governmental, regulatory or other consents and approvals necessary for 
the consummation of the merger would be obtained without any adverse effect on RAI or BAT 
or on the contemplated benefits of the merger.  
J.P. Morgan’s opinion was necessarily based on economic, market and other conditions as 
in effect on, and the information made available to J.P. Morgan as of, the date of such opinion. 
J.P. Morgan’s opinion noted that subsequent developments may affect J.P. Morgan’s opinion, 
and that J.P. Morgan does not have any obligation to update, revise, or reaffirm such opinion. 
J.P. Morgan’s opinion is limited to the fairness, from a financial point of view, of the merger 
consideration to be paid to the holders of RAI common stock (other than the BAT Group) in the 
proposed merger, and J.P. Morgan has expressed no opinion as to the fairness of any 
consideration to be paid in connection with the merger to the holders of any other class of 
securities, creditors or other constituencies of RAI or as to the underlying decision by RAI to 
engage in the merger. Furthermore, J.P. Morgan expressed no opinion with respect to the amount 
or nature of any compensation to any officers, directors, or employees of any party to the merger, 
or any class of such persons relative to the merger consideration to be paid to the holders of RAI 
common stock (other than the BAT Group) in the merger or with respect to the fairness of any 
such compensation. J.P. Morgan expressed no opinion as to the price at which the RAI common 
stock, BAT ordinary shares or BAT ADSs will trade at any future time.  
The terms of the merger agreement, including the merger consideration, were determined 
through arm’s-length negotiations between the Transaction Committee and BAT, and the 
decision to enter into the merger agreement was solely that of the BAT board of directors and the 
RAI board of directors, and, in the case of the decision of the RAI board of directors, based upon 
the approval and recommendation of the Transaction Committee. J.P. Morgan’s opinion and 
financial analyses were only one of the many factors considered by the RAI board of directors in 
its evaluation of the merger and should not be viewed as determinative of the views of the RAI 
board of directors or management with respect to the merger or the merger consideration.  
  
In accordance with customary investment banking practice, J.P. Morgan employed 
generally accepted valuation methodologies in rendering its opinion to the RAI board of 
directors on January 16, 2017. The following is a summary of the material financial analyses 
utilized by J.P. Morgan and contained in the presentation delivered to the RAI board of directors 
on such date in connection with the rendering of such opinion. It does not purport to be a 
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complete description of the analyses or data presented by J.P. Morgan. Some of the summaries of 
the financial analyses include information presented in tabular format. The tables are not 
intended to stand alone, and in order to more fully understand the financial analyses used by J.P. 
Morgan, the tables must be read together with the full text of each summary. Considering the 
data set forth below without considering the full narrative description of the financial analyses, 
including the methodologies and assumptions underlying the analyses, could create a misleading 
or incomplete view of J.P. Morgan’s analyses.  
Analysis of RAI  
Public Trading Multiples Analysis  
Using publicly available information, J.P. Morgan compared selected financial data of RAI 
with similar data for selected publicly traded companies engaged in businesses which J.P. 
Morgan judged to be similar in certain respects to RAI’s business or aspects thereof. The 
companies selected by J.P. Morgan were as follows:  
  
  •   Altria Group Inc.;  
  
  •   British American Tobacco p.l.c.;  
  
  •   Imperial Brands p.l.c.;  
  
  •   Japan Tobacco Inc.;  
  
  •   Philip Morris International Inc.; and  
  
  •   Swedish Match AB.  
These companies were selected, among other reasons, because they are publicly traded 
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be 
considered similar in certain respects to those of RAI based on business sector participation, 
financial metrics and form of operations, including product mix, end markets, customers and 
size, of such companies. However, none of the selected companies reviewed is identical to RAI, 
and certain of these companies may have characteristics that are materially different from those 
of RAI. The analyses necessarily involve complex considerations and judgments concerning 
differences in financial and operational characteristics of the companies involved and other 
factors that could affect the companies differently than they would affect RAI.  
For each company listed above, J.P. Morgan calculated and compared various financial 
multiples and ratios based on publicly available information as of January 13, 2017, and in all 
instances multiples were based on closing share prices on January 13, 2017. For purposes of this 
analysis, J.P. Morgan obtained the amounts of earnings before interest, taxes, depreciation and 
amortization estimated for calendar year 2017 (referred to in this section of the proxy 
statement/prospectus as 2017E EBITDA) and earnings per share estimated for calendar year 
2017, in the case of BAT, from publicly available research analysts’ consensus estimates and, in 
the case of the other selected companies, from FactSet Research Systems. Other financial data 
used for purposes of this analysis, including the market value of equity and stock price 
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information for each selected company, were based on public filings and other publicly available 
information. Among other calculations, the information J.P. Morgan calculated for each of the 
selected companies included:  
  
  
•   the multiple of implied firm value, referred to in this section of the proxy 
statement/prospectus as FV (calculated as the market value of equity plus total debt and 
other adjustments, including minority interests, net of cash and cash equivalents) to 
2017E EBITDA, referred to in this section of the proxy statement/prospectus as 
FV/2017E EBITDA; and   
  
•   the multiple of stock price of its common equity to estimated earnings per share for 
calendar year 2017, referred to in this section of the proxy statement/prospectus as 
P/E 2017E.  
Results of the analysis were presented for the selected companies, as indicated in the 
following table:  
Trading Multiples  
  
     
FV 
(in billions)    
FV/2017E 
EBITDA     P/E 2017E  
Altria Group Inc.    $ 124.5      12.7x      20.3x  
British American Tobacco p.l.c.    $ 135.4      11.7x      17.1x  
British American Tobacco p.l.c.*    $ 93.9      11.6x      17.1x  
Imperial Brands p.l.c.    $ 57.1      11.4x      13.0x  
Japan Tobacco Inc.    $ 64.1      10.1x      16.5x  
Philip Morris International Inc.    $ 166.7      13.5x      18.8x  
Swedish Match AB    $ 6.2      12.0x      17.3x  
  
* Excludes BAT’s proportionate ownership in RAI and ITC Limited.  
For the selected companies, J.P. Morgan’s analysis resulted in a range of FV/2017E 
EBITDA multiples of 10.1x to 13.5x, an average FV/2017E EBITDA multiple of 11.9x and a 
median FV/2017E EBITDA multiple of 12.0x. J.P. Morgan’s analysis also resulted in a range of 
P/E 2017E multiples of 13.0x to 20.3x, an average P/E 2017E multiple of 17.2x and a median 
P/E 2017E multiple of 17.3x for the selected companies.  
Based on the results of this analysis of selected publicly traded companies and J.P. 
Morgan’s professional judgment, J.P. Morgan derived a multiple reference range of 10.0x-13.5x 
for FV/2017E EBITDA and a multiple reference range of 13.0x-20.5x for P/E 2017E. After 
applying such ranges to 2017E EBITDA and estimated earnings per share for calendar year 2017 
of RAI, in each case, as set forth in the RAI projections, the analysis indicated the following 
ranges of implied equity value per share for RAI common stock, rounded to the nearest $0.25:  
RAI Implied Equity Value Per Share  
  
     Low     High   
FV/2017E EBITDA    $    36.50    $    51.75  
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P/E 2017E    $ 32.50    $ 51.25  
The ranges of implied equity value per share for RAI common stock were compared to 
(1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the last 
trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price 
per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI 
common stock prior to the announcement of the merger agreement on January 17, 2017, and 
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which 
was determined by valuing the BAT ADSs included in the merger consideration based on the 
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on 
January 13, 2017 divided by two (which was the number of BAT ordinary shares then 
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per 
BAT ordinary share of $57.61)).  
Selected Transaction Multiples Analysis  
Using publicly available information, J.P. Morgan examined selected transactions since 
2001 involving businesses which, based on J.P. Morgan’s experience and familiarity with RAI’s 
industry, J.P. Morgan judged to be similar in certain respects to RAI’s business or aspects 
thereof, considering, among other reasons, business sector participation, financial metrics and 
form of operations, including product mix, end markets, customers and size, of such businesses.  
  
Using publicly available information, J.P. Morgan calculated, for each of the selected 
transactions, the multiple of the target company’s FV implied by the consideration paid in such 
transaction to the target company’s EBITDA for the twelve-month period prior to the 
announcement date of the applicable transaction, referred to in this section of the proxy 
statement/prospectus as LTM EBITDA.  
The selected transactions, the month and year each such transaction was announced and the 
results of the analysis for each such transaction are as indicated in the following table:  
  
Announcement 
Date    Target    Acquirer    
FV 
(in millions)    
FV / LTM 
EBITDA 
June 2015    TDR d.o.o.    BAT    $ 599    12.5x 
February 2015    Souza Cruz SA    BAT    $ 14,185    16.0x 
July 2014    Lorillard, Inc.    RAI    $ 27,949    13.8x 
July 2014 
   
Lorillard, Inc. and RAI 
assets    
Imperial Tobacco 
Group p.l.c.    $ 7,056    8.8x 
May 2011 
   
Productora Tabacalera 
de Colombia, S.A.S. 
(Protabaco)    BAT    $ 452    11.3x 
June 2009 
   
PT Bentoel 
Internasional Investama 
Tbk    BAT    $ 744    14.0x 
September 




   Rothmans Inc.    
Philip Morris 
International Inc.    $ 1,934    9.7x 
February 2008 
   
Skandinavisk 
Tobakskompagni    BAT    $ 4,141    11.2x 
February 2008    Tekel    BAT    $ 1,720    11.4x 
November 2007   John Middleton Co.    Philip Morris USA    $ 2,900    15.8x 
July 2007 
   Altadis SA    
Imperial Tobacco 
Group p.l.c.    $     22,619    14.1x 
February 2007 
   
Commonwealth Brands 
Inc.    
Imperial Tobacco 
Group p.l.c.    $ 1,900    10.9x 
January 2007 
   
Lakson Tobacco Co. 
Ltd.    
Philip Morris 
International Inc.    $ 675    14.8x 
December 2006    Gallaher Group plc    Japan Tobacco Inc.    $ 18,938    13.0x 
April 2006    Conwood LP    RAI    $ 3,500    13.6x 
March 2005 
   PT HM Sampoerna Tbk    
Philip Morris 
International Inc.    $ 5,082    13.9x 
March 2002 
   
Reemtsma 
Cigarettenfabriken 
GmbH    
Imperial Tobacco 
Group p.l.c.    $ 5,103    13.4x 
June 2001    Austria Tabak AG    Gallaher Group plc    $ 1,871    7.4x 
J.P. Morgan’s analysis resulted in a range of implied FV to LTM EBITDA multiples of 7.4x 
to 16.0x for the selected transactions, a mean implied FV to LTM EBITDA multiple of 12.5x for 
the selected transactions and a median implied FV to LTM EBITDA multiple of 13.0x for the 
selected transactions.  
Based on the results of this analysis and J.P. Morgan’s professional judgment, J.P. Morgan 
derived a multiple reference range of 12.0x-16.0x for implied FV to LTM EBITDA. After 
applying such range to the appropriate metric for RAI (which, in the case of LTM EBITDA of 
RAI, was adjusted for certain cost synergies related to RAI’s acquisition of Lorillard at the 
direction of the management of RAI) as set forth in the RAI projections, the analysis indicated 
the following range of implied equity value per share for RAI common stock, rounded to the 
nearest $0.25:  
RAI Implied Equity Value Per Share  
  
     Low     High   
Implied FV/LTM Adjusted EBITDA    $    43.00    $    60.00  
For reference only and not as a component of its fairness analysis, J.P. Morgan also applied 
the 12.0x-16.0x multiple reference range to the appropriate metric of RAI (without, in the case of 
LTM EBITDA of RAI, giving effect to the adjustment described above) as set forth in the RAI 
projections, and the analysis indicated the following range of implied equity value per share for 
RAI common stock, rounded to the nearest $0.25.  
  




     Low     High   
Implied FV/LTM EBITDA    $    42.00    $    58.75  
The ranges of implied equity value per share for RAI common stock were compared to 
(1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the last 
trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price 
per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI 
common stock prior to the announcement of the merger agreement on January 17, 2017, and 
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which 
was determined by valuing the BAT ADSs included in the merger consideration based on the 
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on 
January 13, 2017 divided by two (which was the number of BAT ordinary shares then 
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per 
BAT ordinary share of $57.61)).  
Discounted Cash Flow Analysis  
J.P. Morgan conducted a discounted cash flow analysis for the purpose of determining an 
implied equity value per share for RAI common stock. A discounted cash flow analysis is a 
method of evaluating an asset using estimates of the future unlevered free cash flows generated 
by the asset, and taking into consideration the time value of money with respect to those future 
cash flows by calculating their “present value.” The “unlevered free cash flows” refer to a 
calculation of the future cash flows generated by an asset without including in such calculation 
any debt servicing costs. “Present value” refers to the current value of the cash flows generated 
by the asset and is obtained by discounting those cash flows back to the present using a discount 
rate that takes into account macro-economic assumptions and estimates of risk, the opportunity 
cost of capital and other appropriate factors. “Terminal value” refers to the present value of all 
future cash flows generated by the asset for periods beyond the projections period. The 
discounted cash flow analysis conducted by J.P. Morgan treated stock-based compensation as a 
cash expense.  
J.P. Morgan calculated the present value of unlevered free cash flows that RAI is expected 
to generate during the period from calendar year 2017 through the end of 2021 using the RAI 
projections. J.P. Morgan also calculated a range of terminal values for RAI at December 31, 
2021 by applying a terminal growth rate ranging from 0.0% to 1.0% to the RAI projections 
during 2021 to derive terminal period unlevered free cash flows for RAI. The unlevered free cash 
flows and the range of terminal values were then discounted to present values using a range of 
discount rates from 5.75% to 6.75%, which range was chosen by J.P. Morgan based upon an 
analysis of the weighted average cost of capital of RAI, which included J.P. Morgan’s analysis of 
the selected companies listed under “—Public Trading Multiples Analysis” described above.  
This analysis indicated the following range of implied equity value per share for RAI 
common stock, rounded to the nearest $0.25.  
RAI Implied Equity Value Per Share  
  
     Low     High   
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Discounted Cash Flow Analysis    $    47.50    $    68.75  
The range of implied equity value per share for RAI common stock was compared to (1) the 
closing price per share of RAI common stock of $47.17 on October 20, 2016, the last trading day 
prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price per share of 
RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI common 
stock prior to the announcement of the merger agreement on January 17, 2017, and (3) the 
implied value of the merger consideration on January 13, 2017 of  $59.74 per share (which was 
determined by valuing the BAT ADSs included in the merger consideration based on the 
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on 
January 13, 2017 divided by two (which was the number of BAT ordinary shares then 
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per 
BAT ordinary share of $57.61)).  
Other Information  
Historical Trading Range. For reference only and not as a component of its fairness 
analysis, J.P. Morgan reviewed the trading range of RAI common stock for the 52-week period 
ended October 20, 2016, the last trading day prior to BAT’s announcement of a proposal to 
merge with RAI, which was $43.50 per share to $54.50 per share (with a volume weighted 
average price per share of $48.71 for the three months ended October 20, 2016), and compared 
that to (1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the 
last trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing 
price per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the 
RAI common stock prior to the announcement of the merger agreement on January 17, 2017, and 
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which 
was determined by valuing the BAT ADSs included in the merger consideration based on the 
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on 
January 13, 2017 divided by two (which was the number of BAT ordinary shares then 
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per 
BAT ordinary share of $57.61)).  
Analyst Price Targets. For reference only and not as a component of its fairness analysis, 
J.P. Morgan also reviewed certain publicly available equity research analyst share price targets 
for RAI common stock as of October 20, 2016, the last trading day prior to BAT’s 
announcement of a proposal to merge with RAI, and noted that the range of such price targets 
was $47.00 per share to $62.00 per share, and compared that to (1) the closing price per share of 
RAI common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s 
announcement of a proposal to merge with RAI, (2) the closing price per share of RAI common 
stock of $55.97 on January 13, 2017, the last trading day of the RAI common stock prior to the 
announcement of the merger agreement on January 17, 2017, and (3) the implied value of the 
merger consideration on January 13, 2017 of $59.74 per share (which was determined by valuing 
the BAT ADSs included in the merger consideration based on the exchange ratio in the merger 
of 0.5260 and the closing price per BAT ADS of $115.21 on January 13, 2017 divided by two 
(which was the number of BAT ordinary shares then represented by one BAT ADS and which 
calculation resulted in an implied hypothetical price per BAT ordinary share of $57.61)).  
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J.P. Morgan noted that the analyses described above under “—Analysis of RAI” were 
hypothetical, illustrative analyses only and were not a prediction as to future share trading.  
Analysis of BAT  
Public Trading Multiples Analysis  
Using publicly available information, J.P. Morgan compared selected financial data of BAT 
with similar data for publicly traded companies engaged in businesses which J.P. Morgan judged 
to be similar in certain respects to BAT’s business or aspects thereof. The companies selected by 
J.P. Morgan were the same companies listed under “—Analysis of RAI—Public Trading 
Multiples Analysis” above.  
These companies were selected, among other reasons, because they are publicly traded 
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be 
considered similar in certain respects to those of BAT based on business sector participation, 
financial metrics and form of operations. However, none of the selected companies reviewed is 
identical to BAT and certain of these companies may have characteristics that are materially 
different from those of BAT. The analyses necessarily involve complex considerations and 
judgments concerning differences in financial and operational characteristics of the companies 
involved and other factors that could affect the companies differently than they would affect 
BAT.  
  
Based on the results of the analysis described under “—Analysis of RAI—Public Trading 
Multiples Analysis” and J.P. Morgan’s professional judgment, J.P. Morgan derived a multiple 
reference range of 10.0x-13.5x for FV/2017E EBITDA and a multiple reference range of 13.0x-
20.5x for P/E 2017E. After applying such ranges to 2017E EBITDA of BAT (adjusted to include 
BAT’s proportionate ownership in RAI and ITC Limited, converted at unaffected exchange 
rates) and estimated earnings per share for calendar year 2017 of BAT, in each case, as set forth 
in the RAI projections for BAT, the analysis indicated the following ranges of implied equity 
value per BAT ordinary share, rounded to the nearest £0.25:  
BAT Implied Equity Value Per Share  
  
     Low     High   
FV/2017E EBITDA    £    39.25    £    56.25  
P/E 2017E    £ 36.50    £ 57.50  
The ranges of implied equity value per BAT ordinary share were compared to (1) the 
closing price per BAT ordinary share of £48.03 on October 20, 2016, the last trading day prior to 
BAT’s announcement of a proposal to merge with RAI and (2) the closing price per BAT 
ordinary share of £47.30 on January 13, 2017, the last trading day of the RAI common stock 
prior to the announcement of the merger agreement on January 17, 2017.  
Discounted Cash Flow Analysis  
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J.P. Morgan conducted a discounted cash flow analysis for the purpose of determining an 
implied equity value per BAT ordinary share, using the same methodology as described under 
“—Analysis of RAI—Discounted Cash Flow Analysis,” except as noted below.  
J.P. Morgan calculated the present value of unlevered free cash flows that BAT is expected 
to generate during the period from calendar year 2017 through the end of 2021 using the RAI 
projections for BAT. J.P. Morgan also calculated a range of terminal values for BAT at 
December 31, 2021 by applying a terminal growth rate ranging from 0.0% to 1.0% to the RAI 
projections for BAT during 2021 to derive terminal period unlevered free cash flows for BAT. 
The unlevered free cash flows and the range of terminal values were then discounted to present 
values using a range of discount rates from 6.75% to 8.0%, which range was chosen by J.P. 
Morgan based upon an analysis of the weighted average cost of capital of BAT, which included 
J.P. Morgan’s analysis of RAI and the selected companies listed under “—Public Trading 
Multiples Analysis” described above.  
This analysis indicated the following range of implied equity value per BAT ordinary share 
(which includes the implied values of BAT’s minority interests and BAT’s proportionate 
ownership in RAI and ITC Limited, applying, in the case of BAT’s proportionate ownership in 
RAI, a GBP-U.S. dollar exchange rate of 1.2186 as of January 13, 2017), rounded to the nearest 
£0.25.  
BAT Implied Equity Value Per Share  
  
     Low     High   
Discounted Cash Flow    £    41.75    £    58.75  
The range of implied equity value per BAT ordinary share was compared to (1) the closing 
price per BAT ordinary share of £48.03 on October 20, 2016, the last trading day prior to BAT’s 
announcement of a proposal to merge with RAI and (2) the closing price per BAT ordinary share 
of £47.30 on January 13, 2017, the last trading day of the RAI common stock prior to the 
announcement of the merger agreement on January 17, 2017.  
  
Other Information  
Historical Trading Range. For reference only and not as a component of its fairness 
analysis, J.P. Morgan reviewed the trading range of BAT ordinary shares for the 52-week period 
ended October 20, 2016, the last trading day prior to BAT’s announcement of a proposal to 
merge with RAI, which was £35.75 per share to £50.50 per share (with a volume weighted 
average price per BAT ordinary share of £48.32 for the three months ended October 20, 2016), 
and compared that to (1) the closing price per BAT ordinary share of £48.03 on October 20, 
2016, the last trading day prior to BAT’s announcement of a proposal to merge with RAI and 
(2) the closing price per BAT ordinary share of £47.30 on January 13, 2017, the last trading day 
of the RAI common stock prior to the announcement of the merger agreement on January 17, 
2017.  
Analyst Price Targets. For reference only and not as a component of its fairness analysis, 
J.P. Morgan also reviewed certain publicly available equity research analyst share price targets 
for BAT ordinary shares as of October 20, 2016, the last trading day prior to BAT’s 
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announcement of a proposal to merge with RAI, and noted that the range of such price targets 
was £43.00 per share to £58.00 per share, and compared that to (1) the closing price per BAT 
ordinary share of £48.03 on October 20, 2016, the last trading day prior to BAT’s announcement 
of a proposal to merge with RAI, and (2) the closing price per BAT ordinary share of £47.30 on 
January 13, 2017, the last trading day of the RAI common stock prior to the announcement of the 
merger agreement on January 17, 2017.  
J.P. Morgan noted that the analyses described above under “—Analysis of BAT” were 
hypothetical, illustrative analyses only and were not a prediction as to future share trading.  
Other Analyses  
Illustrative Value Creation Analyses  
Illustrative Market-Based Value Creation Analysis. For reference only and not as a 
component of its fairness analysis, J.P. Morgan reviewed certain market-based analyses of the 
potential illustrative value created by the merger for the existing holders of shares of RAI 
common stock (other than the BAT Group) that compared the estimated implied equity value per 
share of RAI common stock on a standalone basis based on the closing price per share of RAI 
common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s announcement 
of a proposal to merge with RAI to the sum of (1) the implied equity value per share of the 
ownership of RAI shareholders (other than the BAT Group) in the pro forma combined company 
and (2) the $29.44 cash per share included in the merger consideration.  
J.P. Morgan determined the pro forma combined company implied equity value by 
calculating: (1) the sum of (a) the implied equity value of BAT using an implied hypothetical 
price per BAT ordinary share of $57.61 on January 13, 2017, the last trading day of the RAI 
common stock prior to the announcement of the merger agreement, which was calculated based 
on a GBP-U.S. dollar exchange rate of 1.2186 as of January 13, 2017, the last trading day of the 
RAI common stock prior to the announcement of the merger agreement on January 17, 2017, and 
a closing price per BAT ADS of $115.21 divided by two (which was the number of BAT 
ordinary shares then represented by one BAT ADS and which calculation resulted in such 
implied hypothetical price per BAT ordinary share of $57.61), (b) the implied equity value of 
RAI common stock not owned by the BAT Group, using the closing price per share of RAI 
common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s announcement 
of a proposal to merge with RAI, (c) $500 million annual run-rate synergies estimated by the 
management of RAI based in part on information provided by the management of the BAT 
Group, capitalized by applying a blended implied FV/EBITDA multiple of 12.5x, and (d) the 
present value of $140 million annual tax efficiencies estimated by the management of RAI based 
in part on information provided by the management of the BAT Group, using a discount rate of 
5.0% and a growth rate of 0.0%, less (2) the sum of (a) the estimated transaction fees and 
expenses relating to the merger provided to J.P. Morgan by the management of RAI, and (b) the 
aggregate amount of cash to be paid to the holders of RAI common stock (other than the BAT 
Group) in the merger.  
  
These analyses indicated that the merger would result in illustrative market-based value 
creation of 25.8% for the holders of RAI common stock (other than the BAT Group) above the 
standalone implied equity value of RAI. There can be no assurance, however, that the synergies, 
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tax efficiencies, estimated transaction-related expenses and other impacts will not be 
substantially greater or less than those estimated by the managements of RAI and the BAT 
Group, as applicable, and described above.  
J.P. Morgan noted that the market-based value creation analysis was a hypothetical, 
illustrative analysis only and was not a prediction of future share trading.  
Illustrative Intrinsic Value Creation Analysis. J.P. Morgan reviewed certain intrinsic 
analyses of the potential illustrative value created by the merger for the existing holders of shares 
of RAI common stock (other than the BAT Group) that compared the estimated implied equity 
value per share of RAI common stock on a standalone basis based on the midpoint value 
determined by J.P. Morgan’s discounted cash flow analysis described above under “—Analysis 
of RAI—Discounted Cash Flow Analysis” to the sum of (1) the implied equity value per share of 
the ownership of RAI shareholders (other than the BAT Group) in the pro forma combined 
company and (2) the $29.44 cash per share included in the merger consideration.  
J.P. Morgan determined the pro forma combined company implied equity value by calculating: 
(1) the sum of (a) the implied equity value of BAT, using the midpoint value determined in J.P. 
Morgan’s discounted cash flow analysis for BAT described above under “—Analysis of BAT—
Discounted Cash Flow Analysis” and a GBP-U.S. dollar exchange rate of 1.2186 as of 
January 13, 2017, the last trading day of the RAI common stock prior to the announcement of the 
merger agreement on January 17, 2017, (b) the implied equity value of RAI common stock not 
owned by the BAT Group using the midpoint value determined in J.P. Morgan’s discounted cash 
flow analysis for RAI described above under “—Analysis of RAI—Discounted Cash Flow 
Analysis,” calculated by using a 6.25% discount rate and a terminal growth rate of 0.5%, (c) the 
present value of $500 million annual run-rate synergies estimated by the management of RAI 
based in part on information provided by the management of the BAT Group, using a 6.25% 
discount rate and a growth rate of 0.0%, and (d) the present value of $140 million annual tax 
efficiencies estimated by the management of RAI based in part on information provided by the 
management of the BAT Group, using a discount rate of 5.0% and a growth rate of 0.0%, less 
(2) the sum of (a) the estimated transaction fees and expenses relating to the merger provided to 
J.P. Morgan by the management of RAI, and (b) the aggregate amount of the cash to be paid to 
the holders of RAI common stock (other than the BAT Group) in the merger.  
These analyses indicated that the merger would result in illustrative intrinsic value creation 
of 9.6% for the holders of RAI common stock (other than the BAT Group) above the standalone 
implied equity value of RAI. There can be no assurance, however, that the synergies, tax 
efficiencies, estimated transaction-related expenses and other impacts will not be substantially 
greater or less than those estimated by the managements of RAI and the BAT Group, as 
applicable, and described above.  
J.P. Morgan noted that the intrinsic value creation analysis was a hypothetical, illustrative 
analysis only and was not a prediction of future share trading.  
Historical Exchange Ratio Analysis  
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For reference only and not as a component of its fairness analysis, J.P. Morgan reviewed the 
per share daily closing market prices of RAI common stock and BAT ordinary shares from 
July 14, 2014, the day prior to the announcement of the Lorillard merger, to January 13, 2017, 
the last trading day of the RAI common stock prior to the announcement of the merger 
agreement on January 17, 2017, and J.P. Morgan calculated the implied historical exchange 
ratios for the periods specified below, including the implied historical exchange ratios after 
adjusting the closing market prices of RAI common stock for the $29.44 cash per share included 
in the merger consideration (referred to in this section of the proxy statement/prospectus as the 
cash adjusted exchange ratio). Specifically, for each trading day, J.P. Morgan divided the daily 
closing price per share of RAI common stock (in case of the cash adjusted exchange ratio, after 
adjustment for the $29.44 cash per share included in the merger consideration) by the closing 
price per BAT ordinary share. J.P. Morgan calculated the average of the implied historical 
exchange ratios (including the cash adjusted exchange ratio) for the one-month, six-month and 
one-year periods ended October 20, 2016, the last trading day prior to BAT’s announcement of a 
proposal to merge with RAI, and the average for the period from June 11, 2015, the date the 
Lorillard merger was completed, until October 20, 2016. J.P. Morgan also calculated the average 
of the implied historical exchange ratios (including the cash adjusted exchange ratio) for the 
period from October 21, 2016 until January 13, 2017, the last trading day of the RAI common 
stock prior to the announcement of the merger agreement on January 17, 2017. The analysis 
resulted in the following implied exchange ratios for the dates and periods indicated, all as 













1-Month Average Ended October 20, 2016  
  0.2897x 
 
  0.7680x 
6-Month Average Ended October 20, 2016  
  0.3298x 
 
  0.8046x 
1-year Average Ended October 20, 2016  
  0.3299x 
 
  0.8287x 
Average for Period from June 11, 2015 to October 20, 2016  
  0.3001x 
 
  0.8071x 
Average for Period from October 21, 2016 to January 13, 
2017 
 
  0.4582x 
 
  0.9864x 
J.P. Morgan also noted that the highest cash adjusted exchange ratio and the highest implied 
historical exchange ratio for the period from June 11, 2015 to October 20, 2016 were 0.4027x 
and 0.9538x, respectively.  
Miscellaneous  
The foregoing summary of certain material financial analyses does not purport to be a 
complete description of the analyses or data presented by J.P. Morgan. The preparation of a 
fairness opinion is a complex process and is not necessarily susceptible to partial analysis or 
summary description. J.P. Morgan believes that the foregoing summary and its analyses must be 
considered as a whole and that selecting portions of the foregoing summary and these analyses, 
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without considering all of its analyses as a whole, could create an incomplete view of the 
processes underlying the analyses and its opinion. As a result, the ranges of valuations resulting 
from any particular analysis or combination of analyses described above were merely utilized to 
create points of reference for analytical purposes and should not be taken to be the view of J.P. 
Morgan with respect to the actual value of RAI or BAT. The order of analyses described does 
not represent the relative importance or weight given to those analyses by J.P. Morgan. In 
arriving at its opinion, J.P. Morgan did not attribute any particular weight to any analyses or 
factors considered by it and did not form an opinion as to whether any individual analysis or 
factor (positive or negative), considered in isolation, supported or failed to support its opinion. 
Rather, J.P. Morgan considered the totality of the factors and analyses performed in determining 
its opinion.  
Analyses based upon forecasts of future results are inherently uncertain, as they are subject 
to numerous factors or events beyond the control of the parties and their advisors. Accordingly, 
forecasts and analyses used or performed by J.P. Morgan are not necessarily indicative of actual 
future results, which may be significantly more or less favorable than suggested by those 
analyses. Moreover, J.P. Morgan’s analyses are not and do not purport to be appraisals or 
otherwise reflective of the prices at which businesses actually could be acquired or sold. None of 
the selected companies reviewed as described in the above summary is identical to RAI or BAT, 
and none of the selected transactions reviewed was identical to the merger. However, the 
companies selected were chosen, among other reasons, because they are publicly traded 
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be 
considered similar in certain respects to those of RAI or BAT. The transactions selected were 
similarly chosen because their participants, size and other factors, for purposes of J.P. Morgan’s 
analysis, may be considered similar in certain respects to the merger. The analyses necessarily 
involve complex considerations and judgments concerning differences in financial and 
operational characteristics of the companies involved and other factors that could affect the 
companies compared to RAI or BAT and the transactions compared to the merger.  
  
As a part of its investment banking business, J.P. Morgan and its affiliates are continually 
engaged in the valuation of businesses and their securities in connection with mergers and 
acquisitions, investments for passive and control purposes, negotiated underwritings, secondary 
distributions of listed and unlisted securities, private placements, and valuations for corporate 
and other purposes. J.P. Morgan was selected to advise RAI with respect to the merger and 
deliver an opinion to the RAI board of directors with respect to the merger on the basis of, 
among other things, such experience and its qualifications and reputation in connection with such 
matters and its familiarity with RAI, BAT and the industries in which they operate.  
For services rendered in connection with the merger (including the delivery of its opinion), 
RAI has agreed to pay J.P. Morgan a fee of 0.07% of the total consideration payable in the 
merger, which includes the merger consideration to be paid to holders of RAI common stock 
(other than the BAT Group) and equity awards at the closing of the merger, the value of any 
equity awards of RAI to be assumed by BAT, any dividends or other distributions declared by 
RAI with respect to its capital stock following October 30, 2016 (other than normal recurring 
cash dividends in amounts not materially greater than then-currently paid) and amounts paid by 
RAI to repurchase any securities of RAI outstanding on November 22, 2016 (other than in the 
ordinary course of business). Based on the closing price per BAT ADS on June 8, 2017, J.P. 
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Morgan’s fee would be approximately $39.1 million of which $1.0 million became payable upon 
the execution of the engagement letter with J.P. Morgan on November 22, 2016, $2.0 million 
became payable upon the delivery by J.P. Morgan of its opinion, $1.0 million became payable on 
January 30, 2017 and $1.0 million became payable on April 30, 2017 (and additional $1.0 
million installments will subsequently become payable on each three-month anniversary of 
April 30, 2017 until October 30, 2017 if the merger has not been completed before that date), and 
the remainder of which will be due upon the completion of the merger. In addition, RAI may, in 
its sole discretion, based on its assessment of J.P. Morgan’s performance of its services, pay J.P. 
Morgan an additional fee of up to 0.01% of the total consideration payable in the merger 
described above. Based on the closing price per BAT ADS on June 8, 2017, the maximum 
amount of such additional fee would be approximately $5.6 million. In addition, RAI has agreed 
to indemnify J.P. Morgan for certain liabilities arising out of J.P. Morgan’s engagement.  
During the two years preceding the date of J.P. Morgan’s opinion, J.P. Morgan and its 
affiliates have had commercial or investment banking relationships with RAI and BAT, for 
which J.P. Morgan and such affiliates have received customary compensation. Such services 
during such period have included acting as sole arranger and bookrunner on an amendment and 
extension of RAI’s revolving credit facility in October 2015 and on an extension of such facility 
in November 2016; as lead left arranger and bookrunner on RAI’s syndicated facility in June 
2015; as bookrunner on an offering of debt securities by RAI in June 2015; as M&A financial 
advisor to RAI on its sale of the international rights to the NATURAL AMERICAN SPIRIT 
brand name and associated trademarks outside the United States in January 2016; as joint 
bookrunner on an offering of debt securities by BAT in June 2015 and as joint bookrunner on an 
offering of debt securities by BAT in September 2016. During such period, J.P. Morgan and its 
affiliates have provided treasury and asset management services to RAI and asset management 
services to BAT, in each case for customary compensation. In addition, J.P. Morgan’s 
commercial banking affiliate is an agent bank and a lender under the outstanding revolving credit 
facility of RAI, for which it receives customary compensation or other financial benefits. During 
such two year period, the aggregate fees received by J.P. Morgan from RAI and BAT for such 
services were approximately $54.0 million and $4.9 million, respectively. In addition, J.P. 
Morgan and its affiliates hold, on a proprietary basis, less than 1% of the outstanding RAI 
common stock and BAT ordinary shares (including BAT ordinary shares represented by BAT 
ADSs). In the ordinary course of their businesses, J.P. Morgan and its affiliates may actively 
trade the debt and equity securities or financial instruments (including derivatives, bank loans or 
other obligations) of RAI or BAT for their own account or for the accounts of customers and, 
accordingly, J.P. Morgan may at any time hold long or short positions in such securities or other 
financial instruments.  
Preliminary Financial Analyses by J.P. Morgan  
In addition to the financial analyses utilized by J.P. Morgan and contained in its 
presentation delivered to the RAI board of directors on January 16, 2017 in connection with the 
rendering of its opinion, J.P. Morgan, in  
its capacity as financial advisor to the RAI board of directors, conducted a series of preliminary 
financial analyses. J.P. Morgan discussed these preliminary financial analyses with the RAI 
board of directors on November 8, 2016, December 7, 2016, December 20, 2016, January 10, 
2017 and January 14, 2017 (such preliminary financial analyses are collectively referred to in 
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this section of the proxy statement/prospectus as the J.P. Morgan preliminary financial analyses). 
Copies of the written materials containing the J.P. Morgan preliminary financial analyses have 
been attached as exhibits to the Schedule 13E-3 filed by RAI and the Schedule 13E-3 filed by 
BAT with the SEC. These written presentations will be available to any interested shareholder of 
RAI (or any representative of a shareholder who has been so designated in writing) to inspect 
and copy at RAI’s principal executive offices during regular business hours.  
The J.P. Morgan preliminary financial analyses primarily addressed the continuing 
negotiations of a potential transaction between RAI and BAT and included summaries of the 
various proposals submitted by BAT and described above under “—Background of the Merger,” 
various summary data, illustrative analyses and other information that J.P. Morgan utilized in 
formulating its preliminary perspectives regarding a potential transaction. The J.P. Morgan 
preliminary financial analyses were prepared for discussion purposes only and did not make any 
recommendations or constitute, or form the basis or part of, its fairness analysis or J.P. Morgan’s 
opinion dated January 16, 2017 with respect to the fairness, from a financial point of view, of the 
merger consideration to be paid to holders of RAI common stock (other than the BAT Group) in 
the proposed merger. Except for the assumptions and qualifications set forth in the materials 
containing such preliminary analyses, the J.P. Morgan preliminary financial analyses were 
substantially similar to, and were prepared using substantially the same methodologies as, the 
financial analyses described above and contained in the presentation delivered to the RAI board 
of directors on January 16, 2017 in connection with the rendering of J.P. Morgan’s opinion. A 
summary of the written materials and the J.P. Morgan preliminary financial analyses is provided 
below. The following summary, however, does not purport to be a complete description of these 
materials or of the J.P. Morgan preliminary financial analyses included in these materials.  
November 8, 2016 Materials  
The November 8, 2016 materials discussed with the RAI board of directors included, 
among other information, a summary of BAT’s October 20 Proposal, a summary of selected 
news and commentary regarding a potential transaction between RAI and BAT, a summary of 
certain preliminary financial forecasts for RAI prepared by the management of RAI and provided 
to J.P. Morgan (referred to in this section of the proxy statement/prospectus as the preliminary 
RAI projections), a summary of certain preliminary financial forecasts for BAT based on 
publicly available equity analysts’ consensus estimates and extrapolations that had been 
reviewed and approved for J.P. Morgan’s use by the management of RAI (referred to in this 
section of the proxy statement/prospectus as the preliminary RAI projections for BAT), a 
discussion of the potential synergies and tax efficiencies to be achieved in a potential transaction 
as estimated by BAT and RAI and the implications thereof for a potential transaction, an 
overview of certain considerations relating to the financing of the cash portion of the proposed 
transaction consideration and a discussion of potential strategic alternatives for RAI.  
The November 8, 2016 materials also included, among other information, public trading 
multiples analyses, selected transaction multiples analyses, discounted cash flow analyses, 
historical trading ranges and analyst price targets, illustrative value creation analyses, a historical 
exchange ratio analysis and an illustrative accretion/dilution analysis (which analysis compared 
certain financial metrics for BAT on a standalone basis to the corresponding financial metrics 
implied for the pro forma combined company). Based on certain of these preliminary financial 
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analyses and for purposes of discussing BAT’s October 20 Proposal with the RAI board of 
directors, J.P. Morgan derived the ranges of implied equity values for RAI and BAT set forth 
below:  
Preliminary Analyses of RAI  
  
  
•   A preliminary public trading multiples analysis for RAI, using the preliminary RAI 
projections and focusing on the same six companies identified above under “Opinion of 
J.P. Morgan—Analysis of RAI—Public Trading Multiples Analysis,” indicated ranges of 
implied equity value per share of RAI  
  
  
common stock, rounded to the nearest $0.25, of (1) $38.75 to $52.00 applying a 
FV/2017E EBITDA multiple range of 10.5x to 13.5x and (2) $37.50 to $50.00 applying a 
P/E 2017E multiple range of 15.0x to 20.0x.  
  
  
•   A preliminary selected transaction multiples analysis for RAI, using the preliminary RAI 
projections and focusing on the same nineteen transactions identified above under 
“Opinion of J.P. Morgan—Analysis of RAI—Selected Transaction Multiples Analysis,” 
indicated ranges of implied equity value per share of RAI common stock, rounded to the 
nearest $0.25, of (1) $42.00 to $58.75 applying a FV/2016E EBITDA multiple range of 
12.0x to 16.0x and (2) $43.00 to $60.00 applying a FV/2016E EBITDA multiple range of 
12.0x to 16.0x (with 2016E EBITDA being adjusted, at the direction of the management 
of RAI, for certain cost synergies related to RAI’s acquisition of Lorillard).  
  
  
•   A preliminary discounted cash flow analysis for RAI, using the preliminary RAI 
projections and applying a terminal growth rate ranging from 0.0% to 1.0% and a range 
of discount rates from 6.0% to 7.0%, indicated a range of implied equity value per share 
of RAI common stock, rounded to the nearest $0.25, of $45.75 to $65.00.  
Preliminary Analyses of BAT  
  
  
•   A preliminary public trading multiples analysis for BAT, using the preliminary RAI 
projections for BAT and focusing on the same six companies identified under “Opinion 
of J.P. Morgan—Analysis of BAT—Public Trading Multiples Analysis,” indicated ranges 
of implied equity value per BAT ordinary share, rounded to the nearest £0.25, of (1) 
£43.00 to £58.25 applying a FV/2017E EBITDA multiple range of 10.5x to 13.5x and (2) 
£42.50 to £56.75 applying a P/E 2017E multiple range of 15.0x to 20.0x.  
  
  
•   A preliminary discounted cash flow analysis for BAT, using the preliminary RAI 
projections for BAT and applying a terminal growth rate ranging from 0.0% to 1.0% and 
a range of discount rates from 7.0% to 8.0%, indicated a range of implied equity value 
per BAT ordinary share, rounded to the nearest £0.25, of £40.00 to £54.50.  
December 7, 2016 Materials  
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The December 7, 2016 materials discussed with the RAI board of directors included, among 
other information, a summary of BAT’s October 20 Proposal and December 5 Proposal, 
summaries of the preliminary RAI projections and the preliminary RAI projections for BAT and 
a discussion of potential synergies and tax efficiencies to be achieved in a potential transaction as 
estimated by RAI and BAT and the implications thereof for a potential transaction.  
The December 7, 2016 materials also included, among other information, public trading 
multiples analyses, selected transaction multiples analyses, discounted cash flow analyses, 
historical trading ranges and analyst price targets, illustrative value creation analyses and an 
analysis of historical premia paid by shareholders acquiring companies in which such 
shareholders already owned a significant portion of the stock. Based on certain of these 
preliminary financial analyses and for purposes of discussing BAT’s October 20 Proposal and 
December 5 Proposal with the RAI board of directors, J.P. Morgan derived the ranges of implied 
equity values for RAI and BAT set forth below:  
Preliminary Analyses of RAI  
  
  
•   A preliminary public trading multiples analysis for RAI, using the preliminary RAI 
projections and focusing on the same six companies identified above under “Opinion of 
J.P. Morgan—Analysis of RAI —Public Trading Multiples Analysis,” indicated ranges of 
implied equity value per share of RAI common stock, rounded to the nearest $0.25, of 
(1) $36.50 to $49.75 applying a FV/2017E EBITDA multiple range of 10.0x to 13.0x and 
(2) $36.25 to $48.75 applying a P/E 2017E multiple range of 14.5x to 19.5x.   
  
•   A preliminary selected transaction multiples analysis for RAI, using the preliminary RAI 
projections and focusing on the same nineteen transactions identified above under 
“Opinion of J.P. Morgan—Analysis of RAI —Selected Transaction Multiples Analysis,” 
indicated ranges of implied equity value per share of RAI common stock, rounded to the 
nearest $0.25, of (1) $42.00 to $58.75 applying a FV/2016E EBITDA multiple range of 
12.0x to 16.0x and (2) $43.00 to $60.00 applying a FV/2016E EBITDA multiple range of 
12.0x to 16.0x (with 2016E EBITDA being adjusted, at the direction of the management 
of RAI, for certain cost synergies related to RAI’s acquisition of Lorillard).  
  
  
•   A preliminary discounted cash flow analysis for RAI, using the preliminary RAI 
projections and applying a terminal growth rate ranging from 0.0% to 1.0% and a range 
of discount rates from 5.75% to 6.75%, indicated a range of implied equity value per 
share of RAI common stock, rounded to the nearest $0.25, of $47.75 to $69.00.  
Preliminary Analyses of BAT  
  
  
•   A preliminary public trading multiples analysis for BAT, using the preliminary RAI 
projections for BAT and focusing on the same six companies identified under “Opinion 
of J.P. Morgan—Analysis of BAT—Public Trading Multiples Analysis,” indicated ranges 
of implied equity value per BAT ordinary share, rounded to the nearest £0.25, of (1) 
£40.50 to £55.75 applying a FV/2017E EBITDA multiple range of 10.0x to 13.0x and (2) 





•   A preliminary discounted cash flow analysis for BAT using the preliminary RAI 
projections for BAT and applying a terminal growth rate ranging from 0.0% to 1.0% and 
a range of discount rates from 6.75% to 8.0%, indicated a range of implied equity value 
per BAT ordinary share, rounded to the nearest £0.25, of £40.25 to £57.00.  
December 20, 2016 Materials  
The December 20, 2016 materials discussed with the RAI board of directors included, 
among other information, a summary of BAT’s October 20 Proposal, December 5 Proposal and 
December 20 Proposal, an illustrative discussion of the effect of an increase in the stock portion 
of the proposed transaction consideration to be paid by BAT on the implied offer price per share 
of RAI common stock and an illustrative overview of the effect of different share prices for BAT 
on the implied offer price per share of RAI common stock.  
The December 20, 2016 materials also included, among other information, illustrative value 
creation analyses, historical trading ranges and analyst price targets, an illustrative 
accretion/dilution analysis and, for purposes of discussing BAT’s October 20 Proposal, 
December 5 Proposal and December 20 Proposal, the same public trading multiples analysis, 
selected transactions multiples analysis and discounted cash flow analysis with the same ranges 
of implied equity values per share of RAI common stock that were included in the December 7, 
2016 materials described above.  
January 10, 2017 Materials  
The January 10, 2017 materials discussed with the RAI board of directors included, among 
other information, a summary of BAT’s October 20 Proposal, December 5 Proposal and 
December 20 Proposal and an illustrative overview of the effect of different exchange ratios on 
the implied offer price per share of RAI common stock.  
The January 10, 2017 materials also included, among other information, an analysis of 
historical premia paid by shareholders acquiring the remaining outstanding stock of U.S. 
companies in which such shareholders already owned 30% to 49% of the target company’s 
stock. For purposes of this analysis, J.P. Morgan reviewed the premia paid in 27 closed 
transactions from 1995 until June 30, 2016, each with a total enterprise value of greater than $1.0 
billion. Using information from Dealogic and Bloomberg, premia paid were calculated as a  
 percentage by which the per share consideration paid in each such transaction exceeded the 
closing price per share of the relevant target company one week prior to the transaction 
announcement. The analysis indicated a range of premia paid of (6.0)% to 80.1%, a median 
premium of 20.5% and a mean premium of 24.0%.  
January 14, 2017 Materials  
The January 14, 2017 materials discussed with the RAI board of directors included, among 
other information, a summary of BAT’s October 20 Proposal and January 10 Proposal.  
Each of the J.P. Morgan preliminary financial analyses was subsequently updated and 
refined by J.P. Morgan. Each of the J.P. Morgan preliminary financial analyses was based on 
market, economic and other conditions as in effect on, and the information made available to J.P. 
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Morgan as of, the dates on which J.P. Morgan performed such analyses. Accordingly, the results 
of the J.P. Morgan preliminary financial analyses and other information differed due to changes 
in those conditions. Among other things, the results of certain financial analyses changed as the 
management of RAI revised or adjusted its financial forecasts for RAI and as the management of 
RAI provided J.P. Morgan certain financial forecasts for BAT, which were based in part on 
certain financial information for BAT prepared by the management of the BAT Group and 
provided to RAI.  
  
B. ANNEX C TO PROXY STATEMENT, FAIRNESS OPINION OF JP 
MORGAN 
 
Annex C  
  
 
January 16, 2017  
The Board of Directors  
Reynolds American Inc.  
401 North Main Street  
Winston-Salem, NC 27101  
Members of the Board of Directors:  
You have requested our opinion as to the fairness, from a financial point of view, to the holders 
of common stock, par value $0.0001 per share (the “Company Common Stock”), of Reynolds 
American Inc. (the “Company”) (other than the Acquiror or any Parent Subsidiaries (as defined 
below)) of the consideration to be paid to such holders in the proposed merger (the 
“Transaction”) of the Company with a wholly-owned subsidiary of British American Tobacco 
p.l.c. (the “Acquiror”). Pursuant to the Agreement and Plan of Merger (the “Agreement”), among 
the Company, the Acquiror, BATUS Holdings Inc. (the “US Acquiror”) and the Acquiror’s 
subsidiary, Flight Acquisition Corporation (“Acquisition Sub” and, together with the Acquiror 
and the US Acquiror, the “Acquiror Group”), the Company will become a wholly-owned 
subsidiary of the Acquiror, and each outstanding share of Company Common Stock, other than 
shares of Company Common Stock owned by the Acquiror or any Parent Subsidiaries (as 
defined in the Agreement) and other than Dissenting Shares (as defined in the Agreement), will 
be converted into the right to receive consideration per share equal to (i) $29.44 in cash (the 
“Cash Consideration”) and (ii) a number of American depositary shares of the Acquiror (the 
“Acquiror ADSs”) equal to 0.5260 divided by the number of ordinary shares, par value 25 
British pence per share, of the Acquiror (the “Acquiror Ordinary Shares”) represented by one 
Acquiror ADS as of the effective time of the Transaction (the “Stock Consideration” and, 
together with the Cash Consideration, the “Consideration”).  
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In connection with preparing our opinion, we have (i) reviewed a draft dated January 16, 2017 of 
the Agreement; (ii) reviewed certain publicly available business and financial information 
concerning the Company and the Acquiror and the industries in which they operate; 
(iii) compared the proposed financial terms of the Transaction with the publicly available 
financial terms of certain transactions involving companies we deemed relevant and the 
consideration paid for such companies; (iv) compared the financial and operating performance of 
the Company and the Acquiror with publicly available information concerning certain other 
companies we deemed relevant and reviewed the current and historical market prices of the 
Company Common Stock, the Acquiror Ordinary Shares and the Acquiror ADSs and certain 
publicly traded securities of such other companies; (v) reviewed certain internal financial 
analyses and forecasts prepared by the management of the Company relating to the businesses of 
each of the Company and the Acquiror (which, in the case of the forecasts for the Acquiror, were 
based in part on certain financial information for the Acquiror prepared by the management of 
the Acquiror and provided to the Company), as well as the estimated amount and timing of the 
cost savings and related expenses and synergies expected to result from the Transaction (the 
“Synergies”); and (vi) performed such other financial studies and analyses and considered such 
other information as we deemed appropriate for the purposes of this opinion.  
In addition, we have held discussions with certain members of the management of the Company 
and the Acquiror with respect to certain aspects of the Transaction, and the past and current 
business operations of the Company and the Acquiror, the financial condition and future 
prospects and operations of the Company and the Acquiror, the effects of the Transaction on the 
financial condition and future prospects of the Company and the Acquiror, and certain other 
matters we believed necessary or appropriate to our inquiry.  
  
In giving our opinion, we have relied upon and assumed the accuracy and completeness of all 
information that was publicly available or was furnished to or discussed with us by the Company 
and the Acquiror or otherwise reviewed by or for us. We have not independently verified any 
such information or its accuracy or completeness and, pursuant to our engagement letter with the 
Company, we did not assume any obligation to undertake any such independent verification. We 
have not conducted or been provided with any valuation or appraisal of any assets or liabilities, 
nor have we evaluated the solvency of the Company or the Acquiror Group under any state or 
federal laws relating to bankruptcy, insolvency or similar matters. In relying on financial 
analyses and forecasts provided to us or derived therefrom, including the Synergies, we have 
assumed that they have been reasonably prepared based on assumptions reflecting the best 
currently available estimates and judgments by management as to the expected future results of 
operations and financial condition of the Company and the Acquiror to which such analyses or 
forecasts relate. We express no view as to such analyses or forecasts (including the Synergies) or 
the assumptions on which they were based. We have also assumed that the Transaction and the 
other transactions contemplated by the Agreement will have the tax consequences described in 
discussions with, and materials furnished to us by, representatives of the Company, and will be 
consummated as described in the Agreement, and that the definitive Agreement will not differ in 
any material respects from the draft thereof furnished to us. We have also assumed that the 
representations and warranties made by the Company and the Acquiror Group in the Agreement 
and the related agreements are and will be true and correct in all respects material to our analysis. 
We are not legal, regulatory or tax experts and have relied on the assessments made by advisors 
to the Company with respect to such issues. We have further assumed that all material 
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governmental, regulatory or other consents and approvals necessary for the consummation of the 
Transaction will be obtained without any adverse effect on the Company or the Acquiror or on 
the contemplated benefits of the Transaction.  
Our opinion is necessarily based on economic, market and other conditions as in effect on, and 
the information made available to us as of, the date hereof. It should be understood that 
subsequent developments may affect this opinion and that we do not have any obligation to 
update, revise, or reaffirm this opinion. Our opinion is limited to the fairness, from a financial 
point of view, of the Consideration to be paid to the holders of the Company Common Stock 
(other than the Acquiror or any Parent Subsidiaries) in the proposed Transaction and we express 
no opinion as to the fairness of any consideration to be paid in connection with the Transaction 
to the holders of any other class of securities, creditors or other constituencies of the Company or 
as to the underlying decision by the Company to engage in the Transaction. Furthermore, we 
express no opinion with respect to the amount or nature of any compensation to any officers, 
directors, or employees of any party to the Transaction, or any class of such persons relative to 
the Consideration to be paid to the holders of the Company Common Stock in the Transaction or 
with respect to the fairness of any such compensation. We are expressing no opinion herein as to 
the price at which the Company Common Stock, the Acquiror Ordinary Shares or the Acquiror 
ADSs will trade at any future time.  
We note that we were not authorized to and did not solicit any expressions of interest from any 
other parties with respect to the sale of all or any part of the Company or any other alternative 
transaction.  
We have acted as financial advisor to the Company with respect to the proposed Transaction and 
will receive a fee from the Company for our services, a substantial portion of which will become 
payable only if the proposed Transaction is consummated. In addition, the Company has agreed 
to indemnify us for certain liabilities arising out of our engagement. During the two years 
preceding the date of this letter, we and our affiliates have had commercial or investment 
banking relationships with the Company and the Acquiror, for which we and such affiliates have 
received customary compensation. Such services during such period have included acting as sole 
arranger and bookrunner on an amendment and extension of the Company’s revolving credit 
facility in October 2015 and on an extension of such facility in November 2016, as lead left 
arranger and bookrunner on the Company’s syndicated facility in June 2015, as bookrunner on 
an offering of debt securities by the Company in July 2015, as M&A financial advisor to the 
Company on its sale of Natural American Spirit in January 2016, as joint bookrunner on an 
offering of debt securities by the Acquiror in June 2015 and as joint bookrunner on an offering of 
debt securities by the Acquiror in September 2016. During such period, we and our affiliates 
have provided treasury and asset management services to the Company and asset management 
services to the Acquiror, in each case for customary compensation. In addition, our commercial 
banking affiliate is an agent bank and a lender under outstanding credit facilities of the 
Company, for which it receives customary compensation or other financial benefits. In addition, 
we and our affiliates hold, on a proprietary basis, less than 1% of the outstanding Company 
Common Stock and Acquiror Ordinary Shares (including Acquiror Ordinary Shares represented 
by Acquiror ADSs). In the ordinary course of our businesses, we and our affiliates may actively 
trade the debt and equity securities or financial instruments (including derivatives, bank loans or 
other obligations) of the Company or the Acquiror for our own account or for the accounts of 
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customers and, accordingly, we may at any time hold long or short positions in such securities or 
other financial instruments.  
On the basis of and subject to the foregoing, it is our opinion as of the date hereof that the 
Consideration to be paid to the holders of the Company Common Stock (other than the Acquiror 
or any Parent Subsidiaries) in the proposed Transaction is fair, from a financial point of view, to 
such holders.  
The issuance of this opinion has been approved by a fairness opinion committee of J.P. Morgan 
Securities LLC. This letter is provided to the Board of Directors of the Company (in its capacity 
as such) in connection with and for the purposes of its evaluation of the Transaction. This 
opinion does not constitute a recommendation to any shareholder of the Company as to how such 
shareholder should vote with respect to the Transaction or any other matter. This opinion may 
not be disclosed, referred to, or communicated (in whole or in part) to any third party for any 
purpose whatsoever except with our prior written approval. This opinion may be reproduced in 
full in any proxy or information statement mailed to shareholders of the Company but may not 
otherwise be disclosed publicly in any manner without our prior written approval.  
Very truly yours,  
J.P. MORGAN SECURITIES LLC  
/s/ J.P. Morgan Securities LLC  
 
 
§ 1.1 LAZARD’S OPINION TO RAI’S BOARD 
C. PROXY DISCUSSION OF OPINION OF LAZARD 
Opinions of RAI’s Financial Advisors  
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in 
connection with the merger. In connection with this engagement, the RAI board of directors 
requested that RAI’s financial advisors deliver the opinions described below. * * *  
Opinion of Lazard  
On January 16, 2017, at a meeting of the RAI board of directors held to evaluate the 
merger, Lazard rendered to the RAI board of directors an oral opinion, which was confirmed by 
delivery of a written opinion dated January 16, 2017, to the effect that, as of that date and based 
upon and subject to the matters described in its opinion, the merger consideration per share of 
RAI common stock, consisting of (1) a number of BAT ADSs representing 0.5260 of a BAT 
ordinary share plus (2) $29.44 in cash to be paid to holders of shares of RAI common stock, 
other than the BAT Group and excluded holders, was fair, from a financial point of view, to such 
holders. For purposes of this section, excluded holders means holders of shares of RAI common 
stock who have not voted, or caused or permitted to be voted, any shares of RAI common stock 
in favor of the adoption of the plan of merger, as defined in the merger agreement, at the special 
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meeting and who have properly asserted (and not lost or effectively withdrawn) their rights of 
appraisal in accordance with Article 13 of the NCBCA.  
The full text of Lazard’s written opinion, dated January 16, 2017, to the RAI board of 
directors which sets forth, among other things, the procedures followed, assumptions made, 
matters considered and limitations on the scope of review undertaken, is attached to this proxy 
statement/prospectus as Annex D and is incorporated into this proxy statement/prospectus by 
reference. The summary of Lazard’s opinion set forth in this proxy statement/prospectus is 
qualified in its entirety by reference to the full text of Lazard’s written opinion attached as Annex 
D. You are encouraged to read Lazard’s opinion and this section carefully and in their entirety. 
Lazard’s opinion was for the benefit of the RAI board of directors (in its capacity as such) 
and Lazard’s opinion was rendered to the RAI board of directors in connection with its 
evaluation of the merger. Lazard’s opinion was not intended to and does not constitute a 
recommendation to any RAI shareholder as to how such shareholder should vote or act 
with respect to the merger or any matter relating thereto.  
In connection with its opinion, Lazard:  
  
  
•   reviewed the financial terms and conditions of the merger agreement, dated as of 
January 16, 2017;  
  
  
•   reviewed certain publicly available historical business and financial information relating 
to RAI and BAT;  
  
  
•   reviewed certain internal financial analyses and forecasts prepared by the management of 
RAI relating to the business of each of RAI and BAT (which, in the case of the forecasts 
for BAT, were based in part on certain financial information for BAT prepared by the 
management of BAT and provided to RAI), and the projected synergies and other 
benefits, including the amount and timing thereof, anticipated by the management of RAI 
to be realized from the merger;  
  
  
•   held discussions with members of the senior management of RAI with respect to the 
businesses and prospects of RAI and BAT, respectively, and the projected synergies and 
other benefits anticipated by the management of RAI to be realized from the merger;  
  
  
•   reviewed public information with respect to certain other companies in lines of business 




•   reviewed the financial terms of certain business combinations involving companies in 
lines of business Lazard believed to be generally relevant in evaluating the businesses of 
RAI and BAT, respectively;  
  
  
•   reviewed historical stock prices and trading volumes of RAI common stock and BAT 





•   reviewed the potential pro forma financial impact of the merger on BAT based on the 
financial forecasts referred to above relating to RAI and BAT; and  
  
  
•   conducted such other financial studies, analyses and investigations as Lazard deemed 
appropriate.  
Lazard assumed and relied upon the accuracy and completeness of the foregoing 
information, without independent verification of such information. Lazard did not conduct any 
independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of 
RAI or BAT or concerning the solvency or fair value of RAI or BAT, and Lazard was not 
furnished with any such valuation or appraisal. At the direction of the RAI board of directors, for 
purposes of its analysis, Lazard utilized forecasts with respect to BAT and the synergies and 
other benefits anticipated to result from the merger that were prepared by management of RAI 
and were based, in part, on financial information provided by BAT to RAI and, as the RAI board 
of directors knew, Lazard did not have discussions with management of BAT in connection with 
the merger. With respect to the financial forecasts utilized in Lazard’s analyses, including those 
related to projected synergies and other benefits anticipated by the management of RAI to be 
realized from the merger, Lazard assumed, with the consent of RAI, that they have been 
reasonably prepared on bases reflecting the best currently available estimates and judgments as 
to the future financial performance of RAI and BAT, respectively, and such synergies and other 
benefits. Lazard expressed no view as to any such forecasts or the assumptions on which they are 
based.  
Further, Lazard’s opinion was necessarily based on economic, monetary, market and other 
conditions as in effect on, and the information made available to Lazard as of, the date of the 
opinion. Lazard assumed no responsibility for updating or revising its opinion based on 
circumstances or events occurring after the date thereof. Lazard did not express any opinion as to 
the prices at which shares of RAI common stock, BAT ordinary shares or BAT ADSs may trade 
at any time subsequent to the announcement of the merger. In connection with Lazard’s 
engagement, Lazard was not authorized to, and Lazard did not, solicit indications of interest 
from third parties regarding a potential transaction with RAI. In addition, Lazard’s opinion did 
not address the relative merits of the merger as compared to any other transaction or business 
strategy in which RAI might engage or the merits of the underlying decision by RAI to engage in 
the merger.  
In rendering its opinion, Lazard assumed, with the consent of RAI, that the merger would 
be completed on the terms described in the merger agreement, without any waiver or 
modification of any material terms or conditions. Lazard also assumed, with the consent of RAI, 
that obtaining the necessary governmental, regulatory or third-party approvals and consents for 
the merger would not have an adverse effect on RAI, BAT or the merger. Lazard did not express 
any opinion as to any tax or other consequences that might result from the merger, nor did its 
opinion address any legal, tax, regulatory or accounting matters, as to which Lazard understood 
that RAI obtained such advice as it deemed necessary from qualified professionals. Lazard 
expressed no view or opinion as to any terms or other aspects (other than the merger 
consideration to the extent expressly specified in the opinion) of the merger, including, without 
limitation, the form or structure of the merger or any agreements or arrangements entered into in 
connection with, or contemplated by, the merger. In addition, Lazard expressed no view or 
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opinion as to the fairness of the amount or nature of, or any other aspects relating to, the 
compensation to any officers, directors or employees of any parties to the merger, or class of 
such persons, relative to the merger consideration or otherwise. The issuance of Lazard’s opinion 
was approved by the Opinion Committee of Lazard.  
  
In preparing its opinion to the RAI board of directors, Lazard performed a variety of 
financial and comparative analyses. The following is a brief summary of the material financial 
and comparative analyses that Lazard deemed to be appropriate for this type of transaction and 
that were reviewed with the RAI board of directors by Lazard in connection with rendering its 
opinion. The summary of Lazard’s analyses described below is not a complete description of the 
analyses underlying Lazard’s opinion. The preparation of a fairness opinion is a complex 
analytical process involving various determinations as to the most appropriate and relevant 
methods of financial analysis and the application of those methods to the particular 
circumstances and, therefore, is not readily susceptible to partial or summary description. In 
arriving at its opinion, Lazard considered the results of all of the analyses undertaken by it and 
assessed as a whole and did not draw, in isolation, conclusions from or with regard to any one 
factor or method of analysis considered by it. Rather, Lazard made its determination as to 
fairness on the basis of its experience and professional judgment after considering the results of 
all of the analyses. Accordingly, Lazard believes that its analyses must be considered as a whole 
and that selecting portions of its analyses and factors or focusing on information presented in 
tabular format, without considering all analyses and factors or the narrative description of the 
analyses, could create a misleading or incomplete view of the processes underlying its analyses 
and opinion.  
In its analyses, Lazard considered industry performance, general business, economic, 
market and financial conditions and other matters, many of which are beyond the control of RAI 
or BAT. No company or business used in Lazard’s analyses is identical to RAI or BAT, and such 
analyses may not necessarily utilize all companies or businesses that could be deemed 
comparable to RAI or BAT. Accordingly, an evaluation of the results of those analyses is not 
entirely mathematical. Rather, the analyses involve complex considerations and judgments 
concerning financial and operating characteristics and other factors that could affect the public 
trading or other values of the companies analyzed. The estimates contained in Lazard’s analyses 
and the ranges of valuations resulting from any particular analysis are not necessarily indicative 
of actual values or predictive of future results or values, which may be significantly more or less 
favorable than those suggested by the analyses. In addition, analyses relating to the value of 
businesses or securities do not purport to be appraisals or to reflect the prices at which businesses 
or securities actually may be sold. Accordingly, the estimates used in, and the results derived 
from, Lazard’s analyses are inherently subject to substantial uncertainty.  
The merger consideration was determined through negotiations between the Transaction 
Committee and BAT and was approved by the RAI board of directors, after unanimous 
recommendation and approval by the Transaction Committee. Lazard was not requested to, and 
it did not, recommend the specific merger consideration payable in the merger or that any given 
merger consideration constituted the only appropriate consideration for the merger. The decision 
to enter into the merger agreement was solely that of the RAI board of directors and the opinion 
of Lazard was only one of many factors taken into consideration by the RAI board of directors in 
its evaluation of the merger. Consequently, the analyses described below should not be viewed as 
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determinative of the views of the RAI board of directors, the Transaction Committee or RAI’s 
management with respect to the merger or the merger consideration.  
The financial analyses summarized below include information presented in tabular 
format. In order to fully understand Lazard’s financial analyses, the tables must be read 
together with the text of each summary. The tables alone do not constitute a complete 
description of the financial analyses. Considering the data in the tables below without 
considering the full narrative description of the financial analyses, including the 
methodologies and assumptions underlying the analyses, could create a misleading or 
incomplete view of Lazard’s financial analyses. Except as otherwise noted, the following 
quantitative information, to the extent that it is based on market data, is based on market 
data as it existed on or before January 13, 2017, the last trading day for RAI common stock 
and BAT ADSs before the public announcement of the merger, and is not necessarily 
indicative of current market conditions.  
  
Introduction  
As more fully described below, Lazard performed (1) with respect to each of RAI and BAT, 
discounted cash flow analyses on a stand-alone basis and selected comparable company 
analyses, (2) with respect to RAI, selected precedent transactions analyses and (3) “has-gets” 
analyses from the perspective of the holders of RAI common stock (other than the BAT Group 
and excluded holders).  
The merger consideration to be paid by BAT in the merger consists of (1) a number of BAT 
ADSs representing 0.5260 of a BAT ordinary share plus (2) $29.44 in cash. Based on the closing 
price of BAT ADSs of $115.21 (each BAT ADS then representing two BAT ordinary shares) on 
January 13, 2017 ($57.61 after giving effect to the BAT ADS ratio change), the last trading day 
of the BAT ADSs before the public announcement of the merger agreement, the merger 
consideration represented approximately $59.74 in value per share of RAI common stock. For 
purposes of these analyses, Lazard assumed a Sterling-Dollar exchange rate as of January 13, 
2017 of 1.2186 $/£.  
Discounted Cash Flow Analyses  
Lazard performed the following discounted cash flow analyses with respect to each of RAI 
and BAT. Financial forecasts and other data for RAI and BAT on a stand-alone basis were 
provided by RAI. See “—RAI Unaudited Prospective Financial Information” beginning on page 
108 of this proxy statement/prospectus.  
Discounted Cash Flow Analysis. Lazard performed a discounted cash flow analysis to 
calculate the estimated present value, as of December 31, 2016, of the unlevered, after-tax free 
cash flows that each of RAI and BAT, on a stand-alone basis, were forecasted to generate during 
the calendar years 2017 to 2021, based on an estimated range of weighted average cost of capital 
of 5.0% to 6.0% for RAI and 6.0% to 7.0% for BAT. The unlevered, after-tax free cash flows 
were calculated by taking the net operating profit after tax (representing earnings before interest 
after tax), then adding depreciation and amortization, subtracting capital expenditures and 
adjusting for changes in working capital and other cash flow items. Lazard then calculated the 
estimated present value of the terminal values of RAI and BAT, respectively, as of December 31, 
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2016, by selecting, based on its judgment and experience, a range of perpetuity growth rates of 
(0.5)% to 0.5% (which implied exit EBITDA multiples ranging from 9.7x to 14.1x for RAI and 
7.9x to 10.9x for BAT) and an estimated range of weighted average cost of capital of 5.0% to 
6.0% for RAI and 6.0% to 7.0% for BAT. The weighted average cost of capital was derived by 
application of the Capital Asset Pricing Model, taking into account certain metrics including 
target capital structure, the cost of long-term Treasury debt, tax rates, unlevered and levered 
betas for the selected comparable tobacco companies discussed below, including RAI and BAT 
as appropriate, as well as certain financial metrics for the U.S. financial markets generally. 
Lazard then calculated a range of implied per share values of RAI common stock and BAT 
ordinary shares by subtracting the net debt of each of RAI and BAT as of December 31, 2016, 
from the estimated enterprise value using the discounted cash flow method and dividing such 
amount by the fully diluted number of outstanding shares of RAI common stock and BAT 
ordinary shares, respectively. This analysis resulted in the following range of implied per share 
values of RAI common stock and BAT ordinary shares, respectively:  
  
Implied per share values  
of RAI common stock 
on a stand-alone basis    
Implied per share values 
of BAT ordinary shares 
on a stand-alone basis 
$50.03 – $73.38 
   
£44.09 – £54.72 
($53.73 – $66.68) 
Lazard also calculated an implied exchange ratio reference range based on the discounted 
cash flow analysis described above by dividing (1) the low end of the per share value range of 
RAI resulting from the discounted cash flow analysis described above (less the $29.44 per share 
of merger consideration to be paid in cash) by the high end of the per share value range of BAT 
resulting from the discounted cash flow analysis described above and (2) the high end of the per 
share value range of RAI resulting from the discounted cash flow analysis  
  
described above (less the $29.44 per share of merger consideration to be paid in cash) by the low 
end of the per share value range of BAT resulting from the discounted cash flow analysis 
described above. This analysis resulted in an implied exchange ratio of 0.3088x to 0.8178x and 
an implied pro forma ownership range for the holders of RAI common stock of 12.1% to 26.6%. 
The exchange ratio provided for in the merger agreement is 0.5260x resulting in a pro forma 
ownership for the holders of RAI common stock of 18.9%.  
Selected Comparable Company Analyses  
Lazard reviewed and analyzed certain financial information, valuation multiples and market 
trading data related to selected publicly traded tobacco companies whose business and operations 
Lazard believed, based on its judgment and experience, including with companies in the tobacco 
industry, to be similar to each of RAI’s and BAT’s business and operations for purposes of these 
analyses, considering, among other factors, business sector participation, financial metrics and 
form of operations, including product mix, end markets, customers and size, of such companies.  
The selected companies used in these analyses, which are referred to in this proxy 
statement/prospectus as the selected comparable tobacco companies, were divided into two 
categories as follows:  
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Global Majors  
  
  •   Philip Morris International;  
  
  •   BAT;  
  
  •   Japan Tobacco Inc.; and  
  
  •   Imperial Brands.  
US/European  
  
  •   Altria Group;  
  
  •   RAI;  
  
  •   Swedish Match; and  
  
  •   Scandinavian Tobacco.  
Although none of the selected comparable tobacco companies (other than RAI and BAT) 
included in the selected comparable company analyses is identical or directly comparable to RAI 
or BAT, the selected comparable tobacco companies included were chosen because they are 
publicly traded companies with certain operations, results, business mixes or product profiles 
that, for the purposes of analysis, may be considered similar to certain operations, results, 
business mixes or product profiles of the RAI Group and the BAT Group.  
  
Lazard calculated and compared various financial multiples and ratios of each of the 
selected comparable tobacco companies, including among other things, the ratio of each 
comparable tobacco company’s (1) enterprise value as a multiple of 2017 calendar year 
estimated EBITDA and (2) share price as a multiple of 2017 calendar year estimated earnings 
per share, referred to as a P/E ratio. The earnings per share and EBITDA estimates for each of 
the selected comparable companies listed above and used by Lazard in its analysis were based on 
information from FactSet Research Systems, which represents publicly available consensus 
estimates, and other public sources. All of these calculations were based on publicly available 
financial data and closing share prices as of January 13, 2017. The results of this analysis are 
summarized in the following table:  
  
    
Share Price 
(as of 
01/13/17)     
EV 
($ in 
billions)     
2017E  
EBITDA 
Multiple     
2017E 
P/E Ratio  
Global Majors                        
Philip Morris 
International    $90.40       $167        13.5x       18.9x   
BAT     £47.30       $86        10.8x       16.7x   
Japan Tobacco 




Brands     £35.90       $57        11.4x       13.1x   
   
High       13.5x       18.9x   
Median       11.1x       16.6x   
Mean       11.5x       16.3x   
Low       10.1x       13.1x   
     
US/European                        
Altria Group     $67.58       $124        12.6x       20.2x   
RAI     $55.97       $91        14.2x       21.9x   
Swedish 
Match     SEK285.10       $6        11.6x       17.2x   
Scandinavian 
Tobacco     DKK121.50      $2        10.0x       12.2x   
   
High       14.2x       21.9x   
Median       12.1x       18.7x   
Mean       12.1x       17.9x   
Low       10.0x       12.2x   
Based on its professional judgment after taking into account, among other things, such 
observed multiples, Lazard selected a range of 2017E EBITDA multiples of 11.0x to 13.0x and a 
range of 2017E P/E ratios of 17.0x to 20.0x for RAI and a range of 2017E EBITDA multiples of 
10.0x to 13.0x and a range of 2017E P/E ratios of 16.0x to 19.0x for BAT. This analysis resulted, 
when applied to corresponding information of RAI and BAT, in the following range of implied 
per share values of RAI common stock and BAT ordinary shares, respectively:  
  
Valuation Methodology    
Implied per share 
values of RAI 
common stock     
Implied per share 
values of BAT 
ordinary shares   
EBITDA Multiple-Based 
   
$ 40.86 – $49.67  
     
£41.79 – £52.04 




   
$ 43.08 – $50.68  
     
£44.74 – £53.13 
($54.52 – $64.74) 
 
 
Lazard also calculated an implied exchange ratio reference range based on the selected 
comparable company analyses described above by dividing (1) the low end of the implied RAI 
per share value range resulting from the selected comparable company analyses described above 
(less the $29.44 per share of merger consideration to be paid in cash) by the high end of the 
implied BAT per share value range resulting from the selected comparable company analyses 
described above and (2) the high end of the implied RAI per share value range resulting from the 
selected comparable company analyses described above (less the $29.44 per share of merger 
consideration to be paid in cash) by the low end of the implied BAT per share value range 
resulting from  
  
the selected comparable company analyses described above. This analysis indicated, on the one 
hand, an EBITDA multiple-based implied exchange ratio of 0.1800x to 0.3972x and an implied 
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pro forma ownership range for the holders of RAI common stock of 7.4% to 15.0%; and, on the 
other hand, a P/E ratio-based implied exchange ratio of 0.2106x to 0.3896x and an implied pro 
forma ownership range for the holders of RAI common stock of 8.5% to 14.7%. The exchange 
ratio provided for in the merger agreement is 0.5260x resulting in a pro forma ownership for the 
holders of RAI common stock of 18.9%.  
Selected Precedent Transactions Analyses  
Lazard performed selected precedent transactions analyses with respect to RAI on a stand-
alone basis by reviewing selected transactions involving the acquisition of a tobacco company 
announced since March 2005 and for which financial information was publicly available, and 
which Lazard viewed, based on its judgment and experience, including with companies in the 
tobacco industry, as generally relevant for purposes of these analyses.  
Although none of the selected transactions included in the selected precedent transactions 
analyses is identical or directly comparable to the merger, the selected transactions included were 
chosen because they involve companies with certain operations, results, business mixes or 
product profiles that, for the purposes of analysis, may be considered similar to certain 
operations, results, business mixes or product profiles of the RAI Group.  
  
For each of the selected transactions, Lazard reviewed, based on publicly available 
information, the enterprise value, implied by each transaction purchase price, as a multiple of 
EBITDA (measured as the most recently available or disclosed LTM EBITDA at the time of the 
announcement of the relevant transaction), for each target company. The results of this analysis 





  Acquirer 
 









ple   
June 2015  
  
BAT  
    TDR   
 
 
$ 603  
  
  12.5x  
February 2015  
  
BAT  
    
Souza Cruz (24.7
%)   
 
 
$         13,741  
  
  15.1x  
July 2014  
  
Imperial Brands  
    RAI   
 
 
$ 7,100  
  
  8.8x  
July 2014  
  
RAI  
    Lorillard   
 
 
$ 27,387  
  
  13.1x  





    Gryson   
 
 
$ 598  
  











   
$ 450  
 
  
  9.9x  
May 2011  
  
BAT  
    Protabaco   
 
 
$ 452  
  
















$ 744  
 
  
  14.0x  
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September 2008  
  
Altria Group  
    UST   
 
 
$ 11,655  
  
  12.2x  






  Rothmans   
  
$ 1,966  
  
  9.6x  
February 2008  
  
BAT  




   
$ 1,720  
  
  11.4x  
February 2008  
  
BAT  







$ 4,089  
  
  11.2x  
November 2007  
  
Altria Group  
    John Middleton   
 
 
$ 2,900  
  
  15.7x  
July 2007  
  
Imperial Brands  
    Altadis   
 
 
$ 22,370  
  
  14.2x  
February 2007  
  
Imperial Brands  







$ 1,899  
  
  10.9x  






  Larkson Tobacco   
  
$ 675  
  
  14.6x  





    Gallaher Group   
 
 
$ 19,036  
  
  12.8x  
April 2006  
  
RAI  
    
Conwood 
Company   
 
 
$ 3,500  
  
  13.5x  










$ 5,120  
  
  14.0x  
 
 
   
 
     
 
     
 
      
  
 
   
 
     
 
     
 
    —     
 
   
 
    High  
 
    
 
    15.7x   
 
   
 
    Median  
 
    
 
    12.5x   
 
   
 
    Mean  
 
    
 
    12.5x   
 
   
 
    Low  
 
    
 
    8.8x  
Based on its professional judgment after taking into account, among other things, such 
observed multiples, Lazard then applied a selected range of EBITDA multiples of 12.0x to 15.0x 
to RAI’s last twelve months, referred to as LTM, EBITDA as of December 31, 2016, and to 
RAI’s LTM adjusted EBITDA as of December 31, 2016, which included adjustments in the 
amount of $113.6 million to reflect the run-rate synergies associated with the Lorillard merger. 
This analysis resulted in the following ranges of implied per share values of RAI common stock, 
respectively:  
  
Implied per share values 
of RAI common stock 
(2016 EBITDA)    
Implied per share values 
of RAI common stock 
(Adjusted 2016 EBITDA) 
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$42.08 – $54.50    $43.03 – $55.69 
  
 “Has-Gets” Analyses from the Perspective of the Holders of RAI Common Stock (Other than 
the BAT Group and Excluded Holders)  
Lazard reviewed and analyzed certain financial information, multiples and ratios in order to 
compare the stand-alone per share value of RAI common stock to the per share value of BAT 
ordinary shares on a pro forma basis after giving effect to the merger from the perspective of the 
holders of RAI common stock (other than the BAT Group and excluded holders). These 
comparison analyses are referred to as the “has-gets” analyses.  
Accordingly, Lazard performed (1) a discounted cash flow analysis, (2) selected 
comparable company analyses based on EBITDA multiples and (3) selected comparable 
company analyses based on P/E ratios, in each case for RAI on a stand-alone basis and for BAT 
on a pro forma basis after giving effect to the merger. The pro forma analyses were conducted 
assuming a merger consideration to be paid by BAT per share of RAI common stock in the 
merger comprised of (1) a number of BAT ADSs representing 0.5260 of a BAT ordinary share 
plus (2) $29.44 in cash. Financial forecasts and other data used for each of these analyses were 
provided by RAI. Lazard factored into its analyses the present value of the illustrative projected 
dividends to be received by the holders of RAI common stock, in each case over the relevant 
time periods.  
Discounted Cash Flow “Has-Gets” Analyses. Lazard performed a discounted cash flow 
analysis to calculate the estimated present value, as of June 30, 2017, of the unlevered, after-tax 
free cash flows that BAT on a pro forma basis after giving effect to the merger was forecasted to 
generate during the calendar years 2017 to 2021, based on an estimated range of weighted 
average cost of capital of 5.5% to 6.5% (which was calculated as the weighted average of BAT 
and RAI standalone weighted average cost of capital, based on 2017E EBITDA). The unlevered, 
after-tax free cash flows were calculated by taking the net operating profit after tax (representing 
earnings before interest after tax), then adding depreciation and amortization, subtracting capital 
expenditures and adjusting for changes in working capital and other cash flow items. Lazard then 
calculated the estimated present value of the terminal values of BAT on a pro forma basis after 
giving effect to the merger, as of June 30, 2017, by selecting, based on its judgment and 
experience, a range of perpetuity growth rates of (0.5)% to 0.5% (which implied exit EBITDA 
multiples ranging from 9x to 12.7x). Lazard then calculated a range of implied per share values 
of BAT ordinary shares on a pro forma basis after giving effect to the merger by subtracting the 
estimated projected net debt of BAT on a pro forma basis after giving effect to the merger as of 
June 30, 2017, from the estimated enterprise value using the discounted cash flow method and 
dividing such amount by the fully diluted number of outstanding shares of BAT ordinary shares 
on a pro forma basis after giving effect to the merger. Lazard then discounted the implied 
projected per share values of BAT ordinary shares on a pro forma basis after giving effect to the 
merger as of June 30, 2017, back to December 31, 2016, using a cost of equity range of 6.09% to 
7.27% underlying the estimated weighted average cost of capital of 5.5% to 6.5%, taking into 
account the present value of the illustrative projected dividends to be received by the holders of 
RAI common stock in the interim. This analysis resulted in the following range of implied per 




     
Implied per share values 
of common stock / 
ordinary shares 
“Has”—RAI (Stand-Alone)    $50.03 – $73.38 
“Gets”—BAT (Pro Forma after 
giving effect to the merger)    $56.31 – $70.14 
EBITDA Multiple-Based “Has-Gets” Analyses. Lazard calculated the projected per share 
values of BAT ordinary shares on a pro forma basis after giving effect to the merger by applying 
a selected range of enterprise value to EBITDA multiples of 10.5x-13.0x (calculated as weighted 
average of RAI multiples and BAT multiples, based on Lazard’s analysis of 2017E EV/EBITDA 
of the selected comparable tobacco companies) to the next 12 months estimated EBITDA as of 
June 30, 2017 of BAT on a pro forma basis after giving effect to the merger adjusted to include 
full run-rate synergies. Lazard then discounted the implied projected per share values of BAT 
ordinary shares on a pro forma basis after giving effect to the merger back to December 31, 
2016, using an implied blended cost of equity, taking into account the present value of the 
illustrative projected dividends to be  
  
received by the holders of RAI common stock in the interim. This analysis resulted in the 
following range of implied per share values of BAT ordinary shares on a pro forma basis after 
giving effect to the merger:  
  
     
Implied per share values 
of common stock / 
ordinary shares 
“Has”—RAI (Stand-Alone)    $40.86 – $49.67 
“Gets”—BAT (Pro Forma after 
giving effect to the merger)    $53.51 – $62.40 
P/E Ratio-Based “Has-Gets” Analyses. Lazard calculated the projected per share values of 
BAT ordinary shares on a pro forma basis after giving effect to the merger by applying a selected 
range of P/E ratios of 16.4x-19.4x (calculated as weighted average of RAI multiples and BAT 
multiples, based on Lazard’s analysis of 2017E net income of the selected comparable tobacco 
companies) to next 12 months estimated earnings per share of BAT on a pro forma basis after 
giving effect to the merger as of June 30, 2017, adjusted to include full run-rate synergies. 
Lazard then discounted the implied projected per share values of BAT ordinary shares on a pro 
forma basis after giving effect to the merger back to December 31, 2016, using an implied 
blended cost of equity, taking into account the present value of the illustrative projected 
dividends to be received by the holders of RAI common stock in the interim. This analysis 
resulted in the following range of implied per share values of BAT ordinary shares on a pro 
forma basis after giving effect to the merger:  
  
     
Implied per share values 
of common stock / 
ordinary shares 
“Has”—RAI (Stand-Alone)    $43.08 – $50.68 
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“Gets”—BAT (Pro Forma after 
giving effect to the merger)    $60.82 – $66.98 
Other Analyses  
The analyses and data relating to RAI and BAT described below were presented to the RAI 
board of directors for reference purposes only and did not provide the basis for, and were not 
otherwise material to, the rendering of Lazard’s opinion.  
Historical Stock Trading  
Lazard reviewed historical data with regard to the range of trading prices of shares of RAI 
common stock for the 52-week period to and including October 20, 2016, the last trading day 
prior to BAT’s announcement of a proposal to merge with RAI. During this period, the intraday 
share price of RAI common stock ranged from a low of $43.38 to a high of $54.48 per share. 
Lazard also observed that, during such period, the intraday share price of BAT ordinary shares 
ranged from £35.36 ($43.09) per share to £51.35 ($62.58) per share.  
Lazard also calculated an implied exchange ratio reference range based on trading prices by 
dividing the low end of the 52-week trading price per share range for RAI (less the $29.44 per 
share of the cash portion of the merger consideration) by the high end of the 52-week trading 
price per share range for BAT and by dividing the high end of the 52-week trading price per 
share range for RAI (less the $29.44 per share of the cash portion of the merger consideration) by 
the low end of the 52-week trading price per share range for BAT. This analysis indicated an 
implied exchange ratio reference range of 0.2228x to 0.5811x and an implied pro forma 
ownership range for the holders of RAI common stock of 9.0% to 20.5%.  
Premiums Paid Analysis  
Lazard reviewed a range of premiums paid in public company transactions closed (1) from 
2011 to 2016, involving U.S. targets and transactions valued more than $500 million and 
(2) from 2005 to 2016, in which significant shareholders with more than 20% ownership of the 
target acquired the remaining shares of such  
  
target. Using a 20%-35% premium range based on the median/mean of premiums paid in the 
transactions referenced above and the RAI unaffected closing price per share as of October 20, 
2016 of $47.17, resulted in an implied price per share range for shares of RAI common stock of 
$56.60 to $63.68.  
Analyst Price Targets  
Lazard reviewed selected equity analyst stock price targets for RAI common stock based on 
publicly available research analyst reports in Bloomberg, which indicated as of October 20, 2016 
target prices that ranged from $47.00 to $62.00 per share.  
Lazard also reviewed recently selected equity analyst stock price targets for BAT ordinary 
shares based on publicly available research analyst reports in Bloomberg, which indicated as of 
October 20, 2016 target prices that ranged from £43.00 ($52.40) to £60.00 ($73.12) per share.  
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Lazard also calculated an implied exchange ratio reference range based on research analyst 
price targets by dividing the low end of the share price target range for RAI (less the $29.44 per 
share of merger consideration to be paid in cash) by the high end of the share price target range 
for BAT and by dividing the high end of the share price target range for RAI (less the $29.44 per 
share of merger consideration to be paid in cash) by the low end of the share price target range 
for BAT. This analysis indicated an implied exchange ratio reference range of 0.2402x to 
0.6214x and an implied pro forma ownership range for the holders of RAI common stock of 
9.6% to 21.6%.  
Miscellaneous  
The RAI board of directors selected Lazard to act as its financial advisor in connection with 
the merger based on Lazard’s qualifications, experience, reputation and familiarity with the RAI 
Group and its business. Lazard is an internationally recognized investment banking firm 
providing a broad range of financial advisory and securities services.  
In connection with Lazard’s services as RAI’s financial advisor, RAI has agreed to pay 
Lazard an aggregate fee of 0.02% of the merger consideration, of which $2.0 million was 
payable on the date of the announcement of the merger and approximately $8 million of which is 
contingent upon the closing of the merger. In addition, RAI may, in its sole discretion, based on 
its assessment of Lazard’s performance of its services, pay Lazard an additional fee in an amount 
to be determined by RAI in its sole discretion. RAI has also agreed to reimburse Lazard for 
certain expenses incurred in connection with Lazard’s engagement and to indemnify Lazard and 
certain related persons under certain circumstances against various liabilities that may arise from 
or be related to Lazard’s engagement, including certain liabilities under U.S. federal securities 
laws. The financial advisory business of Lazard in the past has provided certain investment 
banking services to RAI for which Lazard has received compensation, including, during the two-
year period prior to the date of Lazard’s opinion, having acted as financial advisor to RAI in the 
acquisition by RAI of Lorillard in June 2015 for which Lazard received fees of approximately 
$29.5 million. In the two-year period prior to the date of Lazard’s opinion, the financial advisory 
business of Lazard did not receive any other fees from RAI and was not engaged by BAT to 
provide services for which it received compensation.  
Lazard, as part of its investment banking business, is continually engaged in valuations of 
businesses and securities in connection with mergers and acquisitions, negotiated underwritings, 
secondary distributions of listed and unlisted securities, private placements, leveraged buyouts 
and valuations for other purposes. In addition, in the ordinary course, Lazard and its affiliates 
and employees may trade securities of RAI, BAT and certain of their respective affiliates for 
their own accounts and for the accounts of their customers, may at any time hold a long or short 
position in such securities, and may also trade and hold securities on behalf of RAI, BAT and 
certain of their respective affiliates.  
  
 





Annex D  
  
 
January 16, 2017  
The Board of Directors  
Reynolds American Inc.  
401 North Main Street,  
Winston-Salem, NC 27101  
Dear Members of the Board:  
We understand that Reynolds American Inc., a North Carolina corporation (“Company”), 
British American Tobacco p.l.c., a public limited company incorporated under the laws of 
England and Wales (“Parent”), BATUS Holdings Inc., a Delaware corporation and an indirect 
wholly owned subsidiary of Parent and Flight Acquisition Corporation, a North Carolina 
corporation and an indirect wholly owned subsidiary of Parent (“Sub”), propose to enter into an 
Agreement and Plan of Merger, dated January 16, 2017 (the “Agreement”), pursuant to which 
Parent will acquire Company (the “Transaction”). Pursuant to the Agreement, Sub will be 
merged with and into Company and each outstanding share of the common stock, par value 
$0.0001 per share, of Company (“Company Common Stock”), other than shares of Company 
Common Stock (i) owned by Parent or any subsidiaries of Parent or (ii) owned by holders of 
Company Common Stock who shall have not voted, or caused or permitted to be voted, any 
shares of Company Common Stock in favor of adoption of the Plan of Merger, as defined in the 
Agreement, at the Company Shareholders Meeting, as defined in the Agreement, and who shall 
have properly asserted (and not lost or effectively withdrawn) his, her or its appraisal rights for 
such Company Common Stock in accordance with Article 13 of the North Carolina Business 
Corporations Act, as defined in the Agreement (such holders described in clause (ii), 
collectively, “Excluded Holders”), will be converted into the right to receive (A) $29.44 in cash 
(the “Cash Consideration”) and (B) the number of American depositary shares of Parent 
(“Parent ADSs”) equal to (1) 0.5260 divided by (2) the ADS Ratio, as defined in the Agreement 
(such number of Parent ADSs so issuable, the “Stock Consideration” and, together with the 
Cash Consideration, the “Consideration”). The terms and conditions of the Transaction are 
more fully set forth in the Agreement.  
You have requested our opinion as of the date hereof as to the fairness, from a financial 
point of view, to holders of Company Common Stock (other than Excluded Holders, Parent and 
any subsidiaries of Parent) of the Consideration to be paid to such holders in the Transaction.  
In connection with this opinion, we have:  
  





(ii) Reviewed certain publicly available historical business and financial information relating 
to Company and Parent;  
  
  
(iii) Reviewed certain internal financial analyses and forecasts prepared by the management 
of Company relating to the business of each of Company and Parent (which, in the case 
of the forecasts for Parent, were based in part on certain financial information for Parent 
prepared by the management of Parent and provided to Company), and the projected 
synergies and other benefits, including the amount and timing thereof, anticipated by the 
management of Company to be realized from the Transaction;  
  
  
(iv) Held discussions with members of the senior management of Company with respect to 
the businesses and prospects of Company and Parent, respectively, and the projected 
synergies and other benefits anticipated by the management of Company to be realized 
from the Transaction;  
  
  
(v) Reviewed public information with respect to certain other companies in lines of business 




(vi) Reviewed the financial terms of certain business combinations involving companies in 
lines of business we believe to be generally relevant in evaluating the businesses of 
Company and Parent, respectively;  
  
  
(vii) Reviewed historical stock prices and trading volumes of Company Common Stock and 




(viii) Reviewed the potential pro forma financial impact of the Transaction on Parent based on 
the financial forecasts referred to above relating to Company and Parent; and  
  
  
(ix) Conducted such other financial studies, analyses and investigations as we deemed 
appropriate.  
We have assumed and relied upon the accuracy and completeness of the foregoing 
information, without independent verification of such information. We have not conducted any 
independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of 
Company or Parent or concerning the solvency or fair value of Company or Parent, and we have 
not been furnished with any such valuation or appraisal. At your direction, for purposes of our 
analysis, we utilized forecasts with respect to Parent and the synergies and other benefits 
anticipated to result from the Transaction that were prepared by management of Company and 
were based, in part, on financial information provided by Parent to Company and, as you know, 
we did not have discussions with management of Parent in connection with the Transaction. 
With respect to the financial forecasts utilized in our analyses, including those related to 
projected synergies and other benefits anticipated by the management of Company to be realized 
from the Transaction, we have assumed, with the consent of Company, that they have been 
reasonably prepared on bases reflecting the best currently available estimates and judgments as 
to the future financial performance of Company and Parent, respectively and such synergies and 
104 
 
other benefits. We express no view as to any such forecasts or the assumptions on which they are 
based.  
Further, our opinion is necessarily based on economic, monetary, market and other 
conditions as in effect on, and the information made available to us as of, the date hereof. We 
assume no responsibility for updating or revising our opinion based on circumstances or events 
occurring after the date hereof. We do not express any opinion as to the prices at which shares of 
Company Common Stock, Parent Ordinary Shares or Parent ADSs may trade at any time 
subsequent to the announcement of the Transaction. In connection with our engagement, we 
were not authorized to, and we did not, solicit indications of interest from third parties regarding 
a potential transaction with Company. In addition, our opinion does not address the relative 
merits of the Transaction as compared to any other transaction or business strategy in which 
Company might engage or the merits of the underlying decision by Company to engage in the 
Transaction.  
In rendering our opinion, we have assumed, with the consent of Company, that the 
Transaction will be consummated on the terms described in the Agreement, without any waiver 
or modification of any material terms or conditions. We also have assumed, with the consent of 
Company, that obtaining the necessary governmental, regulatory or third party approvals and 
consents for the Transaction will not have an adverse effect on Company, Parent or the 
Transaction. We do not express any opinion as to any tax or other consequences that might result 
from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting 
matters, as to which we understand that Company obtained such advice as it deemed necessary 
from qualified professionals. We express no view or opinion as to any terms or other aspects 
(other than the Consideration to the extent expressly specified herein) of the Transaction, 
including, without limitation, the form or structure of the Transaction or any agreements or 
arrangements entered into in connection with, or contemplated by, the Transaction. In addition, 
we express no view or opinion as to the fairness of the amount or nature of, or any other aspects 
relating to, the compensation to any officers, directors or employees of any parties to the 
Transaction, or class of such persons, relative to the Consideration or otherwise.  
Lazard Frères & Co. LLC (“Lazard”) is acting as financial advisor to Company in 
connection with the Transaction and will receive a fee for such services, a portion of which is 
payable upon the rendering of this opinion and a substantial portion of which is contingent upon 
the closing of the Transaction. We have in the past provided certain investment banking services 
to Company, for which we have received compensation, including, during the past two years, 
having acted as financial advisor to Company in the acquisition by Company of Lorillard, Inc. in 
June 2015. In addition, in the ordinary course, Lazard and its affiliates and employees may trade 
securities of Company, Parent and certain of their respective affiliates for their own accounts and 
for the accounts of their customers, may at any time hold a long or short position in such 
securities, and may also trade and hold securities on behalf of Company, Parent and certain of 
their respective affiliates. The issuance of this opinion was approved by the Opinion Committee 
of Lazard.  
Our engagement and the opinion expressed herein are for the benefit of the Board of 
Directors of Company (in its capacity as such) and our opinion is rendered to the Board of 
Directors of Company in connection with its evaluation of the Transaction. Our opinion is not 
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intended to and does not constitute a recommendation to any stockholder as to how such 
stockholder should vote or act with respect to the Transaction or any matter relating thereto.  
Based on and subject to the foregoing, we are of the opinion that, as of the date hereof, the 
Consideration to be paid to holders of Company Common Stock (other than Excluded Holders, 
Parent and any subsidiaries of Parent) in the Transaction is fair, from a financial point of view, to 
such holders.  
  
Very truly yours, 
 
LAZARD FRERES & CO. LLC 
  
By  /s/ Maxence de Gennaro  
  Maxence de Gennaro  
  Managing Director 
 
